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Adenomatous Polyposis Coli (APC) encodes a tumour suppressor gene that is
mutated in the majority of colorectal cancers, both inherited and spontaneous.
Germline APC mutations are responsible for the human condition Familial
Adenomatous Polyposis (FAP). Patients with FAP develop colorectal adenomas
some of which eventually progress to malignant carcinomas. In the last few years,
strong evidence of a link between APC mutation and human breast cancer has begun
to accumulate. For example, somatic mutations of the APC gene were detected in up
to 18% of primary breast cancers and it has also been shown that the APC promoter
is frequently hypermethylated in human breast cancers.
The main function of APC as a tumour suppressor involves regulating p-catenin
levels in the canonical Wnt signalling pathway and is mediated through at least three
important functional domains. However, most tumourigenic truncation mutations of
APC eliminate some or all of these motifs, resulting in the oncogenic activation of p-
catenin. Wnts have been shown to be involved in both the normal postnatal
development of the mammary gland and mammary tumourigenesis in mice.
Additionally, aberrant Wnt signalling through ectopic expression ofmutant stabilized
forms of P-catenin or Cyclin D1 (a downstream target of the Wnt signalling
pathway) promote mouse mammary tumourigenesis.
In order to analyse the role of Ape both in the development of the mammary gland
and in mammary tumourigenesis a cre-loxP based strategy was used to conditionally
inactivate Ape in mouse mammary secretory epithelium. Virgin mice harbouring
mammary-specific mutations in Ape showed markedly delayed development of the
mammary ductal network. During lactation, mice developed multiple extensive
metaplastic nodules, which surprisingly never progressed to neoplasia.
Immunohistochemical analysis confirmed that these metaplastic areas had lost Ape
expression. In addition, immunohistochemistry established that Ape mutation causes
P-catenin dysregulation and subsequent activation of Wnt target genes, including
Cyclin Dl. A differential display reverse transcription polymerase chain reaction
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approach was used to identify transcriptional changes in response to loss of Ape in
the mouse mammary gland, with the aim of providing insight into this unexpected
phenotype. Genes identified through this screen included casein, al type IV collagen
and the GM2 ganglioside activator protein, Gm2a. Decreased casein expression in
Ape deleted lactating mammary glands correlated with the observation that offspring
from mutant mothers did not thrive. Additionally, expression levels of al type IV
collagen, which is a component of the mammary gland basement membrane, were no
longer downregulated in lactating mammary glands following conditional
inactivation of Ape. Several novel clones found to be differentially expressed
following Ape deletion were subjected to cDNA library screening in an effort to
characterise them further. Despite these efforts, the relationship between mammary
gland metaplasia and Ape deficiency remains unclear. These observations highlight
the complexity of Ape function in mouse mammary gland secretory epithelium.
Finally, as a complementary analysis, two Wnt genes (Wnt8b and WntlOa) identified
in a screen ofmammary gland cDNA were subcloned and their functions tested in a
range of biochemical and functional assays.
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1 Introduction
1.1 Biology of the mammary gland
1.1.1 Growth and development of the mammary gland
Whilst most mammalian organs are patterned during embryogenesis and maintain
their basic structure through to adult life breast tissue is distinct in that it continually
changes in form throughout the lifetime of the reproductively active female. Once the
mammary gland is established, cycles of proliferation, functional differentiation, and
death of alveolar epithelium occur repeatedly with each pregnancy (reviewed by
Hcnnighausen et al., 1998; Hennighausen et al., 2001) (Fig. 1.1).
Two cellular compartments contribute to the gland, the epithelium and the
surrounding stroma, which are separated by a basement membrane (BM) composed
of extracellular matrix (ECM) proteins (including collagens I and IV, laminin,
fibronectin and tenascin). The mammary stroma consists of multiple components
including adipocytes, pre-adipocytes, fibroblasts, blood vessels, inflammatory cells
and ECM proteins. Development of the mammary gland occurs in defined stages that
are connected to sexual development and reproduction. These are embryonic,
prepubertal, pubertal, pregnancy, lactation and involution. Epithelial-stromal
interactions begin during embryonic development of the mammary gland and in
combination with steroid and peptide hormones are necessary for proper ductal
morphogenesis throughout all stages (Hennighausen et al., 2001).
Initial stages of mammary development are dependent on reciprocal signalling
between the epithelium and the mesenchyme (embryonic stroma). In the mouse this
crosstalk specifies the mammary gland at embryonic day 10 (Hennighausen et al.,
2001) when five pairs of ectodermal placodes appear as distinct spots in the mouse
embryo. These placodes form epithelial buds that are surrounded by a layer of






































































































estrogen, some growth factors, BMP4 and FGF7 (fibroblast growth factor 7), and the
transcription factors Lef-1, Msx-1 and Msx-2. Inactivation of the genes encoding
these transcription factors arrests mammary gland development at the bud stage (van
Genderen et al., 1994; Satokata et al., 2000). Embryonic mammary epithelial cells
produce parathyroid hormone related peptide (PTHrP) that signals through receptors
in the surrounding mesenchyme to promote elongation of the bud. This primary
sprout invades from the nipple into a pad of fatty tissue called the mammary fat pad
and forms a small, branched ductal network in the proximal corner of the fat pad.
Interruption of PTHrP signalling arrests development resulting in a lack of primary
sprout growth from the bud (Wysolmerski et al., 1998; Hennighausen et al., 2001).
Following the embryonic and prepubertal stages, further development of the
mammary gland becomes hormone dependent and continues with the onset of
puberty (around three weeks of age). Ovarian steroid hormones control ductal
outgrowth and studies in mice have shown that deletion of the estrogen receptor a
gene blocks this growth (Korach et al., 1996). Other factors shown to be involved in
ductal outgrowth include Insulin-like growth factor-1 (IGF-1) and Epidermal growth
factor (EGF). IGF-1 is a potent mitogen for epithelial cells and has been shown to be
a survival factor in vitro (O'Connor, 1998). Overexpression of IGF-1 in the mouse
mammary gland delays involution and suggests that IGF-1 acts as a survival factor in
mammary epithelial cells (Hadsell et al., 1996; Neuenschwander et al., 1996). EGF
has been shown to control early ductal outgrowth through an action on stromal cells
and can substitute for estrogen in ovariectomized mice (Silberstein, 2001; Coleman
et al., 1988). The distal ends of the mammary ducts swell into bulbous structures
composed of multiple layers of cuboidal epithelial cells, called terminal end buds
(TEBs). The TEBs are the invading fronts of the ducts that proliferate, extend into
the fat pad and branch by bifurcation until the ducts eventually fill the fat pad by
about 10 weeks of age.
In the first stage of pregnancy, ducts branch laterally and form side branches with
concomitant epithelial proliferation. Alveolar structures then form on the expanded
ductal tree and differentiate into lobular alveoli. Finally, the lobular alveoli
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terminally differentiate and the epithelium becomes secretory, ready to provide milk
for suckling pups upon parturition. At this stage, the epithelium has expanded to
almost fill the mammary gland and the large fat cells have dedifferentiated into small
pre-adipocytes. The hormones of pregnancy, progesterone (PG) and prolactin (PRL)
are required for this continued ductal growth and branching and alveolar proliferation
and differentiation. PRL gene and receptor knockout studies in mice show reduced
ductal branching and impaired alveolar development of the mammary gland
(Horseman, 1999; Brisken et al., 1999), while targeted mutation of the PG receptor
affects lobuloalveolar development (Brisken et al., 1998). Finally, activins and
inhibins, members of the TGF-P superfamily, have been implicated in lobuloalveolar
and ductal growth regulation, as both are impaired in inhibinp gene knockout mice
(Robinson and Hennighausen, 1997).
Mammary function during lactation is controlled by prolactin, secretion of which is
tightly regulated and stimulated by suckling (Travers et al., 1996). Prolactin activates
Signal Transducers and Activators of Transcription (STATs) 5a and 5b, which are
members of a family of cytoplasmic proteins with roles as signal messengers and
transcription factors that participate in normal cellular responses to cytokines and
growth factors (Ihle, 1996). Stat5a deficient mice are unable to lactate because of a
failure of the gland to develop fully and undergo functional differentiation during
pregnancy (Liu et al., 1997). Also Oxytocin and the macrophage growth factor
colony-stimulating factor-1 (CSF-1) are both required for milk ejection during
lactation (Young et al., 1996; Pollard and Hennighausen, 1994)
Upon involution, the secretory epithelium of the mammary gland dies by apoptosis,
the fat cells redifferentiate, and the gland is remodelled back to a virgin-like state.
These three processes are controlled by several factors including Stat3, which
induces apoptosis, possibly through upregulation of Insulin-like growth factor
binding protein-5 (IGFBP-5) a known promoter of apoptosis. IGFBP-5 has been
proposed to induce apoptosis by sequestering IGF-1 to casein micelles, thus
preventing it from binding to its receptor (Tonner et al., 1997). Experiments in mice
with conditional knockout of Stat3 from mammary tissue show decreased apoptosis
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and a dramatic delay in involution following weaning. These mice also show
decreased IGFBP-5 expression (Chapman et al., 1999). Proteinases such as plasmin
(an extracellular serine proteinase) and matrix metalloproteinase-3 (MMP-3) are also
involved in involution and studies in mice have shown that deficiencies in either
affects involution (Alexander et al., 2001; Lund et al., 2000). Matrix
metalloproteinases (MMPs) have been shown to be induced during physiological
remodelling reactions and to cleave structural proteins important to maintaining the
basement membrane integrity (Sternlicht and Werb, 1999). One such MMP, MMP-
3/stromelysin-l, is highly expressed during mammary gland involution and cleaves
basement membrane proteins (Mayer et ah, 1993; Werb, 1997). Stromelysin-1 has
been shown to induce unscheduled apoptosis when expressed ectopically in mouse
mammary glands during late pregnancy due to an acceleration of adipocyte
differentiation (Alexander et al., 2001). Plasmin produced from plasminogen (Pig)
by urokinase-type plasminogen activator (uPA) and tissue-type plasminogen
activator (tPA) also plays a role in mammary gland involution through activation of
latent pro-MMPs and direct degradation of ECM substrates (Stemlicht and Werb,
1999). Pig deficient mice have defects in lactation and one-quarter of the mice
studied failed to lactate. In the absence of Pig involution was perturbed with a
reduction in overall mammary gland size after five days of involution being less than
one-third the reduction seen in wt mice (Lund et al., 2000).
1.1.2 Mammary gland branching morphogenesis
During its developmental cycle, the mammary gland displays many of the properties
associated with tumour progression, such as invasion, reinitiation of cell
proliferation, resistance to apoptosis, and angiogenesis. For example, terminal end
buds (TEBs) are bulbous structures located at the migrating ductal forefront
containing stem cells that proliferate and differentiate in response to hormones, and
invade into stromal tissue. However this end bud extension is inhibited both at the fat
pad boundaries and when it is in proximity to other ducts (Silberstein et al., 2001).
Many of the stromal factors necessary for mammary development promote or protect
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against breast cancer by contributing both instructive and permissive signals,
therefore crosstalk between the mammary epithelium and stroma is crucial for proper
patterning and function of the mammary gland (reviewed in Wiseman and Werb,
2002). This is most evident during mammary gland branching morphogenesis. It has
been shown that when some of the factors involved are mis-expressed it results in
excessive side branching and eventual tumourigenesis (see below) (Sternlicht et al.,
1999, Ha et al., 2001).
The mammary gland branches by two mechanistically distinct processes (1) TEB
bifurcation and (2) sprouting of side branches (Fig. 1.2). Bifurcation of TEBs to form
primary and secondary branches occurs only from immature ducts with formation of
the branch point through stromal deposition at the cleft site. Throughout this process
the distal epithelial cells (cap cells) are separated from the adjacent fat cells by a thin
basement membrane and the ducts extend directly into the adipose tissue (Fig. 1.2.L).
The ECM creates a physical barrier that must be penetrated to allow TEB migration
and branching. This is mediated through epithelial-stromal interactions and factors
that regulate the ECM. These include discoidin domain receptor-1 (DDR-1) and pi
integrin, which both act as receptors for ECM proteins. DDR-1 is a collagen receptor
(collagens type I to type IV) and when knocked out in mice results in defective
ductal morphogenesis, enlarged TEBs due to aberrant growth and increased ECM
deposition (Vogel et al., 2001). pi integrin recognises many ECM proteins and when
inhibited resulted in reduction of both TEB number and the extent of the mammary
ductal network. The result was similar when the ECM protein laminin-1, a pi-
integrin receptor ligand, was inhibited (Klinowska et al., 1999). In addition several
MMPs, including Stromelysin-1, and their inhibitors, tissue inhibitors of
metalloproteinases (Timps) are necessary for invasion of the ducts. By virtue of
regulating MMP activity, Timps may control the rapid physical expansion of
mammary ducts through the ECM by limiting or focusing matrix deposition (Fata et
al., 1999). Stromelysin-1 can degrade numerous ECM substrates, including collagens
III, IV, V, IX, X and XI, laminins and fibronectin and promotes proliferation and
branching in ductal cells (in contrast to its role in differentiated secretory alveolar
















































































































mouse mammary epithelial cells promotes mammary carcinogenesis (Sternlicht el
al., 1999) and overexpression of membrane-type MMP-1 (MTI- MMP) in mouse
mammary glands resulted in adenocarcinoma (Ha et al., 2001). Timps are
predominantly expressed in mammary epithelial cells and are found in advancing
TEBs, however down-regulation of epithelial-derived Timp-1 in transgenic mice by
MMTV promoter-directed antisense RNA expression promotes ductal expansion and
increases the number of ducts (Fata et al., 1999).
In contrast, side branching results in the formation of a new branch from a mature
duct. The region where the bud fonns is defined by a specific downregulation of the
growth factor, transforming growth factor-p (TGF-P). TGF-P is localised to the
periductal ECM in mice and acts to inhibit inappropriate side branching. Inhibition of
TGF-P signalling in mammary stroma resulted in excessive side branching
(Silberstein et al., 2001). The emerging bud then extends through and remodels this
region consisting ofmyoepithelial cells, stroma and ECM to form a side branch (Fig.
1.2.ii.). Again, factors that regulate the ECM are required but also the progesterone
receptor and Wnts. Experiments have shown that the progesterone receptor (PR)
induces Wnt4 in mammary epithelial cells, which then regulates the branching of
neighbouring cells. This is confirmed by the findings that ductal side branching fails
to occur in the absence of the PR from mammary epithelium, progesterone induces
Wnt4 expression and Wnt4 null mammary glands show substantial reduction in
ductal branching (Brisken et al., 1998; Brisken et al., 2000).
1.1.3. Mouse mammary tumour virus (MMTV)
Mouse mammary tumour virus (MMTV) infection can promote mouse mammary
tumourigenesis and MMTV integrations have helped to identify a wide variety of
interesting genes that play a role in mammary development and tumourigenesis.
MMTV is a nonacute transforming retrovirus that infects mammary epithelial cells
and randomly inserts its proviral DNA into the host somatic cell DNA during its
replicative cycle (Ringold et al., 1979; Withers-Ward et al., 1994). Thus MMTV
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induces mammary tumours by acting as an insertional mutagen and activating
transcription of nearby genes (Tekmal et al., 1997). These include members of the
Writ (Nusse and Varmus, 1982; Lee et ah, 1995; Roelink et ah, 1990) and fibroblast
growth factor (Fgf) (Dickson et ah, 1984; MacArthur et ah, 1995; Peters et al., 1989)
gene families. Both Wnts and Fgfs play crucial roles in development by acting as
short-range intercellular signalling molecules and become activated by MMTV due
to the effect of enhancer sequences within the long terminal repeat (LTR) of the
integrated MMTV proviral genome on the transcriptional promoter of the adjacent
affected gene (Callahan and Smith, 2000).
Wntl, originally termed Int-1 (for MMTV integration site 1), was the first
protooncogene to be identified in this way (Nusse and Varmus, 1982) and was the
first mammalian Wnt gene to be discovered. The consequences of ectopic activation
of Wntl in the mammary gland were subsequently recapitulated experimentally in
transgenic mice and resulted in premature ductal branching and lobuloalveolar
hyperplasia, similar to that normally observed in pregnancy, with progression to
mammary adenocarcinoma (Tsukamoto et al., 1988). Roelink et al., 1990 showed
that Wnt3 was also activated by proviral insertion in mouse mammary tumours and
ectopic expression of Wnt10b also results in premature ductal branching and alveolar
development and predisposition to mammary carcinoma (Lane and Leder, 1997).
1.2 Wnt Genes in the mammary gland
The observation that Wntl and Wnt3 were activated by a MMTV provirus in virus -
induced mammary carcinomas suggested that Wnt signalling could control the
growth and differentiation ofmammary epithelial cells (MECs). Although neither of
these genes turned out to be expressed in the normal mammary tissue, other Wnt
genes are expressed and differentially regulated during mouse mammary gland
development (Gavin and McMahon, 1992; Buhler et al., 1993; Huguet et al., 1994;
Olson and Papkoff, 1994; Weber-Hall et al., 1994; Lane and Leder, 1997).
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WntlOb expression occurs beginning at very early stages in the mammary rudiment
and continues into puberty (Lane and Leder, 1997). Wnt2, Wnt5a and Wnt6 are
detected in the stroma at a stage preceding ductal outgrowth. During ductal
development expression of these remains strong but Wnt7b is now also detected.
Wnt4, Wnt5b and Wnt6 are induced during pregnancy and decrease after lactation has
commenced. Some Wnt genes (Wnt2, Wnt5a, Wnt5b and Wnt7b) are re-expressed
during involution (Weber-Hall et al., 1994). Although knockout mice have been
generated for most of the Wnt genes the only one so far to produce a mammary gland
phenotype was Wnt4, which has an essential role in side-branching early in
pregnancy (Brisken et al, 2000).
1.3 The WNT/Wingless Signalling Pathway
1.3.1 Wnts
Wnt genes constitute one of the major families of developmentally significant
signalling molecules with a number of actions in a wide variety of organisms. The
Wnt gene family was first identified in the mouse, when Wntl was discovered to
behave as an oncogene (Nusse and Vamius, 1982). This correlation with tumour
development led to a great deal of study, Wntl homologs were quickly identified in
a wide range of species including human, Caenorhabiditis elegans (C. elegans) and
Drosophila; in the latter the conserved protein was known as wingless (wg)
(Cabrera et al., 1987). The discovery that wg was a Wnt family member suggested
that Wnts may be important in embryonic development and importantly has enabled
the powerful genetics of Drosophila to be applied to understanding Wnt gene
function. Wnt genes are highly conserved between vertebrate species sharing overall
sequence identity and gene structure, and are slightly less conserved between
vertebrates and invertebrates. To date, in vertebrates, 16 Wnt genes have been
identified in Xenopus, 11 in chick, and 12 in zebrafish. Humans have 19 Wnt genes
and there are 18 in the mouse. In invertebrates, Drosophila has seven Wnt genes, C.
elegans has five and Hydra at least one. A useful catalogue of Wnt genes can be
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found at the Writ gene homepage http://www.stanford.edu/~musse/wntwindow.html,
maintained by Roel Nusse.
Wnt genes have been subdivided into two distinct classes, the Wntl class, including:
Wntl/3/3a/8, and the Wnt5a class, including Wnt4/5a and Wnl6. This classification is
based on assays carried out using mammary cell lines and Xenopus embryos. Over-
expression of the Wntl class was found to induce morphological transformations in
C57 and RAC311C mammary epithelial cells and axis duplication in Xenopus
embryos, whilst the Wnt5a class was found to alter morphogenetic movement during
gastrulation resulting in a severe shortening of the axis, when ectopically expressed
in Xenopus embryos (Rijsewijk et al., 1987; Wong et al, 1994; Du et al, 1995).
Wnt proteins are secreted growth factors and have the following characteristic
structural features: an amino terminal signal sequence, potential sites for N-linked
glycosylation and all have 23 or 24 cysteine residues, the spacing ofwhich is highly
conserved suggesting that the folding of Wnt proteins depends on the formation of
multiple intramolecular disulphide bonds (Du et al., 1995) (Fig. 1.3). Once secreted,
Wnt proteins associate with glycosaminoglycans in the extracellular matrix (ECM)
and are bound tightly to the cell surface (Bradley et al., 1990 and Reichsman et al.,
1996).
The Wnt/wingless family of genes play important developmental roles; defining
segment polarity in Drosophila, controlling early lineage and gut development in C.
elegans and have been implicated in determining axis formation in Xenopus
(however there are no data concerning an endogenous Wnt in induction of the
primary axis as no known Wnt is expressed in the right place at the right time)
(Nusslein-Volhard and Roth, 1989; McMahon and Moon, 1989; McMahon and
Moon, 1989; Nusslein-Volhard, 1991; Han, 1997). This importance in development
became obvious through studies of mutations in Wnt genes, for example knocking
out of Wntl resulted in a dramatic loss of a portion of the midbrain and deletion of

























































































































































Wnt2 mutants die perinatally owing to placental defects (Monkley, 1996). Wnt4
mutant mice fail to form kidneys (Stark et al., 1994), have defects in mammary gland
morphogenesis during pregnancy (Brisken et al., 2000), and females fail to form a




For many years the identity of Wnt receptors remained elusive, greatly hampering
understanding ofWnt signalling. However Bhanot et al., (1996), found that members
of the Frizzled (Fzd) gene family can function as Wnt receptors. The frizzled loci of a
wide range of species encode seven pass transmembrane proteins; the cysteine-rich
N-terminal portion being exterior with the C-terminal portion extending into the
cytoplasm (Vinson et al., 1996 and Bhanot et al., 1996). This exterior N-terminal
region, containing 10 highly conserved cysteine residues is believed to interact with
the circulating Wnt proteins and thereby transfer growth signals (Bhanot et al.,
1996). Fzd receptors have been identified in vertebrates and invertebrates; there are
ten known members in humans and mice, four in Drosophila and three in C. elegans.
Most Wnt proteins can bind to multiple Fzd's and vice versa, suggesting that
receptor-ligand interactions are promiscuous. This is observed in Drosophila
embryos where wg like phenotypes are only seen when both fz and Dfz2 (two
Drosophila Fzd genes) are removed (Chen and Struhl, 1999; Bhanot et al., 1999).
It is not completely clear how the interactions of some Wnt and Frizzled pairings can
lead to downstream modulation of the rest of the Wnt pathway. The C-terminal
region of many of the Frizzled molecules contain a S/TXV motif, a candidate for
binding with the PDZ domain (Songyang et al., 1997). Dishevelled, a cytoplasmic
scaffold protein that functions as part of the Wnt pathway, contains one of these
domains at its C-terminus but evidence to date suggests that it does not interact
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directly with Frizzled (Cadigan and Nusse, 1997, Nusse 1997; Nusse et al., 1997).
There is some suggestion that G-protein signalling may be involved. Some
Wnt/Frizzled effects, such as regulation of Protein Kinase C in Xenopus, can be
blocked through the application of G-protein inhibitors while two of the target
proteins in the Wnt/wingless cascade, Axin and Dishevelled, contain motifs found in
other molecules known to be involved in G-Protein signalling (Slusarski et al., 1999;
Fagotto et al., 1999; Sheldahl et al., 1999).
1.3.2.2 Low-density lipoprotein (LDL)-receptor related protein (LRP)
Members of the LDL-receptor related protein (LRP) family have been shown to act
as co-receptors for Wnt proteins. Two members of the vertebrate LRP family, LRP-5
and LRP-6, can bind Wnts and may form a ternary complex with a Wnt and a Fzd
(Tamai et al., 2000). Mutations in LRP-6 in mice result in developmental defects
similar to those seen in mice due to mutations in individual Wnt genes. These defects
included a truncation of the axial skeleton similar to Wnt3a mutant mice,
mid/hindbrain defects of the less severe type observed in Wntl mutant mice and limb
defects reminiscent of those observed in Wnt7a mutant mice (Pinson et al., 2000).
Overexpression of LRP-6 in Xenopus can activate the Wnt pathway and resulted in
axis duplication and overexpression of JTht-responsive genes (Tamai et al., 2000). In
Drosophila, arrow the orthologue of LRP-5 and LRP-6 is, required for optimal Wg
signalling (Wehrli et al., 2000).
1.3.2.3 Heparan Sulphate Proteoglycans (HSPGs)
Heparan sulphate glycosaminoglycans (HSGAGs) are members of the
glycosaminoglycan family, which are complex polysaccharides that are characterised
by a repeat disaccharide unit of uronic acid (either iduronic or glucuronic acid)
linked to a glucosamine. In vivo, HSGAGs are usually found covalently attached to
various core proteins; these HSGAG-protein conjugates are termed heparan sulphate
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proteoglycans (HSPGs). The syndecans and the glypicans are the two main groups of
cell surface HSPGs and are involved in cell signalling at the ECM interface, while
the third group the perlecans are mainly secreted (reviewed in Sasisekharan et al.,
2002).
Studies in Drosophila have shown that responses to Wg require heparan sulphate
proteoglycans, which act as co-receptors during signalling (Lin et al, 1999). Wg
signalling is defective in both sulfateless (sfl) and sugarless (sgl) mutants (two genes
in Drosophila encoding enzymes necessary for the formation of heparan
sulphate)(Cumberledge et al., 1997; Lin et al., 1999). The Drosophila gene dally,
encodes a glypican-type heparan sulphate proteoglycan, which when mutated
disrupts wg signalling and has been shown to cooperate with frizzled as a co-receptor
for Wg (Lin et al., 1999). HSPGs are also required for Wnt signalling in vertebrates.
Qsulfl, an avian protein related to heparan-specific N-acetyl glucosamine
sulphatases, has been shown to regulate heparan-dependent Wnt signalling in
cultured cells (C2C12 myogenic progenitor cells) suggesting that it can modulate
Wnt signals by desulphation of cell-surface proteoglycans (Dhoot et al., 2001).
Syndecan-1 (Sdcl) is a cell-surface HSPG predominantly expressed by epithelial
cells and Sdcl deficient mice appear normal and fertile with no defects in the
mammary gland. However when crossed to transgenic mice expressing Wntl in the
mammary gland, a 70% reduction of Wntl induced hyperplasia is observed,
indicating that the Wntl pathway was inhibited. Thus Syndecan-1 is critical forWntl
induced tumourigenesis of the mouse mammary gland (Alexander et al., 2000).
1.3.3 Wnt Antagonists
Several extracellular proteins have been shown to modulate Wnt signalling. These
include members of the Lrizzled-related protein (LRP) family (Moon et al., 1997),
Wnt-inhibitory factor-1 (WIL-1) (Hsieh et al., 1999), Cerberus (Piccolo et al., 1999)
and Dickkopf (Dkk) (Nusse et al., 2001). FRP's, WIF-1, and Cerberus can directly
bind Wnt proteins and antagonise Wnt function by preventing their interaction with
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Fzd receptors. FRP can also interact with Fzd, suggesting that FRP's may antagonise
Wnt signalling through the formation of a non-functional complex with Fzd receptors
(Bafico et al., 1999). Dkk does not bind Wnts but instead interacts with the
extracellular domain of LRP5 and LRP-6; this interaction may alter the conformation
of the LRPs so that they can no longer interact with Wnt and Fzd, thereby blocking
Wnt signalling (Mao et al., 2001).
1.3.4 Wnt Signalling Pathways
Wnt signals are transduced through at least three distinct intracellular signalling
pathways including the canonical 'Wnt/(3-catenin' pathway, the 'Wnt/Ca2+' pathway
and the 'Wnt/polarity' pathway (Adler et al., 2001; Kuhl et al., 2001; Miller et al.,
1999). Distinct sets ofWnt and Fzd ligand - receptor pairs can activate each of these
pathways and lead to unique cellular responses.
The biological function of the 'Wnt/Ca2+' pathway is unclear, however this pathway
involves an increase in intracellular Ca2+ and activation of both Protein Kinase C
(PKC) and calcium/calmodulin-regulated kinase II (CamKII) (Sheldahl et al., 1999,
Kuhl et al., 2000)
The major function of the Wnt/polarity pathway is regulation of cytoskeletal
organisation. In vertebrates this involves controlling polarized cell movements
during gastrulation and neurulation (Tada et al., 2000; Wallingford et al., 2000;
Wallingford et al., 2001). In Drosophila, Wnt signalling has multiple developmental
roles including, controlling the appropriate orientation of trichomes (hairs) of the
adult wing, determining the appropriate chirality of ommatidia in the eye, and
regulating asymmetric cell divisions in neuroblast populations (Adler et al., 2001a,
b).
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1.3.4.1 The Canonical Wnt Pathway
The first Wnt pathway to be discovered and the best understood is the canonical Wnt
pathway. Acting through a core set of proteins that are highly conserved in evolution,
this pathway regulates the ability of [3-catenin to activate transcription of specific
target genes. This regulation, in turn, results in changes in expression of genes that
modulate cell fate, proliferation, and apoptosis (Cadigan and Nusse, 1997; Miller et
al., 1999; Wordaz etal., 1998).
Combined work in Drosophila, C. elegans, Xenopus and mice produced the main
outline of the canonical Wnt/(3-catenin pathway as is currently understood. A
detailed diagram of this pathway can be found at the Wnt gene homepage (see above)
however Fig. 1.4 shows a stripped down version including only the central
components. At the centre of this pathway is P-catenin, a multifunctional protein
with independent roles in cadherin-mediated cell adhesion and Wnt signal
transduction (Ben-Ze'ev et al 1998). The ultimate result of Wnt/p-catenin pathway
activation is the formation of a free, signalling pool of P-catenin in the cell that
enters the nucleus where it interacts with members of the TCF/LEF (T cell factor/
Lymphoid enhancer factor) family of HMG (High Mobility Group)-domain
transcription factors to stimulate expression of target genes (Behrens et al., 1996;
Molenaar et al., 1996; Hsu et al., 1998).
In the absence of a Wnt signal, free cytoplasmic P-catenin is destabilized by a multi-
protein destruction complex containing Axin, glycogen synthase kinase 3p (GSK3P)
and the Adenomatous Polyposis Coli (APC) protein (Zeng et al., 1997; Behrens et
al., 1998; Hart et al., 1998; Fagotto et al., 1999; Kishida et al., 1999). This
destruction complex facilitates the phosphorylation of P-catenin by GSK3p. Axin
binds APC and both are key negative regulators of Wnt signalling by acting as
scaffolds and subsequently binding both p-catenin and GSK3p. This is important for
two reasons; firstly GSK3P requires both APC and Axin for P-catenin binding and
secondly GSK3p also phosphorylates APC and Axin, which leads to enhanced















































residues in the ammo-terminal region of (3-catenin, Ser33, Ser 37 and Thr41. Recent
evidence however has shown that efficient phosphorylation of (3-catenin by GSK3(3
requires casein kinase 1(CK1) phosphorylation at Ser45. This phospho-Ser45 then
serves as a priming site for subsequent phosphorylations by GSK3(3 (Amit et ah,
2002; Liu et al., 2002; Yanagawa et al., 2002). This explains why mutations at Thr41
and Ser45 interfere with (3-catenin turnover and are frequently found in human
tumours (Polakis, 2000). Phosphorylated p-catenin is bound by the F-box protein p-
TrCP, a component of the E3 ubiquitin ligase complex, and is ubiquitinated; the
ubiquitin tag marks P-catenin for destruction by the proteasome (Aberle et al., 1997)
Wnt activation of Fzd and LRP leads to the phosphorylation of Dishevelled (Dsh)
(Axelrod et al., 1998), a cytoplasmic scaffold protein perhaps through stimulation of
casein kinase Is (CKls)(Sakanaka et al., 1999; Peters et al., 1999) and/or casein
kinase 11 (CK1 l)(Willert et al., 1997). Dsh then functions through its interaction
with Axin to antagonize GSK3p, preventing the phosphorylation and ubiquitination
of P-catenin (Kishida et al., 1999; Li et al., 1999; Smalley et al., 1999). In
vertebrates, inhibition of GSK3P may involve GSK3P binding protein (GBP in
Xenopus or its mammalian orthologue Frat 1). GBP/Frat binds to both Dsh and
GSK3P and promotes dissociation of GSK3P from the destruction complex (Li et al.,
1999). Thus, unphosphorylated P-catenin escapes degradation, accumulates in the
cell, and enters the nucleus where it interacts with members of the TCF/LEF family
of HMG -domain transcription factors to stimulate expression of target genes
(Behrens et al., 1996; Molenaar et al., 1996; FIsu et al., 1998). These include
developmental regulatory genes such as siamois, twin, and Xnr-3 in Xenopus
(Brannon et al., 1997; Fan et al., 1998; Laurent et al., 1997; McKendry et al., 1997)
and ultrabiothorax in Drosophila (Riese et al., 1997). Additional target genes in
mammals include c-myc and cyclin D1 genes, which are direct regulators of cell
growth and proliferation and have been implicated in cancer consistent with a role
for the Wnt pathway in cancer (Fie et al., 1998; Tetsu et al., 1999). It is noteworthy
however that c-myc can also activate apoptosis (Prendergast, 1999).
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The activity of TCFs is tightly controlled. In the absence ofWnt signalling, negative
regulators that bind to TCF actively repress TCF target gene transcription. The
transcriptional repressor Groucho (called TLE in vertebrates) can associate with the
TCF/p-catenin complex to downregulate its transcriptional activity (Parkhurst et al.,
1998). Another repressor CBP (Creb-binding protein) competes with P-catenin for
TCF binding and acetylates a lysine residue in the N-terminus of TCF thereby
abolishing its ability to interact with P-catenin and activate transcription. It has been
suggested that CBP raises the threshold for p-catenin binding to TCF, keeping TCF
from activating transcription until the concentration of P-catenin is high (Waltzer et
al., 1998). This tight regulation of TCF thus signifies the importance of incorrect
activation of transcription.
Intriguingly, interactions among Wnt pathway components may vary in different
developmental processes. The C. elegans Wnt pathway that induces endoderm
(intestinal cells) differs at most steps from the pathways described above. For
example, apr-l/APC and sgg-1 /GSK-3/3 are required positively for endoderm
induction, whereas the Drosophila and mammalian counterparts act negatively,
promoting the degradation of P-catenin in the absence of Wnt signals (Han et al.,
1997). A positive role for APC in Wnt signalling has also been suggested in Xenopus
by the observation that XAPC induces a duplication of the body axis similar to that
induced by Wnt (Vleminckx et al., 1997).
1.3.4.2 p-catenin
P-catenin is a multifunctional protein which plays at least two important roles in the
cell, firstly mediating cellular adhesion through its interactions with E-cadherin and
indirectly, the cytoskeleton, and secondly functioning as a key regulator in the
control of expression through the Wnt/Wingless pathway (Gumbiner et al., 1995;
Aberle et al., 1996). P-catenin shows a great degree of cross-species conservation
both in its structure and its function. Human P-catenin consists of 781 amino acids
arranged broadly into 3 important domains (Hulsken et al., 1994); an amino-terminal
domain (130 amino acids) which contains multiple GSK-3P phosphorylation sites
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needed for its degradation (Yost et al., 1996), a central domain containing twelve 42
amino acid armadillo repeats and fomis an important protein interaction domain
while the carboxy terminal (100 amino acids) forms a region of interaction with
nuclear transcription factors (Figure 1.3.b)(van de Wetering et al., 1997; Vleminckx
et al., 1999; Behrens et al., 1996).
The armadillo repeats together form a tightly packed series of short a-helices with a
positively charged central groove, a structure associated with protein-protein
interactions (Huber et al., 1997). Indeed, this central region does appear to be
involved in the interaction of p-catenin with a number of other proteins, including, E-
cadherin (Hulsken et al., 1994), Axin (Nakamura et al., 1998), TCF (Behrens et al.,
1996) and APC (Hulsken et al., 1994; Rubinfeld et al., 1995; Yu et al., 1999;
Hamada et al., 1999). The interactions of the p-catenin armadillo repeat domain with
E-cadherin and with a-catenin play a critical role in cellular adhesion. The
cytoplasmic domains of E-cadherin, a calcium ion dependent cell adhesion molecule,
bind either p-catenin or y-catenin (plakoglobin) (Hinck et al., 1994). Subsequently,
either catenin molecule (y or P) is then complexed with a-catenin, which in turn acts
as a bridge to bind to actin molecules making up the cytoskeleton (Hinck et al.,
1994). In this way, both p-catenin and y-catenin link cell surface adhesion molecules
to the cell architecture (see Figure 1.5).
The multiple functions of P-catenin are possible through a precise subcellular
compartmentalization and the fine-tuning of its concentration in each compartment.
This regulation is based on the observation that most of P-catenin's protein
interacting motifs overlap such that interaction with one partner can block binding of
another at the same time, for example, sequestering of p-catenin by APC prevents
interaction with cadherin (Hulsken et al., 1994; Rubinfeld et al., 1995). Also a subtle
change in the level of signalling-competent P-catenin may have a drastic impact on
gene activation. For example, Larabell et al., 1997, have shown that relatively small



















































































1.4 Adenomatous Polyposis Coli (APC)
APC is a tumour suppressor gene, first identified by virtue of its mutation in Familial
Adenomatous Polyposis (FAP) (see section 1.4.1.2.1) (Groden et al., 1991; Kinzler
et al., 1991). The previous section introduced APC as a member of the Wnt
signalling pathway, however APC is a large multifunctional protein that can affect a
variety of fundamental cellular processes. This section describes the APC gene
including its structure and functions.
1.4.1 APC
1.4.1.1 Genomic organisation in human and mouse
The APC gene is located at human chromosome 5q21 (Kinzler et al., 1991), the
mouse homologue is found on chromosome 18 (Luongo et al., 1993). Originally, the
APC gene was thought to be composed of 15 exons (Groden et al., 1991), exons 1-14
combined occupy the NFf - terminal quarter whereas exon 15 alone occupies three
quarters of the molecule at the COOH terminal (Groden et al., 1995; Joslyn et al.,
1991). However, evidence has accumulated that the APC gene codes for a complex
pattern of gene products that are generated on the basis of alternative splicing
(Bardos et al., 1997) (Fig. 1.6).
To date, at least 21 exons have been identified (Thliveris et al., 1994; Horii et al.,
1993; Sulekova et al., 1995), 17 of these are predicted to be coding exons due to their
location downstream of an initiating methionine codon in exon 1. Four exons 5' to
exon 1 have been identified and these have been termed (from 5' to 3') 0.3, BS
(brain specific), 0.2 and 0.1. The BS exon, expression of which is now known not to
be restricted to the brain (Pyles et al., 1998) is the best characterised of these.
Alternative APC isoforms containing BS do not include exon 1 and are found in
differentiated tissues such as the brain (Santoro and Groden, 1997). Exon 1 contains
a translation start codon for the known APC protein. Therefore transcripts lacking





































































































translation start codons have been identified, one each in exons 0.3, BS, 0.2 and 1,
however three of these (0.3, BS, 0.2) are upstream of a stop codon in exon 1,
suggesting that only alternative APC isoforms lacking exon 1 produce full length
protein (Thliveris et al., 1994; Santoro and Groden, 1997; Pyles et al., 1998).
Oshima et al., 1993 identified APC isoforms lacking exon 7, Horii et al., 1993
reported alternative splicing in exon 9 and Sulekova et al., 1995 identified a novel
exon (exon 10A) located 1.6kb downstream from exon 10. In addition, skipping of
exon 14, resulting in a novel exon 13/15 connection has been reported but this results
in loss of APC exon 15 long open reading frame (Sulekova et al., 1995). The coding
regions for the human APC gene (exons 1-15) are highly conserved in the mouse Ape
gene (86% identical at nucleotide level) (Su et al., 1992) and most of the splice
variants described in human APC have also been identified in murine Ape (Oshima
et al., 1993).
1.4.1.2 Mutations of the APC gene
Mutations of the APC gene have been identified in several species and the
implications of these mutations are discussed in the following sections. Mice
homozygous for the ApcM,Nmutation (truncated after residue 850, see section 1.5.1.1)
display embryonic lethality (Moser et al., 1995), while heterozygotes develop
multiple adenomas of the intestine with progression to tumours (Moser et al., 1990).
Loss of function of a Drosophila APC homologue (D-APC) causes cell death in
neuronal cells (Ahmed et al., 1998) while mutation of another Drosophila APC (E-
APC) results in adhesion defects and activation ofWnt target genes (Hamada et al.,
2002). In C. elegans mutations in APR-1 {APC related gene) inhibit epithelial cell
migration (Hoier et al., 2000). However, mutations of the human APC gene are well
documented and are discussed below.
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1.4.1.2.1 Familial Adenomatous Polyposis (FAP)
The APC gene was initially identified by positional cloning of the Familial
Adenomatous Polyposis (FAP) locus (Groden et al., 1991; Kinzler et al., 1991). FAP
is an autosomal dominant disorder of humans characterised by the development of
multiple adenomas of the colorectum and duodenum with progression to colorectal
carcinoma in the third to fourth decade of life in an untreated individual (Groden et
al., 1991). Tumours arising in patients with FAP show loss of the remaining wild-
type APC allele (Levy et al., 1994; Luongo et al., 1994). FAP patients also present
tumours in other regions of the gastrointestinal tract, and extraintestinal cancers
including tumours in the brain, thyroid, adrenal gland and pancreas (Burt et al., 1991;
Haggitt et al., 1986). APC is also somatically mutated in the majority, (>80%), of
sporadic colorectal tumours (Miyoshi et al., 1992)
Almost all of the mutations of APC, both germline and somatic, result in the
premature truncation of the gene product through nonsense or frameshift mutations
(Miyoshi et al., 1992). While mutations have been found throughout the length of the
APC coding sequence the majority of mutations resulting in deleterious phenotypes,
occur in the 5' portion of the coding sequence. Many of the somatic mutations are
located in the central region of the gene termed the mutation cluster region (MCR)
(Miyoshi et al., 1992). Consequently mutations of the APC gene result in the
expression ofAPC proteins lacking the C-terminal half of the molecule and unable to
perform many of the normal protein interactions as described below (Kinzler et al.,
1996; Polakis, 2000; van Es et al., 2001).
1.4.2. The APC tumour suppressor protein
1.4.2.1 Structure and protein interactions
The APC gene codes for a protein of 2843 amino acids, (-310 kDa) containing a
number of distinct domains and repeated elements (see figure 1.3c) (Polakis, 1995;
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Polakis, 1997). Many of the repeat elements of the APC protein have been
recognized as motifs involved in interaction with other proteins. To date a large
number of these interactions have been confirmed and explored.
Beginning with the amino terminal region of the protein the first recognized active
region of the APC protein is an oligomerisation domain, believed to contain >95% a-
helical conformation. This domain contains a series of heptad repeats, the most
important of which is the first heptad repeat (amino acids 6-57) (Joslyn et al., 1993;
Su et al., 1993). Immunoprecipitation experiments involving truncated and wild type
proteins established that APC has the ability to bind to itself (Su et al., 1993). The
ability of the APC protein to oligomerise may be responsible for the observations of
dominant-negative effects of mutant APC proteins made by some researchers
(Dihlmann et al., 1999). It is also possible that the protein products of certain splice
variants of the APC gene may lack the oligomerisation domain, presumably creating
a protein with altered activity or regulation (Samowitz et al., 1995).
Moving towards the carboxy terminus of the APC protein, the next region is a series
of armadillo repeats (residues 453-767) (Polakis, 1997). These repeats are
homologous to 42 amino acid motifs found initially in the Drosophila armadillo
protein, the homologue of the human (3-catenin protein (Hatzfeld, 1999). This
segment of the APC protein contains 7 armadillo repeats and the function of these
repeats appears to be protein-protein interaction (Hirschl et al., 1996). The armadillo
region of APC has been shown to bind to the regulatory B56 subunit of protein
phosphatase 2a (PP2A) a protein capable of interacting with and involved in the
regulation of Axin, (Seeling et al., 1999; Hsu et al., 1999) and this interaction
facilitates the nuclear import of APC (Galea et al., 2001). The armadillo region is
also known to bind to the APC-stimulated guanine nucleotide exchange factor
(Asef), which acts as a guanine nucleotide exchange factor for the Rac GTP binding
proteins. This interaction stimulates Asef activity, thereby regulating the actin
cytoskeletal network and cell morphology (Kawasaki et al., 2000). Additionally,
APC interacts with the kinesin superfamily (KIF) 3A-KIF3B proteins, microtubule
plus-end-directed motor proteins, through an association with the kinesin
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superfamily-associated protein 3 (KAP3). The authors speculate that the interaction
between APC and KAP3 functions to transport APC along microtubules (Jimbo et
ah, 2003).
The pattern of somatic mutations indicates that the armadillo repeats are typically
retained by the mutant APC proteins and therefore cannot independently convey
tumour suppressor activity. In cases where mutation does cause a loss of some
armadillo repeats from the APC protein the number of repeats lost shows a positive
correlation with development of congenital hyperplasias of the retinas (Davies et al.,
1995; Wallis et al., 1994; Wallis et al., 1999). This may support the observations by
some researchers of a potential partial dominant-negative effect of truncated APC
protein (Dihlmann et al., 1999).
Downstream of the armadillo repeat segment of the APC protein, are found three 15
amino acid repeats, responsible for the binding of p-catenin (amino acids 1020-1169)
(Su et al., 1993). These repeats are not homologous to the motifs found on other
proteins which interact with P-catenin (T-cell factor (TCF)/Lymphocyte enhancer
factor (LEF) transcription factors and cadherins for example) and need not be
removed by truncation mutation to eliminate the tumour suppressor functions of the
APC protein (Kintner, 1992; Ozawa et al., 1995; Polakis, 1995; Beroud and Soussi,
1996).
Following the P-catenin binding repeats are a series of 7 relatively dispersed 20
amino acid motifs (amino acids 1324 -2075) (Groden et al., 1991). These 20 amino
acid repeats bear some resemblance to the 15 amino acid repeats found more N-
terminal and were believed to play a role in the binding and subsequent degradation
of P-catenin. This is in part supported by the fact that most tumourigenic truncation
mutations ofAPC eliminate some or all of these motifs (Polakis, 1995). This may not
be the whole story, however, as interspersed with these p-catenin binding and
degradation domains are amino acid motifs, which bind Axin (Zeng et al., 1997).
Axin acts as a scaffold protein in the canonical Wnt signalling pathway bringing
together a number of proteins in order to function as a regulator of free cellular P-
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catenin levels and hence regulate transcription of Wnt target genes (see section:
1.3.4.1.). It may be that the tumourigenic potential of the truncated APC proteins is
not entirely due to the loss of the 20 amino acid repeats but rather due to the loss of
Axin interaction elements preventing the formation of protein complexes necessary
for p-catenin degradation.
The next region of protein interaction is the basic domain, stretching approximately
from amino acid 2200 to 2400, containing a higher proportion of the basic residues
arginine and lysine (Groden et al., 1991). This region of the APC protein enables it
to bind to microtubules and full length APC is believed to be capable of promoting
the polymerisation of tubulin in vitro, while mutant APC proteins are unable to
encourage this reaction (Smith et al., 1994; Munemitsu et al., 1994). This ability to
assemble and/or associate with microtubules may in part explain the localisation of
APC to the leading edge ofmigrating cells, a region where microtubule assembly is
required, and in addition may lend itself to the observations of disordered cell
migration in models of APC overexpression and in animal models of FAP (Nathke et
ah, 1996; Wong et al., 1996; Mahmoud et al., 1997; Mahmoud et al., 1999).
Finally the C-terminal region of APC interacts with at least two other proteins, end-
binding protein 1 (EB1) and Human Discs Large (hdlg). EB1 is a small microtubule
binding protein and binds APC in the final 170 amino acids (Askham et al., 2000).
The binding site for PDZ domains (protein-protein interaction domains as found in
the human homologue of the Drosophila Discs Large (dig)) resides in the last 15
amino acids (Matsumine et al., 1996). The hdlg protein is the human homologue of
the Drosophila Discs Large (dig) tumour suppressor protein which when lost in
Drosophila results in neoplastic growth in the imaginal disc of the developing
embryo (Bryant et al., 1993).
In addition to the APC protein described above, a second related protein has been
identified in a number of species. APCL in humans (Nakagawa et al., 1998) and
APC-2 in mouse (van Es et al., 1999), which are both highly related and thus called
APC-2/L. In Drosophila there are also two forms of APC, D-APC and E-APC
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(Hayashi et al., 1997; McCartney et al., 1999; Yu et al., 1999). D-APC which was
the first Drosophila APC identified is expressed predominantly in the nervous
system and negatively regulates Arm/p-catenin signalling in the Drosophila eye.
Loss of D-APC therefore, only has an effect in the larval photoreceptors and has no
effect on Wg-dependent patterning at any developmental stage (Ahmed et al., 1998).
These observations suggested the existence of a second APC gene. E-APC is
ubiquitously expressed, interacts directly with Arm and negatively regulates Wg
signalling. Inactivation of E-APC results in the constitutive activation of Wg
signalling but this is restricted to embryogenesis (Hayashi et al., 1997; McCartney et
al., 1999; Yu et al., 1999). In general these related proteins are shorter and lack some
of the typical motifs ofAPC and thus vary in their ability to bind additional proteins,
however they can all function in Wnt signalling (Nakagawa et al., 1998; van Es et
al., 1999; Ahmed et al., 2002).
1.4.2.2 Subcellular localisation
APC protein expression has been detected in four subcellular regions, cytoplasm,
nucleus, associated with the plasma membrane, or associated with microtubule tips
(Nathke et al., 1996; Neufeld & White, 1997). APC protein can also shuttle between
the nucleus and the cytoplasm by virtue of conserved and functional nuclear-export
signals (NESs) (Rosin-Arbesfeld et al., 2000; Henderson et al., 2000; Neufeld et al.,
2000). Nuclear import ofAPC seems to be mediated by the amino terminal armadillo
repeat domain (Rosin-Arbesfeld et al., 2000; Galea et al., 2001) and also by nuclear-
localisation signals (NLSs) (Zhang et al., 2000). The function of APC at each of
these locations is detailed below.
1.4.3 Functions of APC
The role of APC in the prevention of tumour development, or more accurately the
failure of truncated APC to prevent neoplastic transformation, has led to an intense
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study of its role in normal and dysregulated cell functioning. Its main function as a
tumour suppressor involves regulating P-catenin levels in the Wnt signalling
pathway (Munemitsu et al., 1995). In addition APC is linked directly to the
cytoskeleton and plays a role in cytoskeletal regulation, cell migration, cell division
and cell adhesion (Nathke, 1999; Dikovskaya et al., 2001; Bienz, 2002).
1.4.3.1 APC in the Wnt signalling pathway
APC protein functions as a negative regulator of the canonical Wnt pathway by
promoting the destabilisation of P-catenin. APC forms part of the multi-protein
destruction complex that facilitates the phosphorylation of p-catenin by GSK3P
thereby targeting it for ubiquitination and subsequent destruction by the proteasome
(Munemitsu et al., 1995). This function is mediated in part through two distinct P-
catenin binding domains of APC, but also through Axin binding to APC and this
latter activity is crucial for APC's role as a tumour suppressor (Smits et al., 1999;
Rubinfeld et al., 2001). This is supported by the fact that all three Axin-binding
motifs are located downstream of the MCR, resulting in mutant APC that has lost the
ability to bind Axin. Thus the tumourigenic potential of the truncated APC proteins
is not entirely due to the loss of the 20 amino acid repeats but rather due to the loss of
Axin interaction elements preventing the formation of protein clusters necessary for
P-catenin degradation (Smits et al., 1999).
The identification of APC as a shuttling protein has led to speculation that the
nuclear-export function of APC controls the level or transcriptional activity of
nuclear P-catenin (Henderson et al., 2000). It was originally proposed that APC
transports P-catenin directly out of the nucleus (Bienz, 1999). However it is also
possible that APC, by binding P-catenin, blocks TCF/LEF transcriptional activation
and shifts the equilibrium of P-catenin to the cytoplasm where it is then degraded
(Neufeld et al., 2000). Most mutant disease-linked truncated forms of APC lack the
two central nuclear-localisation signals (NLSs) and certain NESs but retain nuclear-
cytoplasmic shuttling activity via an N-terminal NES and nuclear import facilitation
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by the N-terminal ARM domain (Galea et al., 2001). However it is believed that this
compromised nuclear-export activity is insufficient for full tumour suppressor
function. Some studies have shown that an exogenous APC fragment that mimics
typical APC cancer truncations had low nuclear export and failed to reduce TCF
mediated transcription (Rosin-Arbesfeld et al., 2000; Bienz, 2002).
1.4.3.2 APC and the cytoskeleton
APC associates with the cytoskeleton in at least two ways, directly binding
microtubules (Smith et al., 1994; Munemitsu et al., 1994) and indirectly connecting
with the actin cytoskeleton (Townsley et al., 2000).
APC appears to interact with microtubules in at least three ways; the C-terminus
basic domain directly binds microtubules (Munemitsu et al., 1994) and an adjacent
domain binds to End-binding protein 1 (EB1), a microtubule binding protein (Su et
al., 1995). Additionally, it has been reported that APC lacking the basic domain still
associates with microtubules (Dikovskaya et al., 2001; Mimori-Kiyosue et al., 2000;
Zumbrunn et al., 2001). An APC isofonn lacking the EB1 binding site can bind EB3
(an EB1 family member) indicating that there may also be more than one binding site
for EBl-like proteins (Nakagawa et al., 2000). APC was discovered to localise at the
distal tips ('plus ends') of microtubules that meet the plasma membrane in cellular
protrusions of actively migrating cells (Nathke et al., 1996). Here APC is involved in
stabilizing microtubules (Zumbrunn et al., 2001) and there is a correlation between
the dissociation of APC from growing microtubule ends and their subsequent
depolymerization (Mimori-Kiyosue et al., 2000). This function aids in the formation
of cellular protrusions that are important for cell migration.
Defects in epithelial cell migration are apparent upon examination of adenomatous
polyps from both mice and humans (Oshima et al., 1995; Moss et al., 1996; Oshima
et al., 1997) and overexpression of APC in gut epithelia of mice induced disordered
cell migration in the intestinal epithelium (Wong et al., 1996). Normally colonic
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epithelial cells migrate upwards from the crypt base forming coherent columns,
however in FAP patients one reason for polyp formation may be due to defective
epithelial cell migration increasing both the time cells remain in the proliferative
environment of the crypt and their exposure to toxins present in the gut. Mutations in
APR-1 inhibit epithelial cell migration in C. elegans (Hoier et al., 2000).
Microtubules are important for the formation of mitotic spindles that mediate
chromosome segregation during mitosis. In metaphase cells, when the spindle
microtubules attach to kinetochores, APC is localised at microtubule tips (Kaplan et
al., 2001). APC directly binds to a kinetochore protein, Bub 1 thus APC could
promote the growth of spindle microtubules toward the kinetochore, or attach the
kinetochore to the spindle via Bubl (a mitotic checkpoint kinase) (Kaplan et al.,
2001). EB1 also associates at the growing plus ends of cytoplasmic and spindle
microtubules and is required for the APC-mediated attachment of microtubules to
kinetochores (Fodde et al., 2001).
Mutations in the APC gene cause chromosomal instability (CIN). Cells expressing
mutant APC that lacks the C-terminal structural domains are prone to defects in
chromosome segregation and develop aneuploidy (Kaplan et al., 2001; Fodde et al.,
2001) and this has been shown to be an early event in colorectal cancer (Shih et al
2001).
Studies in Drosophila show that APC isoforms that lack microtubule-binding sites
(APC-2/E-APC) associate with actin indirectly (Townsley et al., 2000) possibly
through catenins and other actin-binding proteins such as Dig (Matsumine et al.,
1996). This membrane associated APC has a function in cellular adhesion. Hamada
& Bienz, 1999, show that E-APC containing a missense mutation becomes
delocalised from the plasma membrane and results in adhesion defects at the
phenotypic and ultrastructural levels.
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1.5 The APC Tumour Suppressor Protein in Cancer
Genetic evidence from humans and mouse models suggest that APC is a classic
tumour suppressor, requiring both alleles to be inactivated for tumour growth to
develop (Luongo et al., 1994; Levy et al., 1994; Oshima et al., 1995; Laird et al.,
1995). The type of germline mutation in APC determines the nature of the second hit,
which is either allelic loss or truncation mutation. FAP patients with germline
mutations close to codon 1300 tend to acquire a 'second hit' at APC by allelic loss,
whereas those with germline mutations away from codon 1300 are more likely to
have 'second hits' by truncating mutations in the MCR (Lamlum et al., 1999). Thus
different APC mutations provide cells with different selective advantages, which are
reflected in the probability and rate of tumour growth (FAP patients with germline
mutations around codon 1300 are known to have very severe colonic polyposis)
(Nugent, et al., 1994). In a mouse model ofFAP, the Min mouse (see below), tumour
formation also requires loss of the wild type Ape allele, most commonly by
chromosome loss but also through somatic Ape truncation mutations that resemble
those observed in human intestinal tumours (Luongo et al., 1994).
As mentioned in section 1.4, mutational inactivation of the APC tumour suppressor
gene initiates most hereditary and sporadic colon carcinomas. Both hereditary and
sporadic human colorectal tumours evolve from adenomatous polyps to larger
malignant carcinomas over the course of several decades (Groden et al., 1991;
Powell et al., 1992). APC mutations are a very early event in sporadic colorectal
tumourigenesis and associate with tumour initiation (Powell et al., 1992). Patients
with FAP typically develop hundreds to thousands of colorectal adenomas during
their second and third decades of life and due to their large numbers some eventually
progress to malignant carcinomas (Kinzler and Vogelstein, 1996). Both human
germline and somatic APC mutations almost invariably produce truncated proteins
lacking the C-terminal half of the molecule (Miyoshi et al., 1992). Loss of Axin and
some P-catenin binding sites in the APC C-terminus prevents the downregulation of
p-catenin by APC resulting in its interaction with LEF/TCF transcription factors and
activation of target genes that participate in cancer progression (Munemitsu et al.,
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1995; He et al., 1998). In support of this idea that (3-catenin acts as an oncogene,
mutations in p-catenin have been detected in human colon cancers (Morin et al.,
1997) and cancer cell lines (Rubinfeld et al., 1997) that have wild-type APC.
Additionally, mutations resulting in loss of APC microtubule binding domains results
in defects in cell migration (Oshirna et al., 1995; Moss et al., 1996; Oshima et al.,
1997), adhesion (Hamada & Bienz, 1999) and chromosomal instability (Fodde et al.,
2001), which are all features of colon cancer.
Importantly, mutations of the APC gene have been subsequently implicated in a large
number of tumours derived from other tissues. These tumours, which include
osteomas, desmoid tumours (Miyaki et al., 1993; Davies et al., 1995), brain tumours
(Itoh et al., 1993) and breast tumours (Furuuchi et al., 2000; Virmani et al., 2001; Jin
et al., 2001) were found to be missing alleles of APC and/or to contain mutated
sequences coding for truncated versions of the APC protein. Desmoid tumours are
defined as benign fibrous tumours that do not metastasise and are frequently
observed in FAP patients after abdominal surgery (Miyaki et al., 1993). FAP
patients are 92 times more likely than the general population to develop
medulloblastoma (Hamilton et al., 1995). Medulloblastoma is a malignant invasive
embryonal tumour of the cerebellum with a preferential manifestation in children.
Turcot's syndrome, a condition characterised clinically by the concurrence of a
primary brain tumour and multiple colorectal adenomas, is reportedly due to
germline APC mutation. APC mutations have also been detected in a subset of
sporadic medulloblastomas (Huang et al., 2000). There is continuing debate over
whether APC mutations play a causative role in breast cancer, a topic which is
summarised below.
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1.5.1 The APC tumour suppressor protein and breast cancer
1.5.1.1 The Min (Multiple intestinal neoplasia) mouse
The first evidence that APC mutation may play a role in mammary cancer came from
studies of the Min mouse. Min (multiple intestinal neoplasia) is an ethylnitrosourea
(ENU)-induced mutation in the murine Ape gene (Moser et al., 1990; Su et al.,
1992). ENU, a direct-acting alkylating agent, induces germline mutations that are
usually single base pair changes (Moser et al., 1990). Min is a nonsense mutation at
codon 850 of Ape resulting in premature truncation of the protein just after the
armadillo repeat region, therefore lacking the P-catenin regulatory domains (Su et
al., 1992). This mutation is analogous to that seen in humans with FAP (Joslyn et al.,
1991) and thus represents a mouse model of FAP. Table 1.5.1 summarises the other
identified mouse models of FAP.
On the C57BL/6J (B6) background, Min/+ mice develop more than 50 adenomas
throughout the intestinal tract and rarely survive beyond 120 days due to secondary
effects of tumour growth including severe, chronic anaemia and intestinal blockage
(Moser et al., 1990). Tumour formation in these mice is invariably associated with
somatic loss of the wild type (wt) Ape allele, most commonly by chromosome loss
but also through somatic Ape truncation mutations that resemble those observed in
human intestinal tumours (Luongo et al., 1994; Shoemaker et al., 1997). Mice
homozygous for the Min mutation demonstrate early embryonic lethality at
approximately 6.5 days post-coitum (Moser et al., 1995).
Significantly, Min/+ female mice are also predisposed to spontaneous and carcinogen
induced mammary tumours (Moser et al., 1993). Approximately 5% of B6 Min/+
female mice spontaneously develop a single adenocanthoma, however both the
incidence and multiplicity ofmammary tumours are dramatically increased in Min/+
females by somatic treatment with ENU (Moser et al., 1993). The hormonal
stimulation of pregnancy and lactation were not necessary for Min-induced
mammary cancer as most of the mice that developed mammary tumours were
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virgins. Transplantation experiments, where mammary cells from Min/+ female mice
were transferred to wild type hosts demonstrated that tumour susceptibility is
intrinsic to Min/+ mammary tissue (Moser et al., 1993). APC mutation had not been
reported to be a feature of human breast cancer and this discovery was the first
evidence that Ape mutation was involved in mammary cancer and thus prompted
much research into the human condition.
1.5.1.2 APC and human breast cancer
Somatic mutations of the APC gene, although originally reported to be quite rare in
human breast cancers (Sorlie et al., 1998), were detected in 18% of primary breast
cancers in a later study (Furuuchi et al., 2000). Prior to this, frequent loss of
heterozygosity (LOH) at 5q21 (Thompson et al., 1993; Medeiros et al., 1994;
Kashiwaba et al., 1994) and reduced or lost expression (40.7%) of the APC protein
had been reported in human primary breast carcinomas (Ho et al., 1999).
Aberrant methylation of the APC locus has been reported in about 18% of sporadic
colorectal carcinomas (Hiltunen et al., 1997; Esteller et al., 2000) and is recognised
as an alternative mechanism to gene mutations for the transcriptional silencing of
many tumour suppressor genes (Baylin et al., 1998). Hypermethylation of the APC
promoter CpG island was detected in 30% of primary tumours in one study (Tamura
et al., 2001) and in 44% of breast cancer tumours and cell lines in another (Virmani
et al., 2001). The frequency of methylation in breast cancer increased with tumour
stage and size and the authors suggest methylation status may be associated with
poor prognosis (Virmani et al., 2001).
Additionally, Laken et al., 1997, reported a new mutation in the APC gene, I1307K,
which is caused by a transversion of T-A in nucleotide 3920 creating a hypermutable
tract. This mutation, which was found to be predominant in Ashkenazi Jews,
predisposes to colorectal cancer and has been associated with an increased risk for
breast cancer in the same population. This effect was mainly limited to women who
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also carried BRCA mutations (Redston et al., 1998). BRCA1 and BRCA2 are two
breast-cancer-susceptibility genes and inherited mutations in either predisposes to
breast, ovarian and other cancers (reviewed in Venkitaraman, 2002).
Finally, an APC mutation was identified in a human breast cancer cell line that
resulted in the expression of truncated APC and was associated with increased P-
catenin levels (Schlosshauer et al., 2000). Although reports of overexpression of
several WNTs, including WNT2, WNT4, WNT5A, WNT7B, and WNT10B in a
proportion of breast tumours have been documented (Huguet et al., 1994; Lejeune et
al., 1995; Dale et al., 1996; Bui et al, 1997) this discovery, that due to APC mutation
p-catenin levels were dysregulated, was the first evidence linking Wnt signal
activation to human breast cancer. This correlates with data proposing that high P-
catenin activity is associated with poor prognosis of breast cancer patients (Lin et al.,
2000).
1.5.1.3 Wnt signalling and mouse mammary carcinomas
1.5.1.3.1 p-catenin overexpression
Over the past decade numerous transgenic mice have been generated, in which the
Wnt pathway is activated in the mammary gland. As mentioned in section 1.1.3.1
molecules that activate the Wnt pathway have been expressed ectopically in
mammary epithelium under the control of the MMTV-LTR, including Wntl
(Tsukamoto et al., 1988) and WntlOb (Lane and Leder, 1997) both of which result in
mammary carcinoma. In addition stabilised forms of p-catenin have been
overexpressed from the MMTV promoter in several studies (Michaelson and Leder,
2001; Imbert et al., 2001). MMTV-AN90p-catenin lacks the first 90 codons and mice
expressing this transgene develop mammary gland hyperplasia and adenocarcinoma.
The histopathology of tumours dissected from these mice is reportedly identical to
that observed in tumours derived from MMTV-Wntl and MMTV-Wntl 0b mice
(Michaelson and Leder, 2001). MMTV-AN89p-catenin is deleted in the N-terminal
89 amino acids but retains cadherin/catenin binding and has greater stability in the
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cytoplasmic pool (Imbert et al., 2001; Munemitsu et al., 1996). Female mice
expressing this transgene display precocious lobuloalveolar development and
premature differentiation, as determined by (3-casein expression in the mammary
gland. In addition, all transgenic females develop multiple aggressive
adenocarcinomas, with tumours becoming visible in breeding females from 4 months
of age and virgin females by 7 months (Imbert et al., 2001).
1.5.1.3.2 Cyclin D1 overexpression
Cyclin D1 is a downstream target of the Wnt signalling pathway and is one of the
most commonly overexpressed oncogenes in human breast cancer (Sutherland and
Musgrove, 2002). Cyclin D1 plays a pivotal role in the regulation of progression
from Gi to S phase of the cell cycle through the formation of active enzyme
complexes with cyclin-dependent kinases Cdk4 and Cdk6 (reviewed in Sutherland
and Musgrove, 2002). In humans, in situ hybridisation studies suggest that cyclin D1
overexpression occurs at the transition from in situ to invasive carcinoma, and thus
may represent a late event in tumourigenesis (Weinstat-Saslow et al., 1995). In
contrast, immunohistochemical studies demonstrate cyclin D1 overexpression in
preneoplastic lesions consistent with an early role of cyclin D1 in mammary gland
neoplasia (Alle et al., 1998). Female mice overexpressing cyclin D1 from the MMTV
promoter display increased proliferation and precocious alveolar development in the
virgin mammary gland (Wang et al., 1994). These mice eventually developed
mammary adenocarcinomas after 1 year of age. This data is consistent with cyclin
D1 overexpression contributing to mammary gland hyperplasia.
1.6 Conditional gene targeting in the mouse mammary gland
One method for addressing the significance of gene deficiency in vivo is conditional
gene targeting. Conditional gene targeting is an invaluable method for overcoming
the high incidence of embryonic lethality observed in constitutive knockouts (for
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example Ape), and for discerning the in vivo significance of gene deficiency in
specific tissues. Two methods of conditional gene targeting, the cre-loxP and Flp-frt
systems, are in existing use in mammals. Of these, the cre-loxP system has been used
with the most frequent success.
1.6.1 Cre-loxP recombination system
The cre-loxP recombinase system evolved within bacteriophage PI as a mechanism
to maintain correct unit copy segregation of the prophage within host cells.
Bacteriophage PI encodes a 38-kDa ere recombinase that catalyses site-specific
DNA recombination between 34-base pair repeats termed loci of recombination or
'loxP' sites (Sauer and Henderson, 1988). Cre recombinase, expressed ectopically in
mammalian cells, induces either deletion or inversion of the sequences flanked by the
lox sites dependent upon lox site orientation (Figure 1.7). The cxq-IoxP system can
function in a highly efficient manner in directing tissue-specific, site-specific, and
heritable chromosomal DNA recombination events in transgenic mice in vivo (see
Table 1.6.1). The ability to generate temporally and/or spatially restricted gene
alterations largely resolves two of the main problems associated with conventional
gene 'knock-outs', namely embryonic lethality and secondary effects of the targeting
event, such as developmental compensation.
1.6.2 Conditional p-catenin overexpression
As mentioned previously (section 1.5.1.3.1), several studies have documented the
pathological effect of dysregulated P-catenin in the mammary gland. A criticism of
these studies is that overexpression of P-catenin from an ectopic promoter does not
question the effect of endogenous P-catenin levels on mouse mammary gland
development. Using cre-loxP technology Keiko Miyoshi's research group have
manipulated endogenous P-catenin levels and have reported on the effects of this
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2002). Two different ere transgenes, one using the mammary-specific whey acidic
protein (WAP) gene promoter and the other exploiting MMTV-LTR, were used to
conditionally excise exon 3 of a floxed (3-catenin allele. Wheras WAP-cre is
expressed in mammary alveolar epithelium transiently during oestrus and during
pregnancy (Pittius et al., 1988; Robinson et al., 1995), MMTV-LTR driven ere is
expressed in both ductal epithelium (during puberty) and in alveolar epithelium
(during pregnancy) (Wagner et al., 2001; Walton et al., 2001). Deletion of exon 3
(amino acids 5-80) of the j5-catenin gene removes the N-terminal region that is the
target of GSK3P phosphorylation and consequently renders the protein resistant to
degradation by the proteasome (section 1.3.4.1) (Harada et al., 1999; Miyoshi et al.,
2002). Stabilisation of P-catenin from WAP-cre resulted in the transdifferentiation of
mammary epithelium into epidermal cells and squamous metaplasias during the first
pregnancy. Squamous nodules are frequent dysplasias of the mouse mammary gland
and are characterised by the presence of confluent keratin swirls and cells containing
translucent nuclei (ghost cells). Transdifferentiation into epidermis was confirmed by
the expression of keratins K1 and K5 in the hyperplastic structures and squamous
cells, with expression patterns resembling those seen during epidermal
differentiation. Early activation of P-catenin by MMTV-cre resulted in a similar
phenotype with the notable exception that mice were unable to lactate. Significantly,
in both experiments mice did not develop mammary adenocarcinomas (over a time
period of 6 months) (Miyoshi et al., 2002). The authors argue that the phenotypic
differences observed differ from the previous transgenic studies due to biochemical
differences between the two P-catenin proteins, the floxed mice lacking amino acids
5-80 as compared to the previous studies overexpressing A89 and A90 P-catenin
(Imbert et al., 2001; Michaelson and Leder, 2001). The authors additionally suggest
this difference could be due to the cell types targeted and/or the expression levels of
p-catenin in floxed f5-catenin mice. That transgenic mice overexpressing A89 P-
catenin/ A90 p-catenin from an MMTV promoter develop adenocarcinoma and
MMTV-cre-/oxP-AE3p-catenin mice do not argues against differences in cell type
accounting for differences in phenotype. The issue of altered P-catenin levels in
inducing mammary adenocarcinoma has yet to be fully understood.
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1.6.3 Conditional inactivation of APC
Tetsuo Noda's research group have generated floxed Ape mice in which loxP sites
were introduced into introns 13 and 14 of the Ape gene (see Figure 1.8) These
transgenic mice thus have a conditionally targeted allele of Ape, which upon
recombination mediated by the ere recombinase deletes a region of Ape
encompassing exon 14 and induces a frameshift mutation at codon 580. This
mutation results in a truncated protein where all of the p-catenin regulating motifs
and four of the seven armadillo repeats are missing. Whereas mice heterozygous
(Apc+/580S) or homozygous (Apc580S/580S) for this silent mutant allele were
phenotypically normal, homozygotes displayed decreased Ape expression in the
intestine. Using an adenovirus ere recombinase Ape inactivation was targeted to the
colorectum of Apc580S/580S mice. Homozygotes, but not heterozygous or wild type
mice, subsequently developed colorectal adenomas within 4 weeks. PCR analysis of
genomic DNA from these adenomas confirmed deletion of Ape exon 14 and
established that loss of Ape function was mediated by cre-loxP recombination
(Shibata etal., 1997).
To specifically inactivate Ape in the mouse mammary gland the floxed Ape mice
(Apc580S/580S) mice were crossed to transgenic mice expressing a mammary gland
specific ere recombinase (BLG-cre) (Gallagher et cil., 2002). This transgene (Figure
1.9) is driven from the ovine beta-lactoglobulin (BLG) promoter, which has been
used successfully to target transgenes efficiently and reliably to secretory epithelial
cells of the mammary gland (Whitelaw et al., 1992; Farini et al., 1995). The BLG-cre
transgene has previously been shown to induce very efficient excision of floxed DNA
ligase I in mice. Excision was specific to the mammary gland and was temporally
regulated, predominantly occurring during lactation (Selbert et al., 1998; Chapman et
al., 1999). Subsequent breeding of the BLG-cre transgenic mice to the ere ROSA
reporter strain (Soriano, 1999) was used to measure the extent of cre-recombinase
activity in the mammary gland. Cre ROSA mice carry a flox-STOP p-galactosidase
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Figure 1.8. Establishment of a mutant mouse line carrying a conditionally
targeted Ape allele (Shibata et al., 1997). (1) Structure of the targeting vector
which was introduced into ES cells. (2) Homologous recombination between the
targeting vector and the wild-type allele creates the targeted allele.(3) The
targeted allele (Apc580S) has loxP sites flanking exon 14 of the Ape gene. (4)
Recombination mediated by Cre recombinase produces the deleted allele Apc5mD
lacking exon 14 of the Ape gene. The location of the genotyping primers P3 and
P4 are shown.
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Figure 1.9. Structure of the cre-transgene (Selbert et al., 1998)
Cre recombinase was cloned into the Eco RV site of 4.2kb-BLG/SK+
plasmid. The start of translation is indicated by an arrow.
EcoRV/XhoI BamHI Xhol
NotI BamHI | | |
+ poly(A)/2.5 kb
Figure 1.10. Growth of pups born to cre+^/?c580S/580S females
Weights of pups born to experimental mothers with conditional inactivation of
the Ape gene in the mammary gland (cre+^/7c580S/580S) were compared to those
from littermate control mothers (cre+^(/?c+/580S and cre~ Apc5S0S SH0S).
Growth curvs of pups
Age (days)
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analysis of LacZ-stained mammary glands showed widespread and highly efficient
recombination throughout the epithelium of the virgin gland and thus indicated that
the temporal expression of the BLG-cre transgene was not unique to lactation. By
day 10 of lactation almost all epithelial cells had undergone recombination
(Gallagher et al., 2002). When crossed with floxed Ape mice, BLG-cre excises exon
14 in mammary gland secretory epithelial cells. All mice generated appeared to
develop normally and litter sizes were comparable between cre+ Z/?c580S/580S, cre+
Apc "H0S and ere" Apc580S/580S females. However, we noted that the offspring from
cre+ Apc580S/580S females did not thrive (Figure 1.10) (Gallagher et al., 2002).
Analysis of wholemount virgin mammary gland preparations from these mice
revealed that conditional inactivation ofApe leads to a marked delay in normal ductal
I 5ROS/580S
development. Mammary glands from ere Ape females showed delayed ductal
growth as compared with littermate control genotypes (cre+ Apc+/580S and ere"
Apc5S0S/5S0S) (Figure 1.11), however ductal growth does eventually succeed in
reaching the end of the fat pad (Gallagher et al., 2002). Lactating mammary glands
I ^R0S/5R0S • • •
from ere Ape females showed extensive metaplastic nodules (Figure 1.12).
This phenotype was 100% penetrant and small areas of similar appearance were
observed in virgin mammary gland sections. Metaplastic nodules consisted of tightly
bound balls of epithelial cells emanating from ducts, which transdifferentiate into
squamous cells as determined by histological criteria. Both keratinising squamous
differentiation (characterised by the presence of keratohyaline granules) and non-
keratinising squamous differentiation were observed, the latter being more frequent
and resulting in the appearance of an eosinophoilic material. These areas of
metaplasia increased during lactation, remained after involution and increased in
number and extent after two lactation cycles. Significantly, progression to neoplasia
never occurred, even in mice that have been through up to 4 complete lactation
cycles and one year after the initial lactation cycle (Gallagher et al., 2002).
The observed phenotype of mice with conditional inactivation of the Ape gene (cre+
Ape ) highlights a critical role of Ape in both the growth and development of
the mammary gland. Using the BLG-cre floxed Ape mice (cre+ Zpc580S/580S) this
thesis reports the exploration of the role ofwild type Ape in the mouse mammary
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Figure 1.11. Mammary glands from cre+/4/?c580S/580S female mice
displayed delayed ductal growth. Wholemount mammary preparations from
control (cve+ Apc+l5&os) female mice (a,c,e,g,i) and experimental cre+/t/?c580S/58 littermates
(b,d,f,h,j). Ductal growth initiates at the nipple end of the fat pad (left) and advances
past the lymph node (LN) to completely fill the fat pad. The tip of the growing ductal
network is marked by an arrow and at all stages remains delayed in experimental glands.
Note that (i,j) show a 70 day mammary gland at parturition.








Figure 1.12. Mammary glands from experimental cre+/!/JC580s/580S
female mice display extensive metaplastic lesions. Haematoxylin and eosin
stained sections ofmammary glands from control (cre+^/?c+/580S) female mice (a,c,e)
and experimental cre+^c580S/58 littermates (b,d,f,g,h). Metaplastic lesions are
indicated by arrows and (g,h) show areas where metaplastic lesions extending into
ducts. Magnification X20 for (a-d) and X40 (e-h). Adapted from Gallagher et al., 2002.
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gland. Initial characterisation, involving proliferation analysis (BrdU, TUNEL (TdT-
mediated dUTP nick end labelling)) and immunohistochemical analysis of candidate
proteins (Ape, P-catenin, cyclinDl), supported a role of Ape in canonical Wnt
signalling in mammary gland secretory epithelial cells. DDRT-PCR was
incorporated into this analysis as a means of investigating the effect of Ape deletion
on expression levels of downstream genes. It was hypothesised that by using this
non-candidate gene approach, it would be possible to isolate novel downstream
targets of Ape in the mammary gland, thereby giving insight into this unexpected
phenotype. This involved expression profiling at several critical stages of mouse
mammary gland development, including mid-gestation, parturition, and lactation.
Differentially displayed genes (including Casein, al type IV collagen, Gm2a) were
subsequently cloned and, where possible, identified. Three novel clones isolated
from DDRT-PCR gels were subjected to cDNA library screening in an effort to
characterise them further. Despite these efforts, the relationship between mammary
gland metaplasia and Ape deficiency remains unclear. These observations highlight
the complexity ofApe function in mouse mammary gland secretory epithelium.
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1.7 AIMS
The aims of this thesis are the following:
1) Detailed phenotypic characterisation of the mammary gland of cre+
Apc58°S/58°S mke
2) Differential Display Reverse Transcription Polymerase Chain Reaction
(DDRT-PCR) analysis to identify transcriptional changes in response to loss of
Apc in the mouse mammary gland
3) Biochemical and functional analysis of two Wnt genes and WntlOa)
cloned from mammary gland cDNA
66
2 Materials and Methods
2.1 Basic Cloning Methodology
2.1.1 Agarose gel electrophoresis Of DNA
Agarose gel concentrations used varied from 0.5% to 2% w/v in Tris-borate EDTA
(TBE) depending on the size of the DNA molecules to be resolved. TBE gels were
prepared by boiling an appropriate mass of agarose powder (BioWhittaker Molecular
Applications) in TBE buffer until dissolved and supplementing with O.lmg/ml
ethidium bromide (EtBr)(Fisher Scientific). DNA samples (volumes ranged from 2-
50pl) were mixed with one-sixth volume of type III loading buffer (see Appendix A)
and loaded directly onto the gel. Molecular weight markers, 1Kb or lOObp (New
England Biolabs) were diluted in loading buffer and run parallel to DNA samples.
Electrophoresis was carried out in IX TBE at 50-100V for periods of 30 minutes to 2
hours, with the exception of genomic DNA which was performed at 40 Volts
overnight, and visualised using UV light on a transilluminator (Dual Intensity
Ultraviolet Transilluminator).
2.1.2 Restriction endonuclease digestion of DNA
All restriction endonucleases and appropriate buffers were purchased from Promega
Ltd., Boehringer Mannheim, Roche or New England Biolabs. Suitable amounts of
Plasmid DNA (lpg-5pg) were mixed with 0.1 volumes of 10X reaction buffer, 0.1
volumes of appropriate restriction endonuclease, and the volume made up to 20-50|li1
with ddH20. The digests were incubated for 90 minutes at 37°C. Double digests
were performed in a buffer/temperature combination giving efficient digestion with
both enzymes. Genomic DNA was digested as above however digests were
incubated at 37°C overnight to ensure complete digestion of genomic DNA.
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2.1.3 Phenol: chloroform extraction and ethanol precipitation of DNA
An equal volume of Phenol/Chloroform/Isoamylalcohol solution (P:C:I, 25:24:1,
AMS Biotechnology) was added to the solution containing nucleic acid, gently
vortexed and spun briefly at 13,000rpm for 5 minutes at 4°C. The upper aqueous
phase was removed to a clean tube and an equal volume of chloroform was added
and the sample vortexed and centrifuged as before. Nucleic acid was recovered from
the upper aqueous phase by transferring to a clean tube and the addition of 0.1
volumes of 3M sodium acetate (pH 5.5) and 2.5 volumes of 100% ethanol.
Following mixing by inversion several times the sample was incubated at -20°C for 1
hour to overnight. The nucleic acid precipitate was recovered by centrifugation at 13
OOOrpm for 20 minutes at 4°C. The ethanol was removed and the pellet washed with
200jll1 of 70% ethanol. A further centrifugation step was preformed at 13 OOOrpm for
5 minutes at 4°C. After removal of ethanol, the pellet was air dried at room
temperature for 5 minutes and resuspended in an appropriate volume of dEEO.
2.1.4 Extraction of DNA fragments from agarose gels
The QIAquick™Gel Extraction Kit (Quiagen) was used for the purification of DNA
fragments from agarose gels. DNA was digested with appropriate restriction
endonucleases and electrophoresed on an agarose-TBE gel containing ethidium
bromide. The bands were visualised with UV light and excised from the gel with a
clean scalpel. The gel slice was weighed and 3 volumes of Buffer QG were added
(eg. lOOpl of buffer QG per lOOmg of gel). The solution was heated to 50°C until the
gel had completely dissolved. One gel volume of isopropanol was added to the
solution, mixed briefly and applied to a Quiaquick spin column (placed in a 2ml
collection tube) and centrifuged for 1 minute at 13 OOOrpm. The flow-through was
discarded. To wash the DNA, 0.75ml of buffer PE was added to the column,
centrifuged for 1 minute at 13 OOOrpm and the flow-through again discarded. To
remove the last traces of buffer PE, the column was centrifuged once more then
placed in a 1.5ml eppendorf tube. To the centre of the column 30pl of water was
added and the column allowed to stand at room temperature for 1 minute. To elute
68
the DNA, the column was centrifuged at 13 OOOrpm for 1 minute and the elute
transferred to a fresh 1.5ml eppendorf tube. DNA samples extracted from gels in this
manner were electrophoresed to determine concentration and used immediately or
stored at -20°C.
2.1.5 DNA ligation reactions
2.1.5.1 Dephosphorylation of vector DNA
Vector DNA linearised with a single restriction endonuclease was dephosphorylated
with Calf Intestinal Phosphatase (CIP) (Boehringer Mannheim) prior to ligation with
insert DNA to prevent re-ligation of vector DNA. Blunt end ligation omitted this
step.
Following restriction digestion of an appropriate quantity of vector DNA (e.g. 5pg),
the DNA was phenol/chloroform extracted and ethanol precipitated as previously
described and resuspended in 16pl of water. To the DNA, 2pl (2units/pl) of CIP and
2pl of 10X reaction buffer was added, mixed and incubated at 37°C for 1 hour. To
denature the CIP, the reaction was heated to 70°C for 10 minutes. The
dephosphorylated DNA was purified by phenol/chloroform extraction and ethanol
precipitation as previously described and resuspended in water to a final
concentration of lOng/ul and stored at -20°C. Typically 10-15ng/ul of vector DNA
was used for ligation reactions. Ligation controls were also set up that contained no
insert but only dephosphorylated vector.
2.1.5.2 Ligation reaction (pBluescript® II KS (+) (pBS)(Stratagene),
pZErO™-2 (Invitrogen) and pGEM®-T Easy (Invitrogen))
The DNA to be used as insert in ligation reactions was first purified by agarose gel
electrophoresis and quantified on an agarose gel. An approximate 3-5 fold molar
excess of insert DNA was added to vector DNA (10-15ng/pl) and diluted to 8pl with
water. To the solution lpl of 10X ligation buffer was added followed by 1 jul T4
69
DNA Ligase (1 U/jll1; Boehringer Mannheim). The solution was incubated at 4°C
overnight.
2.1.6 Transformation of competent bacteria
Aliquots of TOP10 One Shot1M ultracompetent E. coli K12 derived cells (Invitrogen)
were removed from storage at -70°C and thawed on ice. Plasmid DNA was added
directly onto the cells and then mixed by tapping the tube gently. The cells and the
DNA were incubated on ice for 30 minutes, heat shocked in a water bath at 42°C for
30 seconds and returned to ice. 250pl of room temperature SOC media (Appendix
A) was added to the tube, which was then incubated at 37°C for 1 hour in a shaking
incubator at 225rpm. The transformed bacteria were plated onto LB-agar plates
containing appropriate antibiotics that selected for transformants. Plates were
inverted and incubated at 37°C overnight. However for routine transformations
DH5a E.coli cells were used. 200pl aliquots were removed from storage at -70°C
and transformations were as above however heat shock was 42°C for 75 seconds
followed by the addition of 400pl of 2XTY medium (Appendix A) and incubation at
37°C in a shaking incubator for 30 minutes before plating onto LB-agar plates
containing appropriate antibiotics that selected for transformants.
2.1.7 Preparation of plasmid DNA
Small-scale preparations of plasmid DNA were purified from transformed bacterial
cells with the QIAGEN QIAprep Spin Miniprep kits in accordance with the
manufacturer's instructions. A single bacterial clone was picked from a LB-agar
plate using a sterile toothpick. The clone was transferred to a Falcon 2059 tube
containing 1.5 ml of LB (see Appendix A) supplemented with appropriate antibiotics
and incubated in a shaking incubator (225rpm) at 37°C overnight. This overnight
bacterial culture was poured in a 1.5ml Eppendorf microcentrifuge tube and spun at
13,000 rpm for 1 minute. The supernatant was discarded and bacterial pellets were
resuspended in 250pl of resuspension buffer (50mM Tris-HCl, pH7.5, lOmM EDTA,
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1OOjag/ml RNase A). RNase A was added to this solution to avoid RNA
contamination in later nucleic acid purification steps. Bacterial lysis was
accomplished by adding 250pl of lysis solution (0.2M NaOH, 35mM SDS) and
mixed by inversion. The lysis reaction was subsequently neutralised by addition of
350pl of neutralisation buffer (1.32M potassium acetate, pH 4.8) and again mixing
by inversion. This latter step produces a protein precipitate, subsequently removed
by centrifugation at 13,000rpm for 10 minutes. Supernatants were transferred to
QIASpin filter tubes and placed in collection tubes; the liquid was passed through the
filter by centrifugation at 13,000rpm for 1 minute. 750pl of wash buffer (80mM
potassium acetate, 8.3mM Tris-HCl pH 7.5, 40pM EDTA, 55% (v/v) ethanol) was
added to the QIASpin filter tube followed by centrifugation for 1 minute at
13,000rpm. The collection tubes were emptied and the filter tubes spun again for 1
minute at 13,000rpm. QIASpin filter tubes were placed on fresh 1.5ml Eppendorf
tubes and 50pl of water was added to each tube. The tubes were incubated at room
temperature for 1 minute. The QIASpin/Eppendorfs were spun at 13,000rpm for 1
minute. The elute containing the DNA was used immediately or stored at -20°C.
In instances where quantities of plasmid DNA greater than that produced by the
miniprep method were required, 'midipreps' were prepared using a midiprep kit,
Qiagen Plasmid Midi Kit. The general protocol consists of inoculating a conical flask
containing 50ml of LB or 2XTY, supplemented with the appropriate antibiotics with
bacteria from suitable miniprep cultures. The bacteria were grown at 37°C for 12-16
hours in a shaking incubator at 225 rpm, harvested by centrifugation (6,000g for 5
minutes at 4°C, Heraeus #3046 roter, in a Heraeus Biofuge centrifuge), resuspended
and lysed and neutralised in manufacturer supplied solutions as for the miniprep
method. Protein precipitate was removed by centrifugation at 20,000g for 30
minutes at 4°C (JA-25 rotor in a Beckman Avanti J-25 centrifuge). Supernatant was
removed and re-centrifuged at 20,000g for 15 minutes at 4°C. Supernatants were
added directly to equilibrated QIAGEN-tips, and allowed to pass through the DNA
binding resin by gravity flow. Columns with bound DNA were washed with the
supplied buffers twice prior to elution ofDNA. DNA was removed from the column
using a supplied elution buffer and 0.7 volumes of isopropanol were added. The
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DNA was collected by centrifugation at 15,000g for 30 minutes at 4°C (JA-25 roter,
in a Beckman Avanti J-25 centrifuge). DNA pellets were washed with 70% ethanol
and recentrifuged. The final DNA pellet was dissolved in lOOpl of water and stored
at -20°C.
2.1.8 Preparation of bacterial glycerol stocks
Single clones were used to inoculate 1.5ml of LB supplemented with the appropriate
antibiotic and grown overnight at 37°C in a shaking incubator. 500pl of this culture
was added to 400pl of glycerol in a 1.5ml eppendorf and stored at -70°C. To
resuscitate the recombinant bacteria when required, a scraping of frozen glycerol
stock was transferred to 3ml of LB medium supplemented with the appropriate
antibiotic and propagated overnight at 37°C as previously described.
2.1.9 ExSite™ PCR-based site-directed mutagenesis
Plasmid DNA (0.5pmol) was added to a 25jul PCR mixture containing the following
reagents:
2.5pj 1 OX mutagenesis buffer




1 pi ExSite DNA polymerase blend
Cycling conditions were as follows
94°C - 4 minutes
50°C - 2 minutes
72°C - 2 minutes
94°C - 1 minute
56°C - 2 minutes
72°C - 1 minute
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72°C - 5 minutes
Following completion of PCR two populations of plasmids exist. The first population
contains the desired linear plasmids that contain the mutations in the double-stranded
DNA. The second population includes the parental plasmids that have not
incorporated the mutation. DNA was subsequently digested with lpl of the
restriction enzyme Dpn I, which cuts methylated DNA and will therefore only cut the
parental plasmid and leaves the PCR product undigested. The undigested linear DNA
was then end polished with 0.5pi of cloned Pfu DNA polymerase and the ends
ligated by incubation at 37°C for 1 hour with lpl of T4 DNA ligase. The ligated
DNA was then ready to be transformed.
2.2 Differential Display RT-PCR
2.2.1 Isolation of total RNA from murine mammary glands
All mammary glands dissected were collected in sterile 1.5ml eppendorf tubes, flash
frozen in liquid nitrogen and transferred to -70°C until required. The preparation of
all total RNA during this project was performed using The RNAzolIM B method
(AMS Biotechnology), based on the guanidinium thiocyante phenol/chloroform
extraction method of Chomczynski & Sacchi (1987). A variable speed polytron
homogeniser was used for the homogenisation of tissue. To clean the homogeniser
probe prior to homogenisation the probe was washed three times in 40ml of 0.2 M
NaOH and three times in 40ml ofwater. RNAzol™ B (2ml per lOOmg of tissue) was
dispensed into 50ml tubes (Greiner Labortechnik Ltd), stored on ice, and the tissue
transferred directly from liquid nitrogen. For homogenisation of mammary gland
tissue, 4ml of RNAzol B was used per 1 OOmg of tissue. The tissue was immediately
homogenised and 1ml aliquots transferred to 2ml eppendorf tubes. To each
homogenate, lOOpl of chloroform was added, the tubes mixed by inversion several
times and centrifuged at 13 OOOrpm for 15 minutes at 4°C. 500pl of the upper
aqueous phase was removed and transferred to a fresh 2ml eppendorf tube. An equal
volume of isopropanol was added and the tubes mixed by inversion several times.
Samples were incubated on ice for 15 minutes then centrifuged at 13 000 rpm for
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15minutes at 4°C. The RNA pellet was washed once with 75% ethanol, the last
traces of which were removed using a P2 Gilson pipette. RNA was resuspended
typically in 400pl of water by pipetting, 0.1 volumes of 3M sodium acetate and 2.5
volumes ethanol were added, the tubes vortexed briefly and stored as ethanolic
precipitates at -20°C. Prior to use, the tubes were vortexed before removing an
aliquot for preparation. To quantitate stock concentrations of total RNA, typically a
1 Opl aliquot was removed, centrifuged and quantified by spectrophotometry
2.2.2 Synthesis of first-strand cDNA
A volume, containing approximately 20pg RNA was centrifuged at 13 OOOrpm for
25 minutes at 4°C. The pellet was washed with 75% ethanol, dried at 45°C for 2
minutes and resuspended in lOpl of RNAse-free water. A small portion (2pl) of each
sample was used for spectrophotometric quantitation (an average of three readings
were taken) and 5pg total RNA (in 5pi volume) was used to synthesise first-strand
cDNA (First-strand cDNA synthesis kit; Amersham Pharmacia Biotech). Reactions
contained lpl DTT (200mM), 5pi of bulk first-strand mix (containing Moloney
Murine Leukaemia Virus reverse transcriptase) and 4pl of either d (T) u MA, d
(T)i2MG, d(T)i2MC, d(T)i2MT primer (24pM; M = A, G or C). Reactions were
mixed and incubated at 37°C for 1 hour and heated to 95°C for 10 minutes to
inactivate reverse transcriptase. Reactions were then dispensed into lpl aliquots on
0.5ml eppendorf tubes and stored at -20°C.
2.2.3 Differential Display PCR
For differential display PCR reactions, lpl of aliquoted cDNA was diluted to 133pl
with water and lOpl of this solution was used for each display PCR (equivalent to the
amount of cDNA produced from 25ng RNA). To each lOpl of cDNA on ice, 2pl of
arbitrary 10-mer primer (5pM) was added and the solution overlaid with 30pl
mineral oil (Sigma). Master mix (8pl) containing 2pl 10X PCR buffer (Boehringer
Mannheim), 2pl dNTPs (20pM; Amersham Pharmacia Biotech), 0.3pl Taq
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polymerase (1.5U; Boehringer Mannheim), 2pl of d(T)i2MN (25pM), lpl a35S
dATP and 0.7pl dH20 was added to each tube. Tubes were centrifuged briefly and
incubated in a Biometra Unoblock PCR machine at 94°C (2 minutes), followed by 40
cycles of 94°C denaturation (30 seconds), 40°C annealing (2 minutes) and 72°C
extension (3- seconds), followed by a final extension step at 72°C for 5 minutes.
Type III loading dye (4pl) was added to each tube and 8pl of each sample loaded
onto a 6% non-denaturing HR-1000 GenomyxLR polyacrylamide gel (Beckman
Instruments Ltd.), using GenomyxLR electrophoresis equipment. Samples were run
for 2 hours 15 minutes at 2700V (50°C) on a GenomyxLR DNA analyser (Beckman
Instruments Ltd.). The gels were transferred to 3MM blotting paper, dried and
subjected to autoradiography. The sequence identities of all arbitrary and anchored
oligonucleotides used for the DDRT-PCR analysis are listed in Appendix C.
2.2.4 Recovery of cDNA from dried polyacrylamide gels
Gel regions correspondi9ng to bands representing candidate cDNAs were excised
using sterile scalpels and transferred to sterile 0.5ml eppendorf tubes. Glogos,M
autoradiograph markers (Stratagene) were used to align the gel with the
autoradiograph and identical regions were excised from test and control lanes (e.g.
Cre+APC580S/+ / Cre"APC580S/580S or Cre+APC580S/580S). The gel fragments were
rehydrated by incubation at room temperature for 15 minutes in lOOpl water, and the
cDNA eluted at 99°C for 15 minutes before transfer of the liquid phase to fresh
0.5ml tubes. cDNA was precipitated by the addition of lpl See-DNA (Amersham
Pharmacia Biotech), 2.5 volumes ethanol, 0.1 volumes of 3M sodium acetate (pH
5.2) and stored on dry ice for 1 hour. Following centrifugation (13 OOOrpm, 25
minutes, 4°C) and washing with 75% ethanol the pellet was resuspended in 4pi of
water.
2.2.5 Modified single-strand conformation polymorphism (mSSCP)
For the mSSCP-PCR reaction 4pl 10X PCR buffer (Boehringer Mannheim), 3.2pl
dNTPs (2.5Mm dGTP, dCTP, dTTP; 0.025 mM dATP; Amersham Pharmacia
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Biotech), 2.5 p,l anchored primer (20p,M), 2.5p,l arbitrary primer (20qM), 0.3pl Taq
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polymerase (1.5U; Boehringer Mannheim), 0.5pl [ P]a-dATP was added to the
DNA and the reaction volume adjusted to 40pj with water. PCR conditions were
similar to those used for display-PCR, with exception that only 5 cycles were
performed. After removing the mineral oil, PCR products were purified by phenol
chloroform extraction. Pellets were washed, resuspended in 8pl of mSSCP loading
buffer (see Appendix A) and denatured at 95°C for 10 minutes prior to loading onto
a 0.5X MDE gel (Flowgen), cast using the GenomyxLR system. Samples were
electrophoresed typically for 18 hours at 8W (25°C) in 0.6X TBE buffer. Following
autoradiography, areas of the gel corresponding to candidate cDNAs were excised,
cDNA eluted and precipitated as previously described.
2.2.6 PCR re-amplification of mSSCP-purified candidate cDNAs
A final reamplification of the recovered cDNA was performed. Instead of the
original anchored and arbitrary primers, oligonucleotides were synthesised with
additional 5' Eco R1 restriction sites to aid cloning (herein referred to as extended
primers). Also, only one anchored oligonucleotide was used to cover d(T)i2MA, GA,
CA or TA. A full listing of oligonucleotides used is provided in Appendix C. The
reaction contained 4pl mSSCP purified cDNA, 4pj 10X PCR buffer (Boehringer
Mannheim), 3.2pl dNTPs (lOmM each dATP, dCTP, dTTP, dGTP, Amersham
Pharmacia Biotech), 2.5 ql each extended primer (20p.M), and 0.5pl Taq polymerase
(1,5U; Boehringer Mannheim) in a 40ql volume. Cycling conditions were as follows
94°C - 2 minutes
94°C - 30 seconds
40°C - 2 minutes — 1 cycle
72°C - 30 seconds
94°C - 30 seconds
58°C - 1 minute — 5 cycles
72°C - 30 seconds —
72°C - 5 minutes
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4°C - Hold
PCR products were subjected to EcoRl restriction endonuclease digestion, prior to
purification and cloning into the EcoRl site of pBluescript SKII+ (Stratagene).
2.2.7 'Cold' Southern blotting
The following procedure was performed for the rapid screening and validation of the
candidate clones prior to northern blotting. To the remaining 16pl of the original
completed DDRT-PCR reaction, 4pl of Type III loading dye was added, the tubes
centrifuged briefly and 10pl loaded onto a 1% TBE-agarose gel. Electrophoresis was
performed at 80V until the bromophenol dye had run approximately three-quarters of
the gel length. The gel was subsequently soaked for 30 minutes in denaturing
solution (1.5M NaCl/0.5M NaOH) and neutralised by soaking in 1.5M NaCl/0.5M
Tris-HCL (Ph 7.5) for 30 minutes. DNA was transferred to Hybond®-N nylon
membrane (Amersham Pharmacia Biotech) overnight by capillary action in 20 X
SSC buffer. Membranes were rinsed briefly in 2 X SSC, UV crosslinked and baked
at 120°C for 20 minutes. Probes were labelled as in section 2.7.4.2, and hybridisation
was as in section 2.7.4.1.
2.3 Polyacrylamide Gel Electrophoresis
2.3.1 Preparation and pouring of polyacrylamide gels
The following procedure was used for the preparation of polyacrylamide gels to be
used for electrophoresis of DDRT-PCR products, modified Single-Stranded
Conformation Polymorphism (mSSCP) products and DNA sequencing products. The
GenomyxLR electrophoresis system, GenomyxLR electrophoresis equipment and
GenomyxLR DNA analyser (Beckman Instruments Ltd.) were used for all three
electrophoresis protocols.
The casting plates were both washed thoroughly prior to preparation of the gel. Both
plates were rinsed with water and the larger of the two plates was cleaned with 50ml
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of 5 M Sodium hydroxide and then rinsed again with water. Both plates were then
cleaned with 100% ethanol and the smaller of the two plates, or notched plate, was
treated with a siliconising agent (Acrylgrease; Stratagene). The two plates were
separated by 0.2mm spacers, held in place by bulldog clips and placed horizontally
over a pouring tray. To the acrylamide solution to be poured, de-gassed under
vacumn, 500pl of 10% Ammonium persulphate (Anachem) and 50pl of N,N,N'N'-
Tetramethylethylenediamine (TEMED; Promega) was added and the solution mixed
by swirling. Using a disposable 50ml syringe (Beckton Dickinson Ltd.), the
acrylamide mix was poured between the glass plates, the appropriate combs placed in
position, held in place by bulldog clips, and the gel allowed to completely
polymerase over a period of 1 hour.
2.3.1.1 Non-denaturing polyacrylamide gels
Non-denaturing polyacrylamide gels were used for DDRT-PCR analysis. To prepare
a non-denaturing 6% polyacrylamide gel the HR-1000 polyacrylamide matrix
(Beckman Ltd.) was used. This was supplied as a 6% solution and required only brief
de-gassing and the addition of ammonium persulphate and TEMED prior to pouring.
2.3.1.2 Denaturing polyacrylamide gels
Denaturing polyacrylamide gels were used for sequencing analysis. The HR-1000
polyacrylamide matrix was used. This was supplied as a 6% acrylamide/8M urea
solution and required de-gassing and the addition of ammonium persulphate and
TEMED prior to pouring.
2.3.1.3 MDE Polyacrylamide Gels
For mSSCP analysis, 0.5X MDE polyacrylamide (Flowgen) was used. To prepare
this, 5.8ml of 10 X TBE and 18ml 2 X MDE solutions were mixed and diluted to
lOOmls with water. Immediately prior to pouring, ammonium persulphate and
TEMED were added.
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2.3.2 Drying of polyacrylamide gels
After electrophoresis was complete, the two glass plates were carefully separated so
that the gel remained on the larger of the two plates. For native polyacrylamide gels,
the gel was then transferred to an equal sized sheet of 3MM paper (Merck), and
secured to the larger plate and dried directly in the GenomyxLR at 50°C for
approximately 15 minutes. In the case of denaturing sequencing gels, the notched
plate was carefully removed and the gel dried directly in the GenomyxLR apparatus
for 15 minutes at 50°C. The gel was rinsed with 2 litres of water to remove urea and
dried again. This cycle of drying and rinsing with water was repeated until all traces
of urea were removed from the gel.
2.4 DNA sequencing
2.4.1 Fluorescent cycle sequencing of DNA (Automated Sequencing)
Plasmid DNA was prepared using the Qiaprep Spin Miniprep Kit (Qiagen) and
sequenced using the ABI BigDye™ Terminator Kit (Perkin Elmer Applied
Biosystems). Reactions were set up as follows in 0.5ml eppendorf tubes; lqg of
Plasmid template (in a volume not greater then 5pl), lpl of 10p.M sequencing primer,
4pj of ready reaction mix (containing dye terminators, deoxynucleoside
triphosphates, Ampli Taq DNA polymerase, magnesium chloride and buffer) and
water to a final volume of 10pl. Tubes were placed in a thermal cycler and cycling
conditions were as follows:
96°C - 1 minute
96°C - 30 seconds
50°C - 15 seconds




Once cycling was complete the DNA was precipitated by the addition of 2pil 1,5M
sodium acetate/ 250mM EDTA (pH= 8) and 50pj of ice cold absolute ethanol and
placed on ice for 10 minutes. Samples were then centrifuged at 13 OOOrpm, 4°C for
30 minutes, the supernatant was removed and the pellet was rinsed briefly in 200pl
of 75% ethanol. Following centrifugation at 13 OOOrpm, 4°C for 10 minutes, the
supernatant was removed and the pellet air-dried. Samples were then posted to the
DNA sequencing facility at the University of Oxford where automated fluorescence
label sequencing was carried out, and the results were received by FTP within a
week.
2.4.2 Fmol cycle sequencing (manual sequencing)
This protocol used the Fmol Cycle Sequencing Kit (Promega Ltd.) and is based on
the chain termination method originally described by (Sanger et ah, 1977). For each
DNA template four 0.5ml eppendorf tubes were labelled and placed on ice. To each
tube, 2pl of the appropriate ddNTP was added. The reactions were set up as follows:
DNA template (lpg) 8pl
Sequencing primer (3pmol/pj) 2pl
Water to a final volume of 1Opl
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To each primer/template sample, 5pl of sequencing buffer, 1 pi of [ ~S]a-dATP and I
pi offmol sequencing enzyme mix was added and mixed. To the inside wall of each
tube containing ddNTP, 4pl of the reaction mix was added. One drop of mineral oil
(Sigma) was added to each tube and after a brief centrifugation step, the tubes were
placed in a thermal cycler preheated to 95°C and the cycling conditions were as
follows:
95°C - 2 minutes
95°C - 30 seconds
55°C - 30 seconds




After the cycling program was complete, 3pi of STOP solution was added to each
tube. Each sample was denatured at 70°C for 5 minutes immediately prior to loading
on a 6% acrylamide/8M urea sequencing gel. In each lane, 3pi of sequencing was
loaded in the order A, G, C, T. Using the GenomyxLR system, the upper and lower
buffers were 0.5 X TBE and 1 X TBE respectively, and electrophoresis was
performed at 2700 V at 50°C for 2 hours and 45 minutes. Reliable sequence reads of
approximately 500bp were obtained.
2.5 Northern blotting
2.5.1 RNA formaldehyde gel electrophoresis
Northern analysis was used to confirm differential expression of the DDRT-PCR
candidate genes. RNA was fractionated by gel electrophoresis through 1%
denaturing formaldehyde agarose gels. To prepare the gels, 2g of RNAse/DNAse-
free agarose (Boehringer Mannheim) was added to 166ml of IX MOPS solution (see
Appendix A) in a 250ml sterile conical flask. The agarose was dissolved by heating
in a microwave on full power setting for 3 minutes. Once dissolved the solution was
allowed to cool to 60°C. Meanwhile, the gel casting tray, electrophoresis unit and
combs were cleaned with RNAseZAP (Invitrogen), followed by rinsing with water.
In a fume hood, 34ml of Formaldehyde (Fisher Scientific) was added to the agarose
solution, mixed and poured into the gel-casting unit. The combs were positioned and
the gel allowed to set for approximately 30 minutes. An appropriate volume ofRNA
(corresponding to lOpg of total RNA) stored as an ethanolic precipitate, was
prepared for gel electrophoresis by transferring to a 0.5ml eppendorf tubes on ice.
RNA was pelleted by centrifugation at 13 OOOrpm for 20minutes at 4°C. The ethanol
was removed by aspiration and the pellet washed with lOOpl of ice cold 75%
ethanol. Following a further centrifugation step for 5 minutes at 13 OOOrpm at 4°C
the ethanol was removed by aspiration, and the tubes placed on ice. RNA was
dissolved in 15pl of RNA sample buffer by pipetting. To denature the RNA the
samples were placed in a Biometra Unoblock Thermal Cycler (Anachem) and heated
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to 65°C for lOminutes. To each sample, 1 pi of a lOmg/ml stock of ethidium bromide
and 4pl of Typelll loading buffer was added. The tubes were pulse centrifuged and
placed on ice.
The combs were removed from the set agarose gel and the unit placed in the
electrophoresis apparatus and submerged in IX MOPS running buffer. The denatured
RNA samples were loaded into the appropriate wells of the gel. Electrophoresis was
performed at 60 Volts for approximately 3 hours. On completion of electrophoresis,
the gel was photographed in an identical fashion to DNA agarose gels, with the
exception that the UV transilluminator was first cleaned with RNAseZAP
(Invitrogen) and rinsed with water.
2.5.2 Northern blotting of RNA
After completion of electrophoresis, the formaldehyde agarose gel was first rinsed in
distilled water before submerging in 500mls of transfer buffer (10X SSC) for
approximately 1 hour. Meanwhile a sheet of Hybond®-N nylon membrane
(Amersham Pharmacia Biotech) was briefly equilibrated in transfer buffer. RNA was
transferred from the gel onto the membrane overnight. The membrane was
subsequently rinsed in 2XSSC, UV crosslinked and baked atl20°C for 20 minutes.
Membranes were stored between sheets of Whatman 3MM paper at room
temperature until ready to probe, see protocol for screening cDNA library.
2.6 Southern Blotting
2.6.1 Preparation of genomic DNA
Genomic DNA was prepared from mouse liver using the Nucleon Kit (Amersham
Life Sciences) for the extraction of genomic DNA from hard tissue. Briefly, 25mg of
liver was ground to a fine powder on dry ice using a pestle and morter. This was then
transferred to a 50ml falcon tube and 12ml of reagent B added. RNAse solution was
added to a final concentration of 400ng/ml and the tube incubated in a water bath at
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37°C for 30 minutes. Proteinase K was added to a final concentration of 50jug/ml and
the tube was incubated at 50°C overnight. The tube was centrifuged at 2000g for 5
minutes and the supernatant removed to a new tube. 3ml of 5M Sodium Perchlorate
was added and the tube inverted several times to mix, and then mixed on a rotary
mixer for 10 minutes at room temperature. 11ml of chloroform was added and again
mixed by inverting, followed by 10 minutes on a rotary mixer. The tube was then
centrifuged at 800g for 1 minute and 1600pl of Nucleon resin added gently down the
side of the tube. Taking care not to remix the phases, the tube was centrifuged at
1300g for 3 minutes. Without disturbing the Nucleon resin layer (brown in colour),
the upper aqueous phase was removed to a new 50ml falcon tube and recentrifuged
at 1300g for 3 minutes. The upper aqueous phase was again removed to a clean tube
and 2 volumes of ice-cold ethanol added. The tube was gently mixed by inversion
and the precipitated DNA was spooled out using a heat-sealed Pasteur pipette,
washed briefly in 70% ethanol and transferred to 4mls of TE. Incubating overnight at
37°C with gentle agitation dissolved the genomic DNA. DNA was quantified by
measuring the optical density, under UV light at a wavelength of 260nm, (based on
the fact that an OD of 1 equates to a concentration of 50pg/ml for DNA). 20pg of
genomic DNA was digested with restriction enzyme overnight at 37°C.
Following digestion, all samples were electrophoresed on a 0.8% agarose gel at low
voltage (40V) overnight (-16 hours). The gel was ethidium bromide stained and
images of the electrophoresed DNA were captured on a UV transilluminator (see
above) for later comparison. Transfer of the DNA to the nylon membrane was
improved by partial depurination ('acid nick') of the DNA prior to transfer. Partial
depurination was achieved by soaking the gel for 30 minutes in 0.2M HCI. The gel
was then soaked in 500ml of southern denaturation buffer for 30 minutes to denature
the DNA. After a brief rinse with water the gel was submerged in 500ml of southern
neutralisation buffer for 30 minutes. Meanwhile a sheet of Hybond®-N nylon
membrane (Amersham Pharmacia Biotech) was briefly equilibrated in transfer buffer
(10X SSC). DNA was transferred from the gel onto the membrane overnight. The
membrane was subsequently rinsed in 2XSSC, UV cross linked and baked at 120°C
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for 20 minutes. Membranes were stored between sheets of Whatman 3MM paper at
room temperature until ready to probe, see protocol for screening cDNA library.
2.7 Screening a phage cDNA library
2.7.1 Titration of genomic phage library
The lambda phage library (lactation day 10 mammary gland library) was titrated by
inoculating a known quantity of VCS257 E. coli host strain (Stratagene) with a serial
dilution of the library master stock, followed by culture in top agar to determine the
number of plaque forming units per ml (pfu/ml). The VCS257 E. coli host strain cells
were prepared by inoculating 50mls of lambda broth, supplemented with maltose to
0.2% and culturing overnight at 37°C. The bacteria for infection were grown in the
presence of maltose so as to optimise the efficiency of infection due to the fact that
phage attach to the maltose receptor on the bacterial surface. The culture was then
centrifuged at 6000g for 15 minutes, the pellet resuspended in 25mls of lOOmM
MgSC>4 and stored at 4°C. MgSCL is also required for phage attachment. The phage
library was kindly supplied by Dr. Christine Watson and was reported to have a titre
of 106 pfu/ml. A set of serial dilutions of the library stock were prepared (10~2, 10~4,
10"6 and 10"8 in SM buffer), and lOOul of E. coli cells added to lOpl and lOOpl of
each dilution. Tubes were mixed gently and placed in a 37°C water bath for 15
minutes to allow the phage to absorb to the bacteria. Lambda Top-Agar was melted
in a microwave and cooled to 47°C. 3mls of the molten top-agar was added to each
tube and swirled to mix, then poured onto the centre of a lambda agar plate (pre-
warmed in a 37°C oven). Plates were allowed to stand for 5 minutes to allow top
agar to set, then incubated overnight at 37°C. The plaques were counted and the
pfu/ml calculated.
pfu/ml = (no. of plaques) x (dilution factor) x(l x 103)
(no. of pi dilution used)
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2.7.2 Plating of genomic phage library
To get an appropriate representation of all the genes in the library ~1 million plaques
were plated out on a suitable number of 20cm x 20cm plates. The minimum number
ofmicrolitres of library stock needed per plate to achieve this density of plaques was
calculated from the pfu/ml determined for the stock. For each plate, a 600pl aliquot
of an overnight culture of VCS257 E.coli cells was inoculated with the desired
amount of library master stock (diluted with SM buffer (Appendix A)) and placed in
a 37°C water bath for 15minutes. Lambda Top-Agar was melted in a microwave and
cooled to 47°C. The infected culture was mixed with 25mls of Lambda Top-Agar
and supplemented to lOmM MgSCfi, and poured quickly onto 20cm x 20cm Lambda
Agar plates (pre-warmed in a 37°C incubator). When the agar had set, the plates
were inverted and incubated at 37°C until plaques had formed (~7 hours). Plates
were then Saran wrapped and stored at 4°C until needed.
2.7.3 Phage DNA Lifts
The library DNA was transferred from the plaque plates onto nylon membrane,
Hybond-N+ (Amersham) for screening by hybridisation. Duplicate lifts were taken
for each plate and following hybridisation only plaques that were positive on both
filters were picked. The corners of the membrane were marked for orientation
purposes and the membrane placed onto the agar surface. The plate was marked in
alignment with the marks on the membrane and after 1 minute the membrane was
removed from the agar to Whatman filter paper soaked in denaturing solution and
left for 30 seconds (DNA side facing up). During this time the second membrane was
placed onto the agar surface and marked in alignment with the marks on the plate and
after 1 minute removed to denaturing solution for 30 seconds. The membranes were
then removed to Whatman filter paper soaked in neutralising solution and left for 2
minutes after which time they were placed onto Whatman filter paper, UV cross-
linked and baked at 120°C for 20 minutes. Membranes were stored between
Whatman filter paper at room temperature.
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2.7.4 Primary screen of cDNA library
2.7.4.1 Prehybridisation
The prepared membrane was rolled between two hybridisation meshes in a
hybridisation tube (Hybaid) and 25mls of Church Hybridisation buffer (see
Appendix A), preheated to 65°C, was added, salmon sperm DNA was also added to a
final concentration of O.lmg/ml to reduce background hybridisation. Membrane and
buffer were incubated with rotation at 65 °C for 3 hours in a hybridisation oven
(Hybaid) to allow the membrane to equilibrate. Multiple membranes may be probed
in the same tube so long as sufficient meshes were used to allow even fluid flow.
2.7.4.2 Generation of radiolabeled probes
25-ng of clean probe DNA in 11 pi of dH20 (gel extracted restriction fragment or
PCR product) was radiolabeled with P-dCTP using High Prime enzyme
IT
(Boehringer Mannheim) by addition of 4pl of enzyme and 5pi of P-dCTP followed
by incubation at 37°C for 10 minutes. The reaction was stopped by the addition of
2pl 0.2M EDTA (pH8). Labelled probe was separated from unincorporated
nucleotides using a Sephadex G50 column (Amersham Pharmacia Biotech). The
column is equilibrated by centrifugation at 3000rpm for 1 minute. The radiolabeled
probe solution volume was made up to 50pl with dH20 and added to the column,
centrifuged at 3000rpm for 2 minutes and the elute containing the radiolabeled
probe was collected in a 1.5ml Eppendorf tube. Unincorporated nucleotides remained
in the column and it was discarded. The radiolabeled probe was denatured by
placing in a hot block at 100°C for 10 minutes, cooled rapidly in an ice/ethanol bath
for 1 minute and placed on ice.
2.7.4.3 Hybridisation
Following prehybridisation, the Church buffer was removed and lOmls of fresh
church buffer, preheated to 65°C and containing salmon sperm DNA, was added to
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the hybridisation tube. The radiolabeled probe was then added and the membrane
was incubated with rotation overnight at 65°C. The membrane was washed four
times for 30 minutes each in Church Wash (see Appendix A) at 65°C. Following
these washes the membrane was removed from the hybridisation tube, sealed in
Saran wrap and exposed to MR X-ray film (Kodak) in an autoradiography cassette.
Autoradiography cassettes were stored at -70°C for 2-5 days, depending on signal
strength. Autoradiography films were developed (Flyperprocessor, Amersham) and
primary and secondary filters compared for overlapping signals.
2.7.5 Secondary screen of phage clones
Positive plaques from the 1° screen were then subjected to a further round of
screening so as to achieve single homogenous clones. The positive plaques were
excised from the agar master plates and introduced into a 1.5ml eppendorf tube
containing 500pl of SM buffer and 20pl of chloroform. The phage DNA was left to
elute at 4°C overnight. This eluent was used to infect VCS257 (*) E.Coli cells at a
suitable density for well spread plaques to form on 10cm2 lambda agar plates.
Duplicate membrane lifts were then made and screened as for the 1° screen. Positive
individual clones were then identified and excised as before.
2.7.5.1 Preparation of phage DNA
Phage DNA was isolated using the Rapid Excision Kit (Stratagene) following
manufacturers instructions. Briefly, 5pl of lambda phage (~1000pfu), lOOul of
XPORT cells at OD60o of 1.0 and 10pl of 704 helper phage (10s pfu/ml) were mixed
and 3mls of NZY top agar was added to each sample. The entire sample was plated
separately onto NZY agar plates and incubated overnight at 37°C. The XPORT cells
support growth of the lambda phage, 704 helper phage and phagemid DNA, whereas
the XLOLR cells support only growth of the excised phagemid particles. Plaques
contain lambda phage, 704 helper phage, excised pBluescript® phagemid particles
and infected XLOLR cells. Turbid plaques were picked by touching with a toothpick
and grown overnight in LB-tetracycline-ampicillin broth. Only XLOLR cells
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containing phagemids with the ampicillin antibiotic resistance gene grew and the
DNA was then minipreped.
2.8 In vitro synthesis of capped mRNA
Ambions mMESSAGE mMACHINE™ kit was used for the in vitro synthesis of
capped mRNA (mimics most eukaryotic mRNAs in vivo, because it has a 7-methyl
guanosine cap structure at the 5'end) for subsequent injection into Xenopus embryos.
1 Opg of plasmid DNA (Wnt genes 1, 8b and 10a in the Xenopus expression vectors
pSP64TBX or pSP64TXB) was linearised by restriction digestion. The linearised
DNA was ethanol precipitated and resuspended at lpg/pl. The transcription reaction
was set up as follows:
Linear template DNA 1 pg
The transcription reaction was incubated at 37°C for 4 hours, lpl of DNase 1 was
then added and the reaction incubated for a further 15 minutes. The RNA was
recovered by ethanol precipitation and quantified by denaturing gel electrophoresis
alongside an aliquot ofRNA of known concentration.
2.9 Xenopus embryo injections
RNA transcribed in vitro (10ng/pl) was microinjected ventrally into two-cell stage
Xenopus embryos. Xenopus injections were performed by Dr. Stefan Hoppler.
Embryos were then cultured, at 18°C for 24 - 48 hours, and their development
monitored. Embryos were then fixed for 30 minutes in fresh 4% paraformaldehyde
and washed four times in IX PBS before photographing with a Leica digital camera.
2X NTP/Cap









5 pm sections were cut from paraffin embedded mammary glands and floated onto
vectabond-coated slides. Slides were stained with haematoxylin and eosin for
histological analysis.
2.10.1 Immunohistochemistry
Immunohistochemistry was carried out using either the DAKO EnVision plus system
(cat. no. K4006) or the ImmunoCruz staining system (Santa Cruz Biotechnology Inc.
cat. no. sc-896K) following the manufacturer's instructions. The Dako EnVision plus
system was used for p - catenin and cyclin D1 detection, p - catenin was detected
using a mouse monoclonal antibody (Transduction laboratories, cat. no. CI9220).
Antigen retrieval used lOmM citrate buffer, pH 6 and the slides were microwaved
three times at 700Watts for 5 minutes. The antibody was titrated and used at an
optimal concentration of 1 in 50 dilution overnight at 4°C. Cyclin D1 was detected
using a mouse monoclonal antibody (Nova Castra cat. no. DCS-6). Antigen retrieval
used Dako high pH target retrieval solution (Dako Corporation, cat. no. S3308) and
the slides were incubated in preheated solution in a water bath at 95-99°C for 30
minutes, the slides were then removed from the water bath and allowed to cool in
solution for 20 minutes. Following antibody titre the optimal concentration was 1 in
100 dilution overnight at 4°C. The DAKO EnVision kit comes with a peroxidase
labelled polymer conjugated to goat anti-mouse immunoglobulins. Staining is
visualised with 3,3'-diaminobenzidine (DAB) +substrate-chromagen which results in
a brown-coloured precipitate at the antigen site. The ImmunoCruz staining system
was used for APC and al type IV collagen detection. Antigen retrieval for both was
lOmM citrate buffer, pH 6. Slides were heated in solution at 95°C for 5 minutes,
fresh buffer was added and heated again for 5 minutes at 95°C. Slides were then left
to cool in buffer for 20 minutes. APC was detected using a c-terminus antibody
(Midgeley C.A. et. ah, 1997), at 1 in 100 dilution overnight at 4°C. al type IV
collagen was detected using a rabbit polyclonal antibody (Santa Cruz Biotechnology
Inc. cat. no. sc-11360), at 1 in 100 dilution overnight at 4°C. The ImmunoCruz
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staining system employs a biotinylated goat anti-rabbi secondary antibody, followed
by HRP-streptavidin complex and staining is visualised as before using DAB.
Immunohistochemical techniques were also used to detect BrdU and Tunel (TdT-
mediated dUTP nick end labelling) staining. Animals were injected with BrdU (70pg
in sterile saline, i.p.), 2 hours before sacrifice. Antigen retrieval used 0.1% trypsin in
0.1% calcium chloride for 20 minutes in 37°C water bath, followed by IM HCL for
10 minutes in 60°C water bath. Detection of BrdU incorporation was by an anti-
bromodeoxyuridine-peroxidase antibody (Roche cat. no. 1585 860), at 1 in 10
dilution for 45 minutes at room temperature. The rest of the protocol used the DAKO
EnVision plus system as above. The ApopTag Peroxidase In Situ Apoptosis
Detection Kit (Intergen Company, cat. no. S7101) was used for Tunel detection.
2.11 General tissue culture
2.11.1 Human embryonic kidney (HEK 293) cells
Human embryonic kidney (HEK 293) cells were obtained from European Cell
Culture Collection. To thaw cell lines for culture, aliquots of cells stored in
CryoTubeIM vials (Nunc) were thawed with agitation in a prewarmed 37°C water
bath. The rapidly thawed cell suspensions were then dispersed into 25mls of culture
media, RPMI 1640 medium (Invitrogen) supplemented with 10%(w/v) foetal calf
serum (FCS), 20mM L- Glutamine (Sigma), 20U/ml Penicillin (Sigma) and 20pg/ml
Streptomycin (Sigma). Cells were incubated at 37°C in an atmosphere of 5% CO2 in
Sanyo CO2 incubators. Cells were cultured in disposable sterile plastic ware (flasks
and petri dishes) supplied by Nalge-Nunc or Greiner.
2.11.2 Trypsinisation of cells (T75 flask)
The medium was aspirated off the cells. A few mis of PBS buffer was added and the
flask gently swirled to wash the cells. PBS was then aspirated off and approximately
lml of Trypsin solution was added and gently swirled over the surface of the cells.
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The flask was incubated at 37°C until cells started to come off the culture flask when
gently tapped, typically 2-3 minutes. 2mls of culture medium was added to the flask
and a Pasteur pipette was used to break up the cell clumps and wash the surface of
the flask. All of the liquid was transferred into a 15ml centrifuge tube containing
8ml of culture medium, mixed by pipetting and centrifuged for 5 minutes at
lOOOrpm. The medium was aspirated off and the bottom of the tube tapped to loosen
the pellet. The pellet was resuspended in lOmls of PBS and centrifuged again for 5
minutes at lOOOrpm. PBS was aspirated off and the bottom of the tube tapped to
loosen the pellet. The cells were then either split into fresh medium by resuspending
in l-2mls of medium and plated at a density of 2.5 x 106 cells/ml. Alternatively,
frozen stocks of cells were made by resuspending the pellet in 1-2 mis of freezing
mix to a concentration of 3-5 x 106 cells/ml.
2.11.3 Lipid based transfection with FuGene™6 transfection reagent
Tissue culture cells were transfected with exogenous DNA using FuGeneIM6
transfection reagent (Boehringer-Mannheim), which forms DNA/lipid conjugates.
FuGeneIM6 contains a novel blend of lipids that do not form liposomes and which
have a very low level of cytotoxicity. The reagent can be used in the presence of
serum and yields a high level of transfection efficiency over a broad range of DNA
concentrations. On the day prior to transfection each well of a 6-well plate was plated
withlxlO5 F1EK 393 cells. Each well was therefore approximately 50-80% confluent
upon transfection. lOOpl of serum free medium (RPMI 1640) was aliquoted into a
sterile 1.5ml eppendorf tube, one tube per transfection. Following the addition of 3-
6pl of FuGene1M6, ensuring that the pipette does not touch the sides of the tube, the
tubes were incubated at room temperature for 5 minutes. During this incubation step,
the DNA (0.5 - 1.5pg) to be transfected was aliquoted into separate sterile 1.5ml
tubes. The FuGene1M6/medium mix was added directly to the DNA and tapped to
mix. This was incubated at room temperature for 15 minutes after which time the
entire FuGene™6/medium/DNA mix was added to the corresponding well of a 6-
well plate and swirled to mix. Cells were incubated as before, at 37°C in an
atmosphere of 5% C02 in Sanyo C02 incubators.
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2.11.4 Isolation of stably transfected clones
HEK 293 cells were transfected with a series of Wnt genes {Wnt1, Wnt8b and
WntlOa) in two different expression vectors (Cags and PGK). Both of these
expression vectors carry a second antibiotic resistance gene for Hygromycin B. In
order to select for stably transfected clones the medium was changed after 24 hours
to one which contained Hygromycin B at a concentration of 1 OOpg/ml. Fresh
Hygromycin B containing medium was added after 48 hours so as to remove any of
the dead untransfected cells. The stable clones were grown for about 1 week, after
which time the wells was 100% confluent. Cells were now ready to be split into fresh
Hygromycin B containing medium or to be frozen down as stocks.
2.11.5 Tunicamycin treatment
Tunicamycin (Calbiochem) is an inhibitor of N-linked glycosylation and was added
to subconfluent stably transfected HEK 293 cells at either lpg/ml overnight or at
5|ag/ml for 6 hours prior to protein isolation and electrophoresis.
2.11.6 C57MG mouse mammary epithelial cells
C57MG mouse mammary epithelial cells were grown in DMEM (Invitrogen)
supplemented with 10%(w/v) foetal calf serum (FCS), 20U/ml Penicillin (Sigma),
20pg/ml Streptomycin (Sigma) and 10p.g/ml insulin (Sigma). Cells were incubated at
37°C in an atmosphere of 5% CO2 in Sanyo CO2 incubators. Because the parental
cell line exhibits spontaneous morphological alterations, limited dilution cloning
isolated a subline that more stably maintains a flat morphology. Cells were split as
for section 2.9.2 and stable transfection of Wnt expressing plasmids was performed
as for sections 2.9.3 and 2.94. Stably transfected clones were pooled and after
24hours the medium was changed to one that was serum free as the morphological
changes induced by Wnt genes are more readily observed in this medium. The
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morphology was assessed and cells photographed at confluence with a Leica digital
camera and inverted microscope.
2.11.7 Harvesting cells for protein (T75)
Cells to be harvested for protein analysis were washed twice with ice-cold PBS after
removal of culture media. Cells were removed from the plastic surface in 10 mis of
PBS using a cell-scraper (Nalge-Nunc) and the resulting suspension was collected in
a 15ml centrifuge tube. This was then centrifuged at lOOOrpm for 5 minutes and all
of the PBS aspirated off. The pellet was resuspended in 200pl of TENT buffer
(Appendix A) containing ImM Pefabloc, lOmg/ml Aprotinin, 2mg/ml Leupeptin and
1 nig/ml Pepstatin. Cells were lysed by incubation on ice for 20 minutes. Cells were
then centrifuged at 10 OOOrpm, 4°C for 10 minutes. The protein containing
supernatant was then aliquoted into 20pl samples and stored at -70°C.
2.12 Protein quantification
Quantification of protein concentration in tissue lysates was carried out using the
BCA protein Assay Kit (Pierce). Briefly, fifty parts BCA reagent A were mixed with
one part BCA reagent B (see Appendix A) to create the working BCA reagent
solution. A protein concentration standard curve was generated by preparing a set of
dilutions, (2, 1.5, 1.0, 0.750, 0.5, 0.25, 0.125, 0.025 and 0 mg/ml) of Bovine Serum
Albumin (BSA, supplied) in sterile test tubes. lOpl of each standard and unknown
sample to be assayed was placed in a test tube. 200pl of the working BCA reagent
solution was added to each test tube, mixed and incubate at 37°C for 30 minutes. At
the end of this incubation the tubes were cooled to room temperature and the
absorbance at 562nm of each solution determined relative to a water blank. A
standard curve was generated from the 562nm absorbance of the known BSA
concentration samples and the protein content of each of the unknown tissue lysates
determined by comparison to the standard curve.
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2.13 Endoglycosidase treatment
Endoglycosidase H (Endo H) (New England Biolabs) treatment of protein samples,
prior to electrophoresis, removes the N-linked carbohydrates and converts proteins to
their unglycosylated forms. Protein samples (20pg) were denatured in IX denaturing
buffer (0.5% SDS, 1% p-mercaptoethanol) by incubation at 100°C for 10 minutes.
1/10th volume of 10X G5 reaction buffer (50mM Sodium Citrate (pEl 5.5 at 25°C))
and 2.5pi 1 of Endo H were added and the samples incubated at 37°C for lhr/4hr/24hr
prior to protein electrophoresis.
2.14 Western Blotting
2.14.1 Protein electrophoresis
SDS-polyacrylamide gel electrophoresis was accomplished on precast 10% Tris-
Glycine gels in an Xcell SureLock IM mini cell tank (Novex). A volume of sample
containing 20pg of total protein (5-20pl) was made up to a total volume of20pl with
TENT Buffer. 5pl of 4x SDS-Sample Loading buffer (Novex) and 2.5pl of lOx
Sample Reducing agent were added to the protein samples. The samples were heated
to 95°C for 5 minutes and then centrifuged briefly. Gel wells were then loaded with
samples and electrophoresed at 150V in parallel with a molecular weight marker
(Multimark from Invitrogen) in MOPS SDS running buffer (Novex) at room
temperature for 3 hours.
2.14.2 Protein transfer
Protein was transferred onto PVDF membrane (Bio-Rad Laboratories) via
electrophoresis at a constant current of 250mA(I did 50volts) over night in transfer
buffer (Appendix A). Transfer was carried out at 4°C in an XCell II™ blot module
which fits into the Xcell SureLock IM mini cell tank (Novex). Following transfer
gels were stained in GelCode (Pierce) to determine transfer efficiency and to check
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loading levels in the individual wells. Gels were placed in 15 ml of stain solution in a
Coplin jar and gentle rocked for l-2hours then destained in dH^O for 2-6 hours.
Destained gels were place on 3MM Whatman filter paper and dried in a vacuum
apparatus. PVDF membranes were stained in Ponceau S (Sigma) to ensure that the
protein transfer was efficient and even through out. Membranes were placed in 1 Omls
of stain solution in a Coplin jar and incubated for up to one hour with gentle
agitation, then the background removed by rinsing in distilled water. The stain could
be completely removed from the protein bands by continued washing.
2.14.3 Antibody incubation
Protein blots were transferred to 50ml centrifuge tubes with 10ml of blocking
solution (10% non-fat dried milk powder (w/v)(Marvel, Nestle, UK) in TBST
(Appendix A) and placed on a roller mixer. Blots were blocked in this solution for 3
hours at room temperature. Following blocking, a 1/500 dilution of primary antibody
solution (HA-Probe, rabbit affinity-purified polyclonal antibody raised against a
peptide mapping to an internal region of the influenza hemagglutinin (HA) protein
(Santa Cruz Biotechnology, Inc.)), was added to the blocking solution and the blots
incubated in the same manner for 2 hours at room temperature. The primary
antibody solution was then poured off and the blot washed 3 times for 10 minutes in
10ml TBST at room temperature. The blot was then incubated with a 1/5000 dilution
of HRP-conjugate secondary antibody solution (HRP anti-rabbit IgG, Diagnostics
Scotland) in 10ml of 10% Marvel (Nestle, UK) in TBST at room temperature for 1
hour. The blot was washed as above prior to signal detection.
2.14.4 Signal detection
Signals were detected using the ECLimP1us Chemiluminescent detection system
(Amersham Pharmacia Biotech). For each blot detection solutions A and B were
mixed in a ratio of 40:1 (eg. 2ml solution A and 50pl solution) just prior to
application. The blot was placed on a sheet of SaranWrap1M, protein upwards, and
the mixed reagent solution pipetted onto its surface. The reagents were left in contact
95
with the blot for 5 minutes at room temperature then poured off. The blot was then
placed between 2 acetate transparencies, and transferred to an x-ray film cassette.
While in a dark room, the blot was then overlaid with ECL™ film (Amersham) for
periods of 30 seconds to 10 minutes, depending on signal intensity. Films were
developed (Hyperprocessor, Amersham), digitally scanned (DeskScan II, Hewlett
Packard) and bands quantified with densitometry software (Aida, Microsoft).
2.15 Animal work
2.15.1 Isolation of genomic DNA from murine tissues
All mice used were genotyped from tail or ear biopsies. The following protocol was
used to isolate genomic DNA from mouse ear biopsies and quantities were doubled
for tail biopsies. Ear biopsies were supplied in a 1.5ml eppendorf tube and 250pl of
Lysis buffer (Appendix A) was added. Tubes were incubated for 3 hours (if tail
biopsy then overnight) in a 55°C shaking water bath. An equal volume of phenol
chloroform was added to each sample and inverted several times to mix, and
centrifuged at 13 OOOrpm for 1 minute. The upper aqueous phase was transferred to a
fresh 1.5ml eppendorf tube and the DNA precipitated by the addition of l/10th
volume of 3M NaOAc and 2.5 volumes of 100% ethanol. The tubes were vortexed to
mix and incubated at -20°C for at least 1 hour. DNA was pelleted by centrifugation
at 13000rpm for 15 minutes, and 150pl of ddH20 added to each tube. To remove all
traces of ethanol and to dissolve the DNA the tubes were incubated in a PCR block at
55°C for 45 minutes. The samples were vortexed to mix then pulse centrifuged to
collect the sample in the bottom of the tube. DNA was then ready to be used in a
PCR reaction to determine the genotype of the mouse.
2.16 Gene specific PCR
Standard PCR amplification of specific DNA fragments was performed using Taq
thermostable DNA polymerase (Promega) and accompanying 10 X reaction buffer
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(Appendix A) and magnesium chloride (25mM). 25pM dNTP's (Amersham
Pharmacia Biotech) were used at a concentration of lOmM (2.5mM each of dATP,
dCTP, dGTP and dTTP) and unless otherwise stated all primers were used at a
concentration of 1 OpM. (Genotyping primer pairs and reaction conditions were taken
from the referenced publications and for all other reactions primers were chosen
from a number of primer pair options supplied by Primer3, a web base primer design
software program (http://www.genome.wi.mit.edu/cgi-bin/primer/primer3.cgi))
Reaction volumes of 20pi were used and reactions were carried out in 0.5ml thin-
walled microcentrifuge eppendorf tubes in a standard thermocycler (Peltier Thennal
Cycler). Unless otherwise stated, all PCR reactions were set up as follows:
DNA template xpl
Typically a master mix containing all the above reagents was prepared, on ice and an
appropriate volume added to 0.5 ml eppendorf tubes containing DNA template.




Taq DNA polymerase (5U/pl)
Water to a final volume of







Table 2.1 PCR reaction primers and conditions













94°C - 3 minutes
94°C - 30 seconds









180bp 94°C - 3 minutes
94°C - 30 seconds
55°C - 30 seconds








164bp 94°C - 2minutes
94°C - 30 seconds
60°C - 30 seconds









590bp 94°C - 1 minute
94°C - 30 seconds
55°C - 30 seconds









210bp 94°C - 1 minute
94°C - 30 seconds
55°C - 30 seconds









402bp 94°C - 1 minute
94°C - 30 seconds
55°C - 30 seconds








973bp 94°C - 3 minutes
94°C - 30 seconds
55°C - 30 seconds










577bp 94°C - 3 minutes
94°C - 30 seconds
55°C - 30 seconds









497bp 94°C - 3 minutes
94°C - 30 seconds
55°C - 30 seconds








300bp 94°C - 3 minutes
94°C - 30 seconds
50°C - 30 seconds








223bp 94°C - 3 minutes
94°C - 30 seconds
55°C - 30 seconds








261bp 94°C - 3 minutes
94°C - 30 seconds
55°C - 30 seconds








288bp 94°C - 3 minutes
94°C - 30 seconds
55°C - 30 seconds








813bp 94°C - 3 minutes
94°C - 30 seconds
55°C - 30 seconds








255bp 94°C - 3 minutes
94°C - 30 seconds
55°C - 30 seconds
72°C - 40 seconds
34 cycles
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Table 2.2 Primers to PCR novel genes out of library













94°C - 3 minutes
94°C - 30 seconds
55°C - 30 seconds
72°C - 40 seconds
34 cycles
70°C - 10 minutes

















3 Characterisation of cre+ Apc580SI580S mice
3.1. Introduction
Section 1.6.3 introduced a method of conditional inactivation of Ape in the mouse
cor\o/corjo
mammary gland. Briefly, mice harbouring a floxed allele of Ape (Ape ) were
crossed to transgenic mice expressing a transgene that drives expression of ere
recombinase specifically in the mammary gland (BLG-cre), and the progeny, BLG-
l SROS/S^OS # *
ere floxed Ape mice (ere Ape ), underwent specific inactivation ofmammary
Ape (Gallagher et al., 2002). The authors identified a role of Ape in the normal
I SROS/SRflS
growth of virgin mammary glands by observing that mutant (ere Ape ) glands
grow more slowly than controls (cre+ Apc+/580S and ere" /lpc580S 580S)(Figurc 1.11). In
addition, cre+ Apc580S/580S mice develop numerous small areas of metaplasia in the
ductal epithelium as a consequence of loss ofApe. Pregnancy in these mice results in
multiple extensive metaplastic nodules, however none of these lesions progress to
neoplasia (Figure 1.12) (Gallagher et al., 2002).
A variety of approaches were taken to investigate these interesting phenotypes. To
determine the extent of Ape deletion in cre+ Apc5HOS/5HOS mouse mammary glands, a
combination of Southern and northern blot analysis was used to identify levels of
both Ape excision and expression in dissected mammary gland extracts. In addition,
the distribution ofAPC protein was examined using a C-terminal antibody (Pab3161)
(Midgley et al., 1997). Considering the function of APC in the canonical Wnt
signalling pathway (Munemitsu et al., 1995), an immunohistochemical study of
candidate Wnt signalling proteins was incorporated into this analysis in combination




Control genotypes ere Ape and ere" Ape ' gave the same result and thus
only one control image is shown from either genotype.
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3.2.1 Ape excision and expression levels in cre+ Apc580SI580S mouse
mammary glands
Although it was originally anticipated that in driving ere expression from the
promoter of a milk protein gene (BLG) the effects of ere mediated Ape deletion
would be found primarily in the lactating mammary gland, substantial ere activity
was observed at earlier stages of mammary gland development (Gallagher et al.,
(2002). In order to confirm BLG-cre recombinase mediated Ape excision and
* * ~F 580S/580S
determine the temporal deletion of Ape in ere Ape mouse mammary glands,
Southern blot analysis of whole mammary gland extracts (minus lymph node) from
these mice was performed. Genomic DNA extracted from littermate control (cre+
Ape+/580S and ere" Apc580S/580S) and mutant (cre+ Apc580S/580S) mouse mammary glands
at four stages of development (mid-gestation, parturition, lactation day 2 and lactation
day 4) was digested overnight with the restriction enzyme Xbal (see section 2.2.1).
Digested DNA was subsequently electrophoresed on a 0.8% agarose gel, blotted onto
a nylon membrane, and incubated overnight with radiolabelled probe (Probe A,
Shibata et ah, 1997) (see Figure 3.1). Autoradiographs of the Southern blot displayed
I 580S/580S
two major bands in mutant (ere Ape ) lanes (the probe failed to detect the
floxed allele in control samples). The predominant band resolved at approximately
9.0kb, close to the expected size of the floxed allele. The excised allele resolved at
7.0kb and was observed from parturition. Excision levels appeared to increase in
lactating mice however due to the weak signal quantitation was not possible (Figure
3.1). Therefore, alternative methods of calculating Ape deletion in cre+ Apc580S/580S
mouse mammary glands were employed. Nevertheless, this data confirms BLG-cre
recombinase activity in the mouse mammary gland prior to lactation.
Northern analysis was used to examine Ape expression levels in both control (cre+
a +/580S . - A 580S/580S\ . + A 580S/580S , i T , ,Ape and ere Ape ) and ere Ape mouse mammary glands. Total
RNA isolated from both control and mutant mouse mammary glands at four stages of



































































































































agarose gel, blotted onto a nylon membrane and incubated overnight with
radiolabeled probe (see section 2.5). A probe designed against a 160bp region ofApe
exon 14 (the exon deleted during BLG-cre mediated recombination) hybridised with
the transcript derived from the floxed allele of cre+ Apc580s/580s mice. Autoradiographs
• -F 5ROS/5ROS
demonstrated decreased Ape mRNA levels in ere Ape mice from mid
gestation relative to controls. A second smaller band was observed which followed a
similar expression pattern albeit at lower levels which may represent an alternative
splice variant ofApe in the mammary gland (Figure 3.2).
3.2.2 Characterisation of metaplastic lesions from cre+ 4pC580S/580S
mouse mammary glands
As described in section 1.6.3, the phenotype of mice with conditional inactivation of
I S^OS/SROS * " *
the Ape gene (ere Ape ) in the mammary gland includes the formation of
metaplastic nodules. To further characterise these lesions immunohistochemical
staining for Ape, p-catenin, and cyclin D1 was performed on sections of day 10
lactation control (cre+ Ape'1-/5808 and ere" Apc5H<>HoH"s) and mutant (cre+ Apc580S/580S)
mouse mammary glands. In addition analysis of BrdU incorporation and TUNEL
were used to monitor cell proliferation and death in both normal and metaplastic
epithelium. It was anticipated that this analysis may provide clues as to the molecular
events underlying metaplasia in cre+ Apc580S/580S mouse mammary glands.
3.2.2.1 Ape
Ape protein distribution in both control (cre+ Apc+h8{)8 and ere" Apc5S0S/580S) and
I SR0S/^80S * *
mutant (ere Ape ) mouse mammary glands was examined using a C-terminal
Ape antibody (Pab3161), kindly supplied by Dr. Inke Nathke (Figure 3.3a) (Midgley
et al., 1997). Immunohistochemical staining of sections from control day 10 lactating
l f/SROS 580S/580S
mammary glands (ere Ape and ere" Ape ) demonstrated Ape expression
within the alveoli. At high magnification, staining appeared predominantly
cytoplasmic and was concentrated towards the apical surface. Sections from day 10
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Figure 3.3 Immunohistochemical analysis of Ape expression
(a) Structural features of the APC tumour suppressor protein. The region recognised by
the C-terminal APC antibody is indicated (Midgley et al., 1997).
(b) Immunohistochemical analysis ofApe expression in (i) control (cre~^/?c580S/580S) and
(ii) experimental (cre+^/tc580S/580S) lactation day 10 mouse mammary glands. Brown
staining, representing Ape expression, is located cytoplasmically within the alveoli in
control mammary glands. Arrow identifies metaplastic lesion which has lost Ape
expression.
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normal epithelium but exhibited a significant loss of Ape protein within the
metaplastic lesions (see Figure 3.3b).
3.2.2.2 p-catenin
P-catenin (see section 1.3.4.2) functions to mediate cellular adhesion through
interactions with E-cadherin and additionally as a key regulator in the control of gene
expression through the Wnt/Wingless pathway (Gumbiner et al., 1995; Aberle et al.,
1996). Immunohistochemistry was used to examine whether P-catenin was
_i_ 580S/580S
dysregulated as a consequence of Ape deletion in ere Ape mouse mammary
glands (see section 2.8.1). Normal mammary acinar epithelium stained only at the
cell membrane where P-catenin was found in adherens junctions (Figure 3.4(i)). In
contrast, balls of metaplastic squamous epithelium stained strongly for P-catenin
throughout the cell cytoplasm and nucleus (Figure 3.4(h)). However little or no P-
catenin expression was observed in the mature squamous epithelium (Figure 3.4(h)).
3.2.2.3 Cyclin D1
Expression of cyclin D1 (see section 1.5.1.3.2), a putative target gene activated by
the P-catenin-TCF/LEF pathway, was analysed by immunohistochemistry in control
(ere" Ape580S/580S) and mutant (cre+ ^(pc580S/580S) mouse mammary glands (see section
2.8.1). Expression of cyclin D1 was infrequent (<2%) in normal mouse mammary
epithelium (Figure 3.5(i)). In contrast, increased levels of cyclin D1 (-10%) were
detected in the nuclei ofmetaplastic lesions (Figure 3.5(h)).
3.2.2.4 Proliferation analysis
In order to investigate whether the metaplastic areas were composed of cycling cells,
BrdU incorporation assay was used to identify cells that had undergone S phase.
Animals were injected with BrdU (70ug/g in sterile saline, i.p.) 2 hours before
sacrifice. Paraffin-embedded mammary glands were sectioned and stained with an


















































































































































epithelium (where low level BrdU staining was observed)(Figure 3.6(i)), cre+
roAO/^OAC
Ape mouse mammary glands displayed an obvious increase of BrdU labelled
cells in the metaplastic lesions (Figure 3.6(h)). TUNEL analysis was used to identify
cell death within the metaplastic nodules (see section 2.8.1). Squamous cells within
the metaplastic lesions were found to be weakly TUNEL positive (Figure 3.6(iii)).
This observation may reflect a process of anucleation within these cells, which
ultimately results in the formation of 'ghost' nuclei and open spaces (Figure 3.4g).
3.3 Discussion
3.3.1 Ape inactivation dysregulates Wnt signalling in mouse mammary
gland metaplastic lesions
Ape mutation is associated with mammary tumourigenesis in both humans (Furuuchi
et al., 2000) and mice (Moser et al., 1993). Hyperplasia and malignant transformation
have previously been reported in mouse mammary epithelium when Wnt], Wnt10b,
cyclin D1 or truncated forms of [3-catenin (AN89 and AN90) are overexpressed
(Tsukamoto et al., 1988; Edwards et al., 1992; Wang et al., 1994; Imbert et al., 2001;
_l_ SROS/SROR
Michaelson and Leder, 2001). The phenotype of ere Ape mice, which have
undergone conditional inactivation of Ape from the mammary gland, involves the
development of small areas of metaplasia in the ductal epithelium which increase in
size and number during pregnancy but do not progress to neoplasia.
Immunohistochemical staining confirms loss of Ape expression within the
metaplastic lesions. In addition, lesions stain strongly for P-catenin throughout the
cell cytoplasm and nucleus, consistent with a critical role of Ape in regulating p-
catenin levels. Stabilised p-catenin translocates to the nucleus and interacts with
TCF/LEF transcription factors resulting in the activation of target genes, including
cyclin D1 (Behrens et al., 1996; Molenaar et al., 1996; Hsu et al., 1998).
Consequently, metaplastic lesions displayed an increase in cyclin D1 staining, a
feature which correlated with an increase in cell proliferation as determined by the








































































































Ape deletion represent an increase in the numbers of a specific cell type, for example
squamous cells. Importantly, in this study dysregulated Wnt signalling (due to
conditional inactivation of Ape from the mouse mammary gland) did not result in
neoplasia. In this respect it is noteworthy that TUNEL analysis confirmed the
presence of apoptosis in the metaplastic lesions and may represent one mechanism by
which tumourigenesis is suppressed in these mice.
3.3.2 Ape deletion and mouse mammary gland tumourigenesis
Failure to observe mammary gland malignancy in the absence of Ape in ere
Apc580S/5g0S mice contrasts with previous experiments overexpressing WntJ, Wnt10b,
cyclin D1 and mutant forms of /3-catenin in the mammary epithelium of transgenic
mice (Tsukamoto et al., 1988; Edwards et al., 1992; Wang et al., 1994; Imbert et al.,
2001; Michaelson and Leder, 2001). There are several possible explanations why the
effects of inactivating Ape appear to differ from the effects of ectopic Wnt signalling
or overexpression of stabilised /3-catenin, and these can be subdivided into 4
categories: 1) cell type-specific effects, 2) levels of (3-catenin, 3) effects of Ape
mutation and 4) cytoskeletal effects.
First, the transgenes may be expressed in different cell types. The adult mammary
gland contains a population of stem cells that are able to give rise to complete
functional mammary glands (Kordon and Smith, 1998) and it has been suggested that
MMTV-induced mammary tumours arise from infection of these stem cells (Callahan
and Smith, 2000). Thus one possibility was that the BLG promoter was failing to
drive deletion within those stem cells that can give rise to tumours. However,
subsequent breeding of BLG-cre+ Apc580S/580S mice onto a Tcf-1 null background
resulted in the formation of mammary tumours, confirming that BLG-cre can drive
tumour formation (Gallagher et al., 2002). Specifically, the authors report the
I SR0S/SR0S
development ofmammary adenocanthomas by 4 weeks of age in ere Ape Tcf-
1 mice compared with a latency of 7 months in Tcf-1 null mice. Thus it appears that
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the BLG promoter is clearly driving loss of Ape in cells (mammary secretory
epithelial cells), which can form tumours.
Secondly, levels of P-catenin may be a critical determinant in mammary gland
tumourigenesis. Specifically, there may be a threshold level of P-catenin above which
tumourigenesis is triggered. Two groups report that expression of a truncated [3-
catenin (AN89 and AN90) in virgin mammary glands induces inappropriate
lobuloalveolar development, hyperplasia and progression to adenocarcinoma, with
tumour latency decreasing with pregnancy (Imbert et al., 2001; Michaelson and
Leder, 2001). Imbert et al. (2001) have argued that P-catenin levels are not relevant,
as both high and low-expressing lines of their MMTV-ANP-catenin transgenic mice
display the same phenotype, with low expressors showing a longer latency. However,
a criticism of these studies is that overexpression of P-catenin from an ectopic
promoter produces at least threefold more P-catenin from the transgene than the
endogenous locus (Imbert et al., 2001), and therefore does not question the effect of
endogenous P-catenin levels on mouse mammary gland development. To overcome
this, Miyoshi et al. (2002) used cre-loxP technology to conditionally excise exon 3 of
p-catenin from mouse mammary epithelium. Deletion of exon 3 of the P-catenin gene
removed the N-terminal region that is the target of GSK3p phosphorylation and
consequently rendered the protein resistant to degradation by the proteasome (Harada
et al., 1999; Miyoshi et al., 2002). Stabilisation of P-catenin induced squamous
metaplasia during the first pregnancy. Importantly, these mice did not develop
mammary adenocarcinomas (Miyoshi et al., 2002). Similar observations have been
• _l_ SROS/S^OS » • ■
reported in ere Ape ' mice where P-catenin dysregulation due to Ape deletion
directs the formation ofmetaplastic lesions but not neoplasia (Gallagher et al., 2002).
It is noteworthy that when bred onto a Tcf-1 null background these mice developed
mammary tumours by 4 weeks of age. Thus, because tumourigenesis is a phenotype
I SHOS/SXOS " • • • •
of ere Ape Tcf-l null mice, it remains possible that deficiency of Ape alone
was insufficient to result in complete deregulation of P-catenin (Gallagher et al.,
2002). Additionally, mutant forms of P-catenin may have different properties to wild
type P-catenin, and removal of either the 89 or 90 N-terminal amino acids may affect
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more than [5-catenin stability. It has been reported that amino acid alterations of the
N-tenninus of [5-catenin affects signalling independent of any effect on [5-catenin
levels (Guger and Gumbiner, 2000).
Thirdly, the nature of the mutation at the Ape allele may determine the phenotype.
Several Ape mutations have been described (see table 1.5.1) and these have different
phenotypes. However despite the fact that cre-mediated deletion ofApe in colonic
epithelium leads to the formation of colorectal adenomas (Shibata et al., 1997),
direction of this mutation to the mammary gland epithelium does not result in
tumourigenesis. One possibility is that the mammary gland epithelium may require
higher levels of P-catenin for malignant transformation (Gallagher et al., 2002). An
alternative possibility is that an H/?c-independent method of P-catenin regulation,
such as feedback repression by Tcf-1, may prevail in the mammary gland. Tcf-1 is
activated by P-catenin/Tcf-4 and acts within a feedback repressor pathway, where
Tcf-1 isoforms lacking a P-catenin interaction domain bind to DNA target sequences
but fail to mediate gene activation (Roose et al., 1999) The authors argue that Tcf-1
co-operates with Ape and that the combination of the two activities is particularly
important for the prevention ofmammary neoplasia in mice.
Finally, the truncated Ape protein, produced following BLG-cre mediated deletion of
exon 14, has lost all of the C-terminal domains necessary for cytoskeletal regulation
(Shibata et al., 1997). APC associates with the cytoskeleton in at least two ways,
directly binding microtubules (Smith et al., 1994; Munemitsu et al., 1994) and
indirectly connecting with the actin cytoskeleton (Townsley et al., 2000). These
interactions are important for cell migration, adhesion and cell division (section
1.4.3.2). Thus, conditional inactivation of Ape from mouse mammary epithelial cells
may result in migration or cytoskeletal defects. This could explain the observation of
I 580S/^80S
delayed ductal growth in the mammary glands of ere Ape female mice
(Gallagher et al., 2002). Disruption of the cytoskeleton in the absence of Ape could
lead to a decreased ability of the tip of the growing duct to invade or grow through
the fat pad. Consistent with this, Imbert et al. (2001) report a mild retardation in
ductal extension in mice overexpressing AN89P-catenin. N-terminal deleted P-
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catenin has been suggested to interfere with Ape's ability to bundle microtubules at
the tips of cell extensions (Nathke et al., 1996; Pollack et al., 1997).
In conclusion, conditional inactivation of Ape from mouse mammary epithelial cells
leads to dysregulated ductal growth and the formation of squamous metaplastic
lesions but not neoplasia. Metaplastic lesions are characterised by dysregulation of (3-
catenin and activation of cyclin D1 and may represent preneoplastic lesions. One
possibility is that in the mouse mammary gland additional gene mutations/deletions
are required for full progression to neoplasia. In support of this, recent reports on the
combined effect of Ape and Tcf-1 deletion in mouse mammary epithelium highlight
the critical effect of other genes on Ape tumourigenesis in the mammary gland.
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4 Differential Display RT-PCR analysis of gene
expression in the cre+ 4pC580S/580S mouse
mammary gland
4.1 Introduction
4.1.1 Differential analysis of gene expression in the mammary gland of
cre+ Apc580SI580S mice
_l_ 5ROS/5ROS •
Conditional inactivation ofApe in the mouse mammary gland (ere Ape mice)
produced a phenotype of delayed ductal growth in virgin animals and induced the
formation of metaplastic lesions (section 1.6.3.2). These areas of metaplasia
increased in size and number with pregnancy, remained after involution, but did not
progress to neoplasia (Gallagher et al., 2002). In an effort to understand the
relationship between mammary gland metaplasia and Ape deficiency a method of
differential analysis was used to identify transcriptional changes in response to loss
of Ape in the mouse mammary gland. Several widely used techniques exist for the
identification, and subsequent isolation, of differentially expressed genes and include
differential screening, subtractive hybridisation, and differential display reverse
transcription PCR (DDRT-PCR). In this analysis, DDRT-PCR was the method of
choice, for reasons that are summarised below.
4.1.1.1 Differential Screening
Differential screening involves the use of deoxyoligonucleotide primers (such as
d(T)n) or random hexamers to prepare two single-stranded cDNA probes by reverse
transcription of a poly(A)+ RNA template (from test and control tissue) in the
presence of radiolabelled nucleotide. These probes, which are representative of the
total mRNAs present in the sample tissue, are then used to screen cDNA libraries
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prepared from test and control RNA. Differentially expressed clones, identified by
changes in signal strength, are picked and subsequently re-screened to confirm their
differential expression. This method of isolating differentially expressed genes has
several drawbacks. Specifically, the over-representation of moderate to highly
abundant mRNAs, whereby cDNAs of the most abundant mRNAs contribute most of
the radioactivity present in the probe while cDNA copies of less abundant and rare
mRNAs contribute a much smaller fraction. Accordingly, signals corresponding to
such low copy mRNAs may be indistinguishable from background hybridisation. In
addition, large quantities of poly(A)+ RNA starting material are required for this
technique and correspondingly it is useful for the study of a only a very small
number of samples (for example, test and control).
4.1.1.2 Subtractive Hybridisation
Subtractive hybridisation represents a variation of differential screening designed to
overcome much of the problem of sensitivity of mRNA detection inherent in
differential screening. This method involves initial subtraction of all cDNAs shared
between two samples (test and control). Subtraction involves hybridisation of control
cDNA with an excess of biotinylated test cDNA. Biotinylated DNA is subtracted by
avidin binding, and the remaining cDNAs are used to generate subtracted cDNA
libraries for screening or alternatively as probes to screen libraries differentially. This
method offers a slight increase in sensitivity of mRNA detection relative to
conventional differential screening (section 4.1.1.1), but nonetheless has
disadvantages. Complete subtraction of all common cDNAs is not possible, thus this
method produces a significant number of false positives. Furthermore, due to the use
of excess biotinylated subtraction cDNA, transcripts that are subtly differentially
expressed, or alternatively differentially expressed homologous transcripts, may be
subtracted. Finally, as with differential screening, only a small number of samples
(test and control) can be studied, requiring large amounts ofRNA starting material.
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4.1.1.3 Differential Display RT-PCR
The DDRT-PCR technique essentially allows the direct comparison of genes
expressed in multiple samples by the creation of an "RNA fingerprint" for each
sample (Liang and Pardee, 1992). Isolated total RNA is fractionated into specific
subpopulations of cDNA using modified deoxyoligonucleotide (T)i2MN primers for
reverse transcription (where M = A, G or C and N = A, G, C or T). This fractionated
RNA, represented as cDNA, is then used as a template in low annealing temperature
PCR reactions with the original 3' d(T)i2MN primer and an additional 5' 10-mer of
arbitrary but defined sequence. Incorporation of a radiolabeled nucleotide into the
display PCR reactions allows the resulting PCR products (RNA fingerprints) to be
visualised by autoradiography following standard polyacrylamide gel
electrophoresis. Visual comparison of the banding pattern across gel lanes readily
identifies any differentially expressed transcripts on the basis of band intensity. In
comparisons ofmultiple samples (for example developmental stages), the majority of
transcripts displayed should appear identical in intensity in all lanes, while a small
percentage, representing developmentally regulated genes, should vary in intensity
across lanes but display an identical profile in test and control lanes. Both of these
types of expression pattern act as internal controls, and individual transcripts that
differ in expression profile between test and control can be selected with confidence.
Regions corresponding to bands of interest are excised from the dried gel, and the
cDNA is recovered. Recovered cDNA is then reamplified using the appropriate
primer combination (those used to display it) and cloned into an appropriate vector
for further analysis.
In this analysis, DDRT-PCR offers several advantages over alternative techniques as
the method of choice for a comparison of gene expression due to: (1) the low
quantity of starting material required (frequently 1 -5ug of total RNA), (2) the ability
to simultaneously analyse multiple samples (limited only by the number of lanes on
the gel electrophoresis equipment), (3) the sensitivity of the procedure (being PCR
based, low copy number transcripts are included in the analysis, (4) the speed of the
procedure (from extraction of RNA to sequenced clones can be achieved in less than
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one and a half weeks), and (5) the extremely high reproducibility of the technique.
However, criticisms of the technique include reports of significantly high false
positive rates, where expression studies using isolated clones have failed to replicate
the differential expression patterns seen on the original display gel (Li et al., 1994;
Sun et al., 1994). Indeed, clones derived from an apparently single display band
frequently represent a number of different cDNA species, making the identification
of the true candidate cDNAs a time consuming and laborious task (Callard et al.,
1994; Li et al., 1994). Miele et al. (1998 and 1999) have outlined two methods
whereby these problems can be resolved, (1) mSSCP and (2) a 'cold' southern blot
technique, both of which were used in this analysis (see methods section 2.2.5 and
2.2.7).
4.1.1.3.1 Modified Single-Strand Conformation Polymorphism (mSSCP)
Single-strand conformation polymorphism (SSCP) is an electrophoresis protocol
designed to separate single-stranded DNA on the basis of conformation rather than
size. Under standard conditions (Hayashi, 1991), SSCP will separate individual
strands of a DNA duplex. The modified SSCP (mSSCP) protocol described in Miele
et al. (1998) was designed to differentiate between similarly sized fragments of
completely different sequence, thus aiding identification of the excised display
candidate cDNA of interest from potential co-migrating cDNA species. The mSSCP
procedure is performed after first excising gel regions corresponding to DDRT-PCR
bands that represent differentially expressed cDNAs. In addition to recovering cDNA
from display band regions representing a candidate of interest, cDNA is also isolated
from the corresponding 'negative' region to allow identification of co-migrating
cDNAs after mSSCP (Miele et al., 1998). The eluted cDNA is PCR reamplified for
an optimal number of cycles and the products are subjected to mSSCP
electrophoresis. Miele et al. (1998) established that 5 cycles amplifies mouse brain
cDNA sufficiently to permit detection without distorting the relative levels of
different cDNA species recovered (see methods section 2.2.5).
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4.1.1.3.2 'Cold' Southern Blotting
Miele et al. (1999) describe a Southern blotting procedure that can be used prior to
labour intensive expression studies to validate that a particular isolated cDNA clone
does represent the original band of interest. This can be achieved by simple
electrophoresis of DDRT-PCR products through agarose gels, followed by standard
Southern blotting to nylon membranes and the use of isolated cDNAs as
hybridisation probes. Clones representing the candidate DDRT-PCR cDNAs of
interest produce a pattern of hybridisation mirroring the original DDRT-PCR profile
and are detectable after very short exposure times (< 2hours) (see methods section
2.2.7). Clones can then be used as probes to confirm differential expression using
techniques such as northern blot analysis or in situ hybridisation.
4.1.2 DDRT-PCR analysis of gene expression in the mammary gland of
cre+i4pc580S/580S mice
One aim of this thesis was to identify transcriptional changes in response to loss of
Ape in the mouse mammary gland, thus gaining insight into the relationship between
Ape deficiency and the phenotype of mammary gland metaplasia observed in cre+
cor\o/^o/-vo
Ape mice. However a method of identifying differentially expressed genes
that allowed comparison of multiple samples simultaneously was required.
Reasoning for this was that BLG-cre recombinase mediated deletion of Ape was
originally expected to take place exclusively during lactation occurred prior to
lactation, and thus by comparing gene expression at several stages of mammary
gland development it was hypothesised that this would profile gene expression
before, during, and after Ape deletion. DDRT-PCR was the method chosen as it is a
highly reproducible technique and allows the analysis of multiple samples
simultaneously. In addition by incorporating the mSSCP and 'cold' Southern blotting
steps the likelihood of identifying false positives was greatly reduced. Clones were
subsequently identified by cloning and DNA sequencing and used as probes to
confirm differential expression in northern blot analysis (see Figure 4.1).
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Figure 4.1 Overview of the strategy used to identify differentially transcribed genes in
response to loss of Ape in the mouse mammary gland
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Figure key (applies to all figures in Chapter 4)
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4.2 Results
4.2.1 DDRT-PCR experimental design
In order to ensure that any transcript differences on the DDRT-PCR gels was due to
Ape loss and not effects of genetic background variation it was important that the
control and Ape deleted mice were as genetically similar as possible. See Appendix
B for mouse breeding and mammary gland collection data, note at each time point
five mammary glands were collected and pooled in order to minimise the effects of
genotypic variation. Mammary glands were collected from littermate control
genotype (cre+ Apc+/580S and ere" Apc580S/580S) and mutant (cre+ Apc580S/580S) mice at 4
stages of mammary development, mid-gestation, parturition, day 2 lactation and day
4 lactation. Mammary glands were dissected and snap frozen in liquid nitrogen and
stored at -70°C. Once all the samples had been collected RNA extraction and DDRT-
PCR analysis were performed in Dr. Mike Clinton's laboratory at Roslin Institute,
Roslin.
As a first step, it was necessary to estimate the number of DDRT-PCR primer
combinations that would be required to achieve full coverage of gene expression in
the mammary gland. Liang and Pardee (1992) estimate that twenty arbitrary DDRT-
PCR 10-mer primers in conjunction with all anchored oligonucleotides should be
sufficient to provide coverage of 12 000 - 24 000 transcripts in homogenous cell
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lines. Assuming that 10 000 - 15 000 genes are expressed in any particular cell type
at any one time (Liang and Pardee, 1992; Bauer et al., 1994) and assuming that one
DDRT-PCR band represents an individual transcript, this would be sufficient to
examine most expressed genes. However due to constraints of time and resources it
was only possible to perform a quarter of this analysis using only one of the four
cDNA sub-fractions (i.e. d(T)i2MC). DDRT-PCR was performed on this cDNA sub-
fraction using a total of 34 individual arbitrary 5' 10-mer primers (see Appendix C
for DDRT-PCR primers) (Figure 4.2). Assuming a resolution of an average 200-300
DDRT-PCR bands per primer combination, this equates to a total visualisation of
approximately 6 800 - 10 200 individual bands. On the basis that one DDRT-PCR
band represents an individual transcript, the analysis presented in this thesis provides
visualisation of between 6 000-10 200 individual expressed genes in the mouse
mammary gland.
4.2.2 Gene expression in control (cre+ Apc+l580S and cre" 4pc580S/580S) and
Ape deleted (cre+>4pc580S/580S) mouse mammary glands
The majority of DDRT-PCR autoradiographs presented in this thesis (Figure 4.2)
display four individual "RNA fingerprints" between control and mutant (cre+
Ape ) mice mammary glands. As can be seen from Figure 4.3, the consistency
of banding patterns within a particular primer combination was extremely high and
j | /fOAC
the reproducibility between the developmental timepoints of control (ere Ape
and ere" ^pc580S/580S) and mutant (cre+ Apc580SI580S) mammary material was excellent
for each primer combination. Additionally the expression profiles of at least half of
the transcripts did not change throughout the developmental period of study, while
about 25%, representing developmentally regulated genes, displayed the same
differential expression profile in the control and mutant mammary gland samples.
Both types of expression profile act as internal controls, and individual transcripts
that differ between control (cre+ Apc+l580S and ere" Apc580S/580S) and mutant (cre+
580S/580S
Ape ) mammary glands can be selected with confidence.
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Figure 4.2 DDRT-PCR autoradiographs
All DDRT-PCR gels produced using the primer d(T)pMC with 34 individual
arbitrary 5' 10-mer primers. These are presented in greater detail in Appendix D.
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MC-DM 8 MC-DM 10 MC-DM 11 MC-DM 12
Ape + Ape - Ape + Ape - Ape + Ape - Ape + Ape -































Figure 4.3 Identification of candidate 1 by DDRT-PCR
DDRT-PCR autoradiograph illustrating the results ofDDRT-PCR with primer pairs
d(T)]2MC and DM 8, 10, 11 and 12. The primer pair d(T)]2MC and DM 10 resulted in
the identification of cDNA candidate 1, representing a transcript downregulated in
mutant (cre+v4/?c580S/580S) mammary glands.
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From an estimated maximum visualisation of 10 200 transcripts in control and Ape
deficient mouse mammary glands, only thirteen individual transcripts were identified
as being differentially expressed during the course of this screen. Of these, six were
successfully cloned and are discussed individually in the following sub-sections of
this chapter.
4.2.3 Transcripts identified as being differentially expressed between
control (cre+ Apc+I5B0S and ere" Apc580SI580S) and mutant (cre+>4pc580S/580S)
mammary glands
From the comprehensive DDRT-PCR analysis (Figure 4.2), several bands
representing potentially differentially expressed transcripts were selected for further
analysis. These isolated cDNAs represent six individual expressed genes. The
isolation, identification and verification of these are presented below.
4.2.3.1 Candidate 1 (Clone 3.4)
As can be seen from Figure 4.3, the d(T)l2MC/DM 10 DDRT-PCR primer
combination resulted in the identification of a cDNA candidate (candidate 1),
representing a transcript which although developmentally regulated (with expression
being exclusive to lactation) appeared dramatically down regulated in mutant (cre+
^C580S/580S) mammary glands. Although the intensity of all Ape deleted-day 4
lactation cDNAs generated using this primer combination appears to be slightly
lower this does not account for the dramatic differential expression seen. This,
together with the reproducibility of this apparent differential expression on several
different occasions provides confidence that this particular transcript is differentially
I ^R0S/580S •
expressed in ere Ape mammary glands. This cDNA was recovered and
subjected to mSSCP analysis to allow identification of co-migrating cDNAs. Figure
4.4, illustrates the mSSCP protocol and confirms the presence of several potential co-
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Figure 4.4 mSSCP analysis of candidates
1, 2, and 6.
mSSCP gel reproduces the differential expression
pattern as seen on the original DDRT-PCR gel.
Additionally candidate cDNA is purified away
from co-migrating cDNA species, and

















reamplified and subsequently cloned (section 2.2.6). Plasmid DNA from two
transformants was sequenced and both were found to be identical. As shown in
Figure 4.5, computer-assisted homology search (BlastN) of the non-redundant
nucleic acid databases revealed that candidate 1 cDNA sequence, 143bp in length,
matched from positions 477 - 615 of Murine casein delta mRNA. 'Cold' Southern
blotting confirmed that candidate 1 (casein delta) represents the original
differentially expressed transcript by producing a pattern of hybridisation that
mirrored the original DDRT-PCR profile (Figure 4.6b). Finally, although capable of
detecting extremely slight differences in gene expression between samples DDRT-
PCR gives no indication as to the absolute level of expression, nor can it be used to
quantitate the extent of the observed differences. For these reasons northern analysis
was carried out to confirm differential gene expression. DDRT-PCR comparison of
gene expression between control (cre+ Apc+l580S and cre"d/?c''80S :iX0S) and mutant (cre+
Apc580S/580S) mouse mammary glands identified casein delta as being downregulated
in ere Ape mammary glands. The casein delta fragment isolated by DDRT-
PCR was used as a probe in northern hybridisation studies of casein expression in
control and mutant mouse mammary glands (section 2.5). As shown in Figure 4.6c,
use of this radiolabelled cDNA as a probe to mammary gland RNA replicates the
general profile of expression observed by DDRT-PCR and confirms casein delta
downregulation in cre+Apc580s/580s mouse mammary glands.
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Sequences producing significant alignments: (bits) Value
gi 2034200 9|re f|XM_109430.11 Mus musculus casein delta (Csn... 276 7e-72
gi 12000467|gb|AC074046.9| Mus musculus 5 BAC RP23-... 276 7e-72
gi 12862198 Idbj|AK021337.1| Mus musculus 10 days lactation,.. 276 7e-72
gi 7106272|ref|NM_009973.1 I Mus musculus casein delta (Csnd.. 268 2e- 69
gi 50770|emb|V00740.1IMMECAS Mouse messenger RNA for epsilo... 268 2e-69
gi 192982|gb|J00379.1|MUSECA mouse epsilon casein mrna 268 2e- 69
>gi I 20342009 | ref |XM_109430 .1 I Mus musculus casein delta (Csnd) , mRNA
Length = 719
Score = 276 bits (139), Expect = 7e-72
Identities = 139/139 (100%)
Query: 1 gcagacctaacacattcaatggaaatgtacaagactagaagatactctggaactattttg 60
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I
Sbjct: 615 gcagacctaacacattcaatggaaatgtacaagactagaagatactctggaactattttg 556
Query: 61 gagcattctgttggtttaccacttctgtatcatttatacatctatcccaatatgttggta 120
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I
Sbjct: 555 gagcattctgttggtttaccacttctgtatcatttatacatctatcccaatatgttggta 496
Query: 121 atgagaagtaattacagca 139
I I I I I I I I I I I I I I I I I I I
Sbjct: 495 atgagaagtaattacagca 477
Figure 4.5 BlastN comparison of candidate 1 cDNA sequence against
non-redundant nucleic acid databases cDNA representing the transcript
presented in Figure 4.3 (candidate 1 ) was cloned, transformed and plasmid DNA
from two transformants sequenced, (a) Candidate 1 cDNA sequence, (b) Computer
assisted homology search of the non-redundant nucleic databases (BlastN) revealed
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Figure 4.6 'Cold' Southern and Northern analysis of candidate 1
(Casein delta) (a) DDRT-PCR differentially expressed transcript, (b) Use of
cloned cDNA as a probe to Southern-blotted DDRT-PCR products formally
proves that the correct cDNA clone has been isolated by producing a pattern of
hybridisation that mirrored the original DDRT-PCR profile, (c) Northern blot of
lOpg total RNA from control (cre+/l/?c+/580S and cre~^/?c580S/580S) and mutant
(ere'N/?e580S/580S) mammary glands hybridised with the casein cDNA probe and
exposed to MR X-ray film (Kodak) for 24 hours at -70°C. Blots were stripped
and re-probed with an 18S rDNA probe to allow normalisation for loading
variations.
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4.2.3.2 Candidate 2 (Clone 7.4)
The d(T)i2MC/A8 DDRT-PCR primer combination was used on several occasions
throughout the entire DDRT-PCR analysis and resulted in the identification of three
separate candidate cDNAs 2, 4 and 6. In the first instance use of this primer
combination identified a transcript (candidate 2) that appears to be developmentally
downregulated in control mammary glands but expression of which remains constant
• ~T 580S/580S •in mutant (ere Ape ) mouse mammary glands (Figure 4.7). This cDNA was
recovered and subjected to mSSCP purification to remove any co-migrating cDNAs
(Figure 4.4). The purified cDNA was recovered, PCR reamplified and cloned
(section 2.2.6). Plasmid DNA was subsequently isolated from six transformants and
the cloned cDNA sequenced. Computer-based homology search (BlastN) of the non-
redundant nucleic acid databases revealed that candidate 2 cDNA sequence, 82bp in
length, matched from positions 5681 - 5762 of the Mus musculus alpha-1 type IV
collagen gene (Figure 4.8). 'Cold' Southern blotting confirmed that the cDNA
(candidate 2 (alpha-1 type IV collagen)) isolated from the DDRT-PCR gel
corresponds to the differentially expressed transcript by producing a pattern of
hybridisation that mirrored the original DDRT-PCR profile (Figure 4.9b). Northern
analysis confirmed differential alpha-1 type IV collagen gene expression in mutant
(cre+ Apc580SI580S) mouse mammary glands (Figure 4.9c).
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MC-A7 MC-A8 MC-DM 8 MC-DM 11
Ape + Ape - Ape + Ape - Ape + Ape - Ape + Ape -
-7 024 -7 024 -7 024 -7 024 -7 024-7 0 24 -7 024 -7 024
Figure 4.7 Identification of candidate 2 by DDRT-PCR
DDRT-PCR autoradiograph illustrating the results of DDRT-PCRwith primer pairs
d(T)pMC and A7, A8, DM 8 and DM 11. The primer pair d(T)12MC and A8 resulted
in the identification of cDNA candidate 2, representing a transcript differentially
regulated in mutant (cre+4pc580S/580S) mammary glands.
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Sequences producing significant alignments: (bits) Value
giI 556296 IgbIJ04694.1IMUSC0L1A4A Mus musculus alpha-1 type ... 147 2e-33
giI 208599911ref|XM_134042.11 Mus musculus procollagen, type... 147 2e-33
gi|1045208|emb|X92439.1|MMCOL4A1G M.musculus mRNA for alpha... 147 2e-33
giI 50233 Iemb|X02201.11MMC4A1NC Mouse mRNA fragment for base... 147 2e-33
>gi I 556296 | gb | J04694 .1IMUSCOL1A4A Mus musculus alpha-1 type IV
collagen (Col4a-l) mRNA, complete cds
Length = 6512
Score = 147 bits (74), Expect = 2e-33
Identities = 81/82 (98%), Gaps = 1/82 (1%)
Query: 1 cctgtgtggtactatgcagctgcttttgtggaagtcatggc-ttcctgtggaataaagat 59
I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
Sbjct: 5681 cctgtgtggtactatgcagctgcttttgtggaagtcatggctttcctgtggaataaagat 5740
Query: 60 ggtccaaaggttagatggaaaa 81
I II I I I I I I I I II I I I I I I I I I
Sbjct: 5741 ggtccaaaggttagatggaaaa 5762
Figure 4.8 BlastN comparison of candidate 2 cDNA sequence against
non-redundant nucleic acid databases cDNA representing the transcript
presented in Figure 4.7 (candidate 2 ) was cloned, transformed and plasmid DNA from
six transformants sequenced, (a) Candidate 2 cDNA sequence, (b) Computer assisted
homology search of the non-redundant nucleic databases (BlastN) revealed the
sequence was 98% identical to positions 5681 - 5762 of the Mus musculus alpha-1
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(b) 'cold' Southern
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Figure 4.9 'Cold' Southern and Northern analysis of candidate 2
(alpha-1 type IV collagen) (a) DDRT-PCR differentially expressed transcript,
(b) Use of cloned cDNA as a probe to Southern-blotted DDRT-PCR products formally
proves that the correct cDNA clone has been isolated by producing a pattern of
hybridisation that mirrored the original DDRT-PCR profile, (c) Northern blot of lOpg
total RNA from control (cre+^/ic+/580S and cre"v4pc580S/580S) and mutant (cre+
Apc.5sos/5HOSj mammary glands hybridised with the alpha-1 type IV collagen cDNA
probe and exposed to MR X-ray film (Kodak) for 24 hours at -70°C. Blots were
stripped and re-probed with an 18S rDNA probe to allow normalisation for loading
variations.
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4.2.3.3 Candidate 3 (Clone 9.1)
The d(T)i2MC/MAX 3 DDRT-PCR primer combination resulted in the identification
of a cDNA candidate (candidate 3) which represents a transcript specific to lactation
m mutant (ere Ape ) mouse mammary glands (Figure 4.10). The observation
that other cDNAs generated using this primer combination appeared almost identical
in intensity between control and mutant provided confidence that this transcript was
differentially expressed in cre+ jpC580S/580S mouse mammary glands. Candidate 3
cDNA was therefore isolated and subjected to mSSCP analysis although in this
particular instance there appeared to be no co-migrating cDNAs (Figure 4.11). This
cDNA was recovered, PCR reamplified and cloned. Plasmid DNA was subsequently
isolated from five transformants and sequenced. As illustrated in Figure 4.12,
computer-based homology search (BlastN) of the non-redundant nucleic acid
databases revealed that this particular candidate cDNA, 182bp in length, matched
from positions 1818 - 1994 of Mils muculus GM2 ganglioside activator protein
(Gm2a) mRNA. Use of cloned cDNA as a probe to Southern-blotted DDRT-PCR
products produced a pattern of hybridisation that mirrored the original DDRT-PCR
profile thus confirming isolation of the correct cDNA clone (Figure 4.13b). However
northern analysis revealed expression of three Gm2a transcripts, only one of which
appears differentially regulated (Figure 4.13c). This transcript was specific to cre+
Apc5H0S/580S mouse mammary glands and may represent the differential transcript
identified by DDRT-PCR.
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Figure 4.10 Identification of candidate 3 by DDRT-PCR
DDRT-PCR autoradiograph illustrating the results ofDDRT-PCR with primer pairs
d(T)|2MC and DM 20, R4 and MAX 3. The primer pair d(T)]2MC and MAX 3
resulted in the identification of cDNA candidate 3, representing a transcript specific
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Figure 4.11 mSSCP analysis of
candidates 3, 4, and 5.
mSSCP gel reproduces the differential expression
pattern as seen on the original DDRT-PCR gel.
Additionally candidate cDNA is purified away
from co-migrating cDNA species, and




















Sequences producing significant alignments:
giI 13435547|gb|BC004651.1| Mus musculus, GM2 ganglioside ac
gi|22474421|emb|AL772357.8| Mouse DNA sequence from clone R.
giI 540017|gb|U09816.1IMMU09816 Mus musculus GM2 activator p...
giI 16507969|ref|NM_000405.2| Homo sapiens GM2 ganglioside a.,
gi1185597 611ref|XM_041978.3| Homo sapiens GM2 ganglioside a..
gi 113435547 | gb | BC004651.11 Mus musculus, GM2 ganglioside
activator protein, clone MGC:5949 IMAGE: 3482848, mRNA, complete
cds
Length = 2024
Score = 335 bits (169), Expect = le-89
Identities = 175/177 (98%)
Query: 1 gcaagttaaaaagatttattgccagaccagtgttgtagtccagaacctgggctgtccgag 60
I I I I 1 I I II II I I II I I I I I I I I I I I I I I I I II I I I I I I I I I I I II I I I I I I I I II I I
Sbjct: 1994 gcaagttaaaaagatttattgccagaccagtcttctagtccagaacctgggctgtccgag 1935
Query: 61 gaggctcaggaagttgtcatggtgcaacctgatgtgggacccactctcttcacaggaccc 120
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I II I I I I I I I I I I I I I I
Sbjct: 1934 gaggctcaggaagttgtcatggtgcaacctgatgtgggacccactctcttcacaggaccc 1875
Query: 121 ctgttccacgtggtggctgctaggtgggatctactccagtgtgaacccctctactct 177
I I I I I II I II I I I I I I I I I I I I I I I I I I I I I II I I I I I II I I I I I I I I I I I I I I I I I
Sbjct: 1874 ctgttccacgtggtggctgctaggtgggatctactccagtgtgaacccctctactct 1818
Figure 4.12 BlastN comparison of candidate 3 cDNA sequence against
non-redundant nucleic acid databases cDNA representing the transcript
presented in Figure 4.10 (candidate 3 ) was cloned, transformed and plasmid DNA from
five transformants sequenced, (a) Candidate 3 cDNA sequence, (b) Computer assisted
homology search of the non-redundant nucleic databases (BlastN) revealed the
sequence was 98% identical to positions 1818 - 1994 of the Mus musculus GM2
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(b) 'cold' Southern
Ape+ Ape -
-7 0 2 4 -7 0 2 4
(c) Northern
Ape + Ape -
-7 0 2 4 -7 0 2 4
Figure 4.13 'Cold' Southern and Northern analysis of candidate 3
(GM2 ganglioside activator protein) (a) DDRT-PCR differentially expressed
transcript, (b) Use of cloned cDNA as a probe to Southern-blotted DDRT-PCR
products formally proves that the correct cDNA clone has been isolated by producing
a pattern of hybridisation that mirrored the original DDRT-PCR profile, (c) Northern
blot of lOpg, total RNA from control (cre+^pc+/580S and cre~ Apc580S/580S) and mutant
(cre+Ape580S/580S) mammary glands hybridised with the GM2 ganglioside activator
cDNA probe and exposed to MR X-ray film (Kodak) for 24 hours at -70°C. Arrow
indicates transcript specific to mutant mammary glands. Blots were stripped and re-
probed with an 18S rDNA probe to allow normalisation for loading variations.
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4.2.3.4 Candidate 4 (Clone 11.2)
Candidate 4 cDNA represents the second cDNA differentially expressed when the
DDRT-PCR primer combination d(T)i2MC/A8 was used (Figure 4.14). This
transcript appears to be very subtly differentially regulated in mutant mouse
mammary glands. Specifically, candidate 4 appears to be developmentally
upregulated in control (cre+ Apc+hS0S and ere" Apc580S/580S) but remains constant in
~F ^80S/580S *
mutant (ere Ape ) mouse mammary glands. This cDNA was recovered and
mSSCP analysis confirmed the presence of several potential co-migrating cDNAs
(Figure 4.11). Following mSSCP purification, the cDNA was recovered, PCR
reamplified and cloned. Plasmid DNA from six transformants was sequenced and
computer-assisted homology search (BlastN) of the non-redundant nucleic acid
databases revealed that candidate 4 cDNA sequence, 176bp in length, matched from
positions 1 - 33 ofMus musculus clone MBI-32 miscellaneous RNA (Figure 4.15).
This cDNA was termed 'novel 1' as MBI-32 encodes a novel, small, non-messenger
RNAs (Fluttenhofer et al., 2001). Additionally, 'Cold' Southern blotting confirmed
that novel 1 represents the original differentially expressed transcript by producing a
pattern of hybridisation that mirrored the original DDRT-PCR profile (Figure 4.16b).
However northern analysis did not confirm the pattern of differential expression
represented by the DDRT-PCR gel. Use of novel 1 cDNA as a probe to northern
blotted mammary gland RNA from control and Ape deficient mammary glands
revealed expression of an alternative differentially expressed transcript that appears
_l S80S/S80S
to be specifically upregulated in mutant (ere Ape ) mouse mammary glands
(Figure 4.16c).
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MC-A7 MC-A8 MC-DM 8 MC-DM 11
Ape + Ape - Ape + Ape - Ape + Ape - Ape + Ape -
-7 024 -7 024 -7 024 -7 024 -7 024-7 0 24 -7 024 -7 024
Figure 4.14 Identification of candidate 4 by DDRT-PCR
DDRT-PCR autoradiograph illustrating the results of DDRT-PCR with primer pairs
d(T)pMC and A7, A8, DM 8 and DM 11. The primer pair d(T)]2MC and A8
resulted in the identification of cDNA candidate 4, representing a transcript
developmentally upregulated in control mammary glands but remains constant in









Sequences producing significant alignments: (bits) Value
gi|14277082|gbIAF357487.1|AF357487 Mus musculus clone MBI-3... 66 2e-08
>gi | 142770821 gb [AF357487 .11AF357 4 87 Mus musculus clone MBI-32
miscellaneous RNA, partial sequence
Length = 181
Score = 65.9 bits (33), Expect = 2e-08
Identities = 33/33 (100%)
Query: 130 cttgagaggccctgggcttgttttaacatctgg 162
I I II I II I I II I I I I I I I I I II I I I I I I I I I I I
Sbjct: 1 cttgagaggccctgggcttgttttaacatctgg 33
Figure 4.15 BlastN comparison of candidate 4 cDNA sequence against
non-redundant nucleic acid databases
cDNA representing the transcript presented in Figure 4.14 (candidate 4 ) was cloned,
transformed and plasmid DNA from six transformants sequenced, (a) Candidate 4
cDNA sequence, (b) Computer assisted homology search of the non-redundant nucleic
databases (BlastN) revealed the sequence was 100% identical to positions 1 - 33 of the
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(b) 'cold' Southern
Ape+ Ape -
-7 0 2 4 -7 0 2 4
(c) Northern
Ape+ Ape -
-7 0 2 4 -7 0 2 4
Figure 4.16 'Cold' Southern and Northern analysis of candidate 4
(novel 1) (a) DDRT-PCR differentially expressed transcript, (b) Use of cloned
cDNA as a probe to Southern-blotted DDRT-PCR products formally proves that
the correct cDNA clone has been isolated by producing a pattern of hybridisation
that mirrored the original DDRT-PCR profile, (c) Northern blot of 1 Opg total
RNA from control (ere' Apc+Ism^ and cre"^/>c580S/580S) and mutant (cre+
jpC580s/580s^ mammary glands hybridised with the candidate 4 cDNA probe and
exposed to MR X-ray film (Kodak) for 24 hours at -70°C. Blots were stripped
and re-probed with an 18S rDNA probe to allow normalisation for loading
variations.
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4.2.3.5 Candidate 5 (Clone 12.3)
The d(T)i2MC/DM6 DDRT-PCR primer combination resulted in the identification of
a cDNA candidate (candidate 5) which represents a transcript that appears to be
developmentally downregulated in control mammary glands but expression of which
• • 4- 580S/S80S
remains constant in mutant (ere Ape ) mouse mammary glands (Figure 4.17).
Candidate 5 cDNA was isolated and subjected to mSSCP analysis which identified
one co-migrating cDNA species (Figure 4.11). The purified cDNA was recovered,
PCR reamplified and cloned. Plasmid DNA was subsequently isolated from five
transformants and sequenced. Computer-based homology search (BlastN) of the non-
redundant nucleic acid databases revealed that candidate 5 cDNA sequence, 436bp in
length, matched from positions 19006 - 19233 of Mus musculus chromosome 15
clone RP24-116K14 (Figure 4.18). Thus, candidate 5 cDNA was renamed novel 2 as
it encoded an unknown gene. 'Cold' Southern blotting confirmed that novel 2 cDNA
isolated from the DDRT-PCR gel corresponds to the differentially expressed
transcript by producing a pattern of hybridisation similar to the original DDRT-PCR
profile (Figure 4.19b). Northern analysis revealed differential expression of a
transcript, however the pattern was not identical to that observed by DDRT-PCR
(Figure 4.19c).
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Figure 4.17 Identification of candidate 5
by DDRT-PCR DDRT-PCR autoradiograph
illustrating the results ofDDRT-PCR with primer
pairs d(T)|2MC and DM 6 and DM 7. The primer pair
d(T)pMC and DM6 resulted in the identification of cDNA candidate 5, representing
a transcript differentially regulated in mutant (cre+v4/>c580S/580S) mammary glands.
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Sequences producing significant alignments: (bits) Value
giI 22748533|gbIAC112158 . 4 | Mus musculus chromosome 15 clone... 436 e-120
>gi 122748533 | gb IAC112158.4 | Mus musculus chromosome 15 clone
RP24-116K14, complete sequence
Length = 175171
Score = 436 bits (220), Expect = e-120
Identities = 226/228 (99%)
Query: 21 gcagacatattactcaccagtgggtctacctataattaaagtttcatgtattggtaaata 80
I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I
Sbjct: 19233 gcagacatattactcaccagtgggtctacctataattaaagtttcatgtattggtaaata 19174
Query: 81 agactagatttaaatctatgaaagaatagtaagagatgaaataaattcccagtagagtct 140
I II I I I I I I I I I I II I I I I I I I I I I I I II I I I I I I I I I I I I I I II I I I I I I I I I I I I I I
Sbjct: 19173 agactacatttaaatctatgaaagaatagtaagagatgaaataaattcccagtagagtct 19114
Query: 141 gacatgtttgattcaaaatgttagtcttaatcacacaagcttctgattgctaacaattaa 200
I I I I II I II I I II I I I II I I I I I I I I I I I I I I I I I I II I I I I I I I I II I I I I I I I I I II I
Sbjct: 19113 gacatgtttgattcaaaatgttagtcttaatcacacaagcttctgattgctaacaattaa 19054
Query: 201 aatcctgttctttctctttctcgtcctgtgaaatgaaagcctttgtgg 248
I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
Sbjct: 19053 aatcctgttctttttctttctcgtcctgtgaaatgaaagcctttgtgg 19006
Figure 4.18 BlastN comparison of candidate 5 cDNA sequence against
non-redundant nucleic acid databases cDNA representing the transcript
presented in Figure 4.17 (candidate 5) was cloned, transformed and plasmid DNA from
five transformants sequenced, (a) Candidate 5 cDNA sequence, (b) Computer assisted
homology search of the non-redundant nucleic databases (BlastN) revealed the sequence
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Figure 4.19 'Cold' Southern and Northern analysis of candidate 5
(novel 2) (a) DDRT-PCR differentially expressed transcript, (b) Use of cloned
cDNA as a probe to Southern-blotted DDRT-PCR products formally proves that the
correct cDNA clone has been isolated by producing a pattern of hybridisation that
mirrored the original DDRT-PCR profile, (c) Northern blot of lOpg total RNA from
control (cre+v4/?c+/580S and creM/?c580S/580S) and mutant (cre+v4pc580S/580S) mammary
glands hybridised with the candidate 5 cDNA probe and exposed to MR X-ray film
(Kodak) for 24 hours at -70°C. Blots were stripped and re-probed with an 18S rDNA
probe to allow normalisation for loading variations.
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4.2.3.6 Candidate 6 (Clone 13.4)
Candidate 6 cDNA represents the final cDNA differentially expressed when the
DDRT-PCR primer combination d(T)i2MC/A8 was used (Figure 4.20). This
transcript appears to be expressed at mid-gestation in both control (cre+ Apc+/580S and
ere" Apc580S/580S) and mutant (cre+ Apc580S/s80S) mouse mammary glands, but becomes
differentially regulated during lactation when Ape has been deleted. Candidate 6
cDNA was isolated and subjected to mSSCP analysis, which separated out several
co-migrating cDNAs (Figure 4.4). Subsequently, the purified cDNA was PCR
reamplified and cloned. Plasmid DNA from four transformants was sequenced and
computer-assisted homology search (BlastN) of the non-redundant nucleic acid
databases revealed that candidate 6 cDNA sequence, 187bp in length, matched from
positions 752 - 901 of H.sapiens mRNA for the 3'UTR of an unknown protein
(Figure 4.21). However despite exhaustive attempts, use of cloned candidate 6 cDNA
(novel 3) to probe either Southern blotted DDRT-PCR products or northern blot of
control and mutant RNA have been unsuccessful.
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Figure 4.20 Identification of candidate 6 by
DDRT-PCR DDRT-PCR autoradiograph illustrating
the results ofDDRT-PCR with primer pairs d(T)]2MC
and DM10,A7, A5 and A8. The primer pair d(T)pMC and A8 resulted in the identification
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Sequences producing significant alignments:
gi11743253|emb|Y09836.11HS3UTRUNK H.sapiens mRNA for 3'UTR ...
giI 23273179|gb|BC033486.1| Homo sapiens, clone IMAGE:519336...
giI 213066411gb|AC012609.7| Homo sapiens chromosome 5 clone ...
>gi | 1743253 | emb | Y09836 . 1 | HS3UTRUNK H . sapiens mRNA for 3'UTR of
unknown protein
Length = 1420
Score = 218 bits (110), Expect = 2e-54
Identities = 144/153 (94%), Gaps = 3/153 (1%)
Query: 16 cttcagatttagaagaaacgatcctgtttccatttgaaaggaactgtaaagcttttttat 75
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I II I I II I I I I II
Sbjct: 752 cttcagatttagaagaaaagatcctgtttccatttgaaaggaactgtaa-gctttt—at 808
Query: 76 catttaaccaactgaacaacacaccaaaagcagcctagggatgagcacttctttgaaggc 135
I I I I I I I II II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II
Sbjct: 809 cttttaaccaactgaacaatacaccaaaagcagcctagggatgagcatttctttgaaagc 868
Query: 136 gattaggttattcacctggtattaaaactattt 168
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
Sbjct: 869 aattaggttattcacctggtattaaaactattt 901
Figure 4.21 BlastN comparison of candidate 6 cDNA sequence
against non-redundant nucleic acid databases
cDNA representing the transcript presented in Figure 4.20 (candidate 6) was
cloned, transformed and plasmid DNA from four transformants sequenced, (a)
Candidate 6 cDNA sequence, (b) Computer assisted homology search of the non-
redundant nucleic databases (BlastN) revealed the sequence was 94% identical to




DDRT-PCR comparison of gene expression between control (ere Ape and ere"
Apc5S0S,580S) and mutant (cre+ Apc580S/580S) mouse mammary glands identified six
differentially expressed transcripts. A comprehensive and detailed study to isolate
and identify these six candidate cDNAs was undertaken. Genes identified through
this screen included casein delta, al type IV collagen, Gm2a and three novel genes,
each ofwhich are discussed below (and summarised in Table 4.3.1).
4.3.1 Candidate 1/ Casein delta
Candidate 1 cDNA when cloned and sequenced was identified to be 100% identical
to Mus musculus casein delta mRNA. The caseins are the predominant proteins in
milk. They are synthesised in great abundance in the mammary gland during
gestation and lactation and are regulated by a variety of factors including peptide and
steroid hormones (Prolactin and glucocorticoid hormones), cell-cell and cell-
extracellular matrix interactions (Doppler et al., 1990; Boudreau et al., 1995).
Hennighausen and Sippel (1982) report the identification of seven murine caseins,
encoded by five mRNAs, designated al, a2, pi, P2, y, 5, and s. DDRT-PCR
identified expression casein delta as being exclusive to lactation, which correlates
nicely with its identification as a milk protein gene (Figure 4.3). Casein delta
appeared downregulated in mutant (ere Ape ) mammary glands and this
differential expression was verified by subsequent northern analysis using the
isolated casein delta cDNA as a probe (Figure 4.6c). Therefore, Ape deleted (cre+
Ape ) mouse mammary glands produce less milk than controls. One
explanation for this may be the presence of extensive areas of metaplasia throughout
the lactating gland of creh Apc58QS/5WS mice resulting in less functional secretory
epithelium (Figure 1.12). These metaplastic nodules consisted of tightly bound balls
of epithelial cells emanating from ducts, which transdifferentiate into squamous cells
as determined by histological criteria. Both keratinising and non-keratinising
squamous differentiation occur within these lesions with the latter being more
151
Table 4.3.1 - Summary of DDRT-PCR results
Differentially Function Expression in Cre+/tpc580S/580S




Milk protein gene Casein expression was downregulated









Alpha-1 type IV collagen expression
was not developmentally downregulated
in cre+Apc580S/580S mammary glands, as











Three Gm2a mRNA transcripts were
observed by northern analysis, only
one ofwhich was differentially
expressed, with expression being
specific to cre+Apc580S/580S mammary
glands.
(4)






Function unknown Novel 2 expression was downregulated






Function unknown Novel 3 expression was upregulated
during lactation in cre+Apc580S/580S
mammary glands. However it most
likely represents a false positive of
DDRT-PCR.
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frequent and resulting in the appearance of an eosinophoilic material. These areas of
metaplasia increased during lactation, remained after involution and increased in
number and extent after two lactation cycles (Gallagher et ah, 2002). One possibility
* ~F ^0S/S80Sis that Ape deletion from the secretory epithelium of ere Ape mouse
mammary glands disrupts normal function and consequently less milk is produced.
The observation that offspring from ere Ape females did not thrive supports
this hypothesis (Figure 1.10). These observations highlight the effectiveness of
DDRT-PCR as a method for identifying differentially expressed transcripts in cre+
a 580S/580S . .
Ape mouse mammary glands.
4.3.2 Candidate 2 / Mus musculus alpha-1 type IV collagen
Sequencing revealed that candidate 2 cDNA was 98% identical to the Mus musculus
alpha-1 type IV collagen gene. Type IV collagen is a major structural component in
basement membrane and is a known component of mammary gland basement
membrane (section 1.1.1) (Muthukumaran et al., 1989; Hennighausen et ah, 2001).
Collagen IV consists of two chains, al(IV) and a2(IV), which are 43% identical.
The al chain of mouse collagen IV is 1669 amino acids in length, including a
putative 27-residue signal peptide, which is cleaved to produce the mature protein
(Muthukumaran et ah, 1989). Initial identification of this cDNA transcript by
DDRT-PCR indicated that its expression was specific to the mid-gestation time point
in control mouse mammary glands and was consistent throughout all time points in
l 580S/580S *
Ape deleted (ere Ape ) mouse mammary glands (Figure 4.7). Northern
analysis confirmed that while alpha-1 type IV collagen was expressed at mid
gestation in control mammary glands its expression was developmentally
downregulated through parturition and lactation to almost undetectable levels at day
4 lactation. In agreement with this another study reports that collagen IV expression
in the mouse mammary gland peaks at mid-pregnancy with subsequent
downregulation to almost undetectable levels in the lactating gland (Keely et ah,
I 580S/580S
1995). However, ere Ape mice, having undergone conditional inactivation of
Ape from the mammary gland, express alpha-1 type IV collagen at equivalent levels
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throughout all developmental time points examined (Figure 4.9c). This observation
I 5H0S/580S
may detail a role of collagen in metaplasia formation in ere Ape mouse
mammary glands. Further analysis of the relationship between collagen and
metaplastic lesions is discussed in Chapter 5.
4.3.3 Candidate 3 / Mus musculus GM2 ganglioside activator protein
mRNA
Candidate 3 cDNA was identified to be 98% identical to Mus musculus GM2
ganglioside activator protein (Gm2a) mRNA. The GM2 activator protein is an
essential component for the lysosomal degradation of GM2 ganglioside by
hexosaminidase A. Gangliosides are glycosphingolipid constituents of the outer
surface of most cell membranes, hydrolysis of which requires three gene products.
Whereas two of these proteins are the alpha- (HEXA gene) and beta- (HEXB)
subunits of the lysosomal enzyme (3-N-acetylhexosaminidase A, the third gene
GM2A encodes the human GM2 activator protein. A deficiency in any one of these
proteins leads to the storage of the ganglioside, primarily in the lysosomes of
neuronal cells, and one of the three forms of GM2 gangliosidosis, Tay-Sachs disease,
Sandhoff disease or the AB-variant form (Bellachioma et al., 1993; Mahuran, 1999).
DDRT-PCR identified the Gm2a cDNA transcript as one specific to lactation in
I S80S/580S
mutant (ere Ape ) mouse mammary glands (Figure 4.10). It was hypothesised
that due to this expression pattern, candidate 3 cDNA may represent a gene activated
in the mouse mammary gland as a consequence of Ape deletion during lactation.
Northern analysis using the cloned Gm2a cDNA as a probe revealed that this was not
strictly accurate. Three GM2 activator protein mRNA transcripts were observed by
northern analysis, two of which were expressed at equivalent levels across all time
points in both control (cre+ Ape"58"8 and ere" Apc580s/580s) and mutant (cre+
/4/>c580S/580S) mouse mammary glands. The final and smallest of the three transcripts
was specific to ere Ape mouse mammary glands and may represent the
differential transcript identified by DDRT-PCR. The role of Gm2a expression in the
mouse mammary gland was further examined in Chapter 5.
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4.3.4 Candidate 4 / Novel 1
Sequencing and subsequent computer-assisted homology search (BlastN) of the non-
redundant nucleic acid databases revealed that candidate 4 cDNA sequence, 176bp in
length, was 100% identical to a 33bp sequence of Mus musculus clone MBI-32
miscellaneous RNA. This small RNA was isolated in a screen for the detection of
novel, small, non-messenger RNAs from two mouse brain cDNA libraries (generated
from small RNA molecules)(Huttenhofer et al., 2001). The authors concluded that
MBI-32 represented one of several novel, small, non-messenger RNAs that may
represent degradation products of unknown human RNAs (Huttenhofer et al., 2001).
Thus candidate 4 cDNA represented a novel gene and was tenned 'novel V. DDRT-
PCR identified novel 1 cDNA transcript as one subtly differentially regulated in
mutant mouse mammary glands. While novel 1 appears to be developmentally
■h +/580S 580S/580S
upregulated in control (ere Ape and ere" Ape ) mouse mammary glands
I S80S/580S
expression remained constant in mutants (ere Ape ). Northern analysis did not
confirm the DDRT-PCR expression pattern expected, revealing instead a
contradictory differential expression pattern that appears to be specifically
l S80S/580S
upregulated in mutant (ere Ape ) mouse mammary glands (Figure 4.16c).
Several possible explanations exist for this apparent difference and are discussed in
turn. First, the cDNA isolated off the DDRT-PCR gel and cloned did not represent
the candidate of interest. However, the results of both mSSCP purification and 'cold'
Southern analysis argue that this was unlikely. mSSCP analysis confirmed the
presence of several potential co-migrating cDNAs and made capable the isolation of
candidate 4 cDNA (Figure 4.11). 'Cold' Southern blotting confirmed that candidate 4
(novel 1) represents the original differentially expressed transcript by producing a
pattern of hybridisation that mirrored the original DDRT-PCR profile (Figure 4.16b).
Thus, the correct cDNA was isolated from the DDRT-PCR gel, cloned, sequenced
and used to probe both Southern blotted DDRT-PCR products and northern blotted
control and mutant RNA. A second explanation why northern analysis revealed an
alternative differentially expressed transcript may be the existence of alternatively
spliced family members which appear identical in size by northern analysis and mask
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the differential expression pattern expected. Finally, there is also the possibility that a
different member of the same gene family was being detected. This subject, and
further characterisation of novel 1 are described in Chapter 5.
4.3.5 Candidate 5 / Novel 2
Candidate 5 cDNA when cloned and sequenced was identified to be 99% identical to
positions 19006 - 19233 of Mus musculus chromosome 15 clone RP24-116K14.
Therefore, this cDNA represented an unknown gene and was termed 'novel 2\
DDRT-PCR identified novel 2 cDNA as representing a transcript that appears to be
developmentally downregulated in control mammary glands but expression of which
remains constant in mutant (cre+ Apc580S/580S) mouse mammary glands (Figure 4.17).
It was confirmed by 'Cold' Southern blotting that this cDNA (novel 2) isolated from
the DDRT-PCR gel corresponds to the differentially expressed transcript by
producing a pattern of hybridisation similar to the original DDRT-PCR profile
(Figure 4.19b). However northern analysis revealed a discrepancy as the pattern of
hybridisation observed following use of novel 2 cDNA as a probe was different from
that observed by DDRT-PCR (Figure 4.19c). Although different the pattern of
hybridisation displayed similarities with the DDRT-PCR profile. Specifically, the
northern blot showed a marked downregulation of novel 2 mRNA expression.
Further characterisation of novel 2 is described in Chapter 5.
4.3.6 Candidate 6 / Novel 3
Sequencing and subsequent computer-assisted homology search (BlastN) of the non-
redundant nucleic acid databases revealed that candidate 6 cDNA sequence was 94%
identical to positions 752 - 901 of H.sapiens mRNA for the 3'UTR of an unknown
protein. This cDNA, identified by DDRT-PCR, represented a transcript that becomes
differentially regulated during lactation as a consequence of Ape deletion (cre+
^c580S/580S mice)(Figure 4.20). Despite exhaustive attempts, use of cloned candidate
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6 cDNA (novel 3) to probe either Southern blotted DDRT-PCR products or northern
blot of control and mutant RNA proved unsuccessful. Chapter 5 details further
analysis of novel 3.
157
5 Further analysis of differentially expressed
transcripts in cre+ Apc580SI580S mouse mammary
glands
5.1 Introduction
Chapter 4 described the identification of six transcripts differentially expressed in
I SROS/SHOS .
ere Ape mouse mammary glands. These included casein delta, al type IV
collagen, Gm2a and transcripts from three presumed novel genes. In this chapter, I
describe further investigation of the roles of these genes in the mouse mammary
gland. It was anticipated that this information may help to understand the relationship
between mammary gland metaplasia and Ape deficiency. Casein delta represents one
of seven murine caseins, which are the major proteins in milk (Hennighausen and
Sippel, 1982). DDRT-PCR identified casein delta as a gene downregulated in cre+
Ape mouse mammary glands during lactation and this was confirmed by
northern blot analysis (section 4.2.3.1). The observation that Ape deleted mouse
I SROR/SROS
mammary glands (ere Ape ) produced less milk than controls although
interesting, is not surprising when one considers that these glands at lactation show
extensive metaplasia resulting in less functional secretory epithelium (Figure 1.12).
This is further supported by the observation that offspring from cre+ Apc580S/:,80S
females did not thrive (Figure 1.10). Further analysis of casein delta was not pursued
* * ... . * q- 5ROS/5ROS
in this thesis, as its differential expression in ere Ape mouse mammary
glands was considered most likely a consequence of metaplasia.
Gm2a encodes the murine ganglioside activator protein gene. This gene bears
several hallmarks of a housekeeping gene including a highly GC rich 5' portion and
several common putative promoter elements, Spl, API and AP2. Consistent with
this, Gm2a expression has been observed in a wide variety of tissues including
placenta, bone marrow, brain, spleen, mammary gland, lung, heart, and pancreas,
albeit at varying transcript levels (Beccari et al., 2001). The Gm2a activator protein
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functions in lysosomal metabolism and is specifically required for the hydrolysis of
GM2 ganglioside by the lysosomal enzyme (3-N-acetylhexosaminidase A (Mahuran,
1998). DDRT-PCR identified Gm2a expression specifically during lactation in
I 5ROS/5ROS
mutant (ere Ape ) mouse mammary glands. However subsequent northern
analysis revealed three Gm2a mRNA transcripts, two of which were expressed at
j I jco
equivalent levels across all time points in both control (ere Ape and ere"
Apc580S/580S) and mutant (cre+ Apc580s/58"s) mouse mammary glands. The third Gm2a
transcript was specific to cre+ Apc^808'5808 mouse mammary glands and may represent
the differential transcript identified by DDRT-PCR. A specific role of Gm2a in the
mouse mammary gland has not been identified, however it has been reported that
Gm2a is also a secretory protein and thus it is conceivable it has a function in
mammary gland secretory epithelium (Rigat et al., 1997). Several Gm2a transcripts
have been identified and are reported to result from alternative splicing (Klima et al.,
1991; Nagarajan et al., 1992). In addition, a processed pseudogene (Gm2a-related
sequence) has been identified (Yamanaka et al., 1994). Consequently, further
analysis of Gm2a function in the mammary gland is complex and has no immediately
obvious association with mammary gland development and/or metaplasia. Therefore,
no further analysis of Gm2a in the mouse mammary gland was undertaken.
The remaining genes identified in Chapter 4 (al type IV collagen, and novel genes 1-
3) are further analysed in the mouse mammary gland and are discussed in turn below.
5.2 alpha-1 type IV collagen
5.2.1 Introduction
Type IV collagen is a major structural component in basement membrane (a thin
sheet of highly specialised extracellular matrix present at the epithelial/mesenchymal
interface of most tissues) and is a known component of mammary gland basement
membrane (section 1.1.1) (Muthukumaran et al., 1989; Hennighausen et al., 2001). It
is considerably different from fibrillar collagens, types I-III, for example, unlike
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fibrillar collagens nonhelical regions creating flexibility frequently interrupt the triple
helical domain of type IV collagen (Sakurai et al., 1986). Collagen IV consists of
two chains, al(IV) and a2(IV), which are 43% identical at the amino acid level
(Muthukumaran et al., 1989). Type IV collagen mRNA expression in the mammary
gland is well documented with levels peaking at mid-pregnancy and falling to almost
undetectable levels in the lactating gland (Keely et al., 1995). Expression was
localised to the stroma and the cells of the connective tissue sheath surrounding the
mammary epithelium. The authors suggest that this temporal and spatial localisation
of type IV collagen is consistent with a role in triggering epithelial cells to switch
from ductal formation to alveolus formation (Keely et al., 1995). In agreement with
the type IV collagen expression pattern observed by Keely et al. (1995), northern
analysis (section 4.2.3.2) revealed that alpha-1 type IV collagen mRNA expression in
control mouse mammary glands, although high at mid-gestation, was
developmentally downregulated through parturition and lactation to almost
undetectable levels at day 4 lactation. However, in Ape deleted (cre+ Apc580S/580S)
mouse mammary glands alpha-1 type IV collagen expression was consistent at all
time points. It was hypothesised that alpha-1 type IV collagen plays a role in
metaplastic lesion formation, following specific inactivation of Ape in the mouse
mammary gland. To further investigate alpha-1 type IV collagen expression in
metaplastic lesions, alpha-1 type IV collagen immunohistochemistry was performed.
5.2.2 Results
al type IV collagen protein distribution in both control (cre+ Apef/58HS and ere"
Apc580S/580S) and mutant (cre+ Apc580S/580S) mouse mammary glands was examined
using a rabbit polyclonal antibody against the carboxy terminus of human al type IV
collagen (amino acids 1452-1685)(see section 2.8.1). Immunohistochemical staining
_l_ +/5 80Sof sections from control day 10 lactating mammary glands (ere Ape and ere"
Ape ) demonstrated weak al type IV collagen expression in the stromal cells
and the cells of the connective tissue sheath surrounding the mammary epithelium
























































































displayed extensive al type IV collagen protein deposition within the metaplastic
lesion (Figure 5.1 ii).
5.2.3 Discussion
As introduced in chapter 1 (section 1.1.1), the mammary gland comprises stromal and
epithelial cells that communicate with each other through a basement membrane
composed of extracellular matrix (ECM) proteins. These interactions begin during the
embryonic development of the mammary gland and in combination with steroid and
peptide hormones are necessary for proper ductal morphogenesis throughout all
stages of mammary gland development (Hennighausen et al., 2001; Wiseman and
Werb, 2002). One of the major structural components of the basement membrane is
type IV collagen and its synthesis by mammary cells (stromal/mesenchymal) is
important for the growth and/or survival of the mouse mammary epithelium. There is
considerable evidence indicating that collagen production is tightly coupled to a
mitogenic response in mammary epithelial cells. Significantly, Salomon et al. (1981)
found that the ability to synthesise and accumulate type IV collagen was important
for the proliferation of rat mammary epithelial cells. In the latter studies, cells
maintained on plastic or collagen type I required epidermal growth factor and
glucocorticoids to promote the accumulation of type IV collagen necessary for
attachment and growth. However, cells grown on type IV collagen did not require
these factors for proliferation thus highlighting the important role of type IV collagen
in growth and development of the mammary epithelium. In breast cancer increased
synthesis and degradation of ECM components has been observed and is associated
with tumour progression and invasion (Liotta et al., 1983; Lochter and Bissell, 1995).
Additionally, a study by Nerlich et al. (1997) detailing gene expression and protein
deposition ofmajor basement membrane components in human breast cancer reported
that mammary carcinomas show enhanced mRNA synthesis for major basement
membrane proteins including fibronectin and type IV collagen. In all mammary
carcinomas investigated, regardless of the degree of tumour cell differentiation, both
tumour and stromal cells displayed strong mRNA expression for type IV collagen as
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opposed to normal breast tissue where weak expression was observed (Nerlich et al.,
1997). In this study upregulation of al type IV collagen protein expression was
observed in the mouse mammary gland following conditional inactivation of Ape
(cre+ Apc580S/580S mice). This upregulation was localised to the metaplastic lesions that
arise following Ape loss, and is indicative of a dysregulated basement membrane
within these lesions. It is unclear how Ape deletion in cre+ Apc580S/580S mouse
mammary glands leads to an upregulation of al type IV collagen expression, however
the spatial and temporal expression of al type IV collagen is consistent with a
possible role in metaplastic lesion formation.
5.3 Novel genes
5.3.1 Introduction
As described in Chapter 4, DDRT-PCR identified three novel genes differentially
expressed in Ape deleted mouse mammary glands (cre+ Apc580S/580S mice). These
genes were termed 'novel' as sequencing and subsequent computer-assisted
homology search (BlastN) of the non-redundant nucleic acid databases revealed they
had no significant match to any known gene. In this analysis these novel cDNAs were
used as probes to screen a mouse mammary gland day 10 lactation cDNA library with
the aim of isolating full-length clones. It was anticipated that with increased sequence
information the novel genes may match known genes in the non-redundant nucleic
acid databases or alternatively have sequence motifs that may provide clues as to the
functions of the novel genes.
5.3.2 Results
A lambda phage cDNA library prepared from lactation day 10 mouse mammary
gland mRNA was kindly supplied by Dr. Christine Watson. Approximately 1 million
plaques were plated out on a total of six 20cm x 20cm plates, sufficient to represent
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all the genes in this library. Following plaque formation library DNA was transferred
onto nylon membrane for screening by hybridisation with probes specific for each of
the novel genes (section 2.7.3). Duplicate lifts were taken from each plate and
following hybridisation only plaques that were positive on both filters were picked
and subjected to a further round of screening in an effort to achieve single
homogenous clones (section 2.7.5). Again, duplicate lifts were taken from each plate
and hybridised in turn with each of the novel genes. Phage DNA was isolated from
positive plaques (on both filters) and sequenced (section 2.7.5.1). The results for
each novel gene are discussed in turn below.
5.3.2.1 Characterisation of transcript'Novel 1'
In chapter 4, a 33bp region in novel 1 cDNA (176bp) was shown to be 100%
identical to the first 33bp of the Mus musculus clone MBI-32 miscellaneous RNA
(section 4.3.4). Prior to cDNA library screening, the 176bp sequence of novel 1 was
subjected to computer-assisted homology search (BlastN) of the expressed sequence
tagged (EST) databases. Novel 1 significantly matched a mouse cDNA clone with
GenBank accession no. BG298761, which had been originally cloned from a murine
retina cDNA library (Figure 5.2). This EST clone was obtained from the MRC UK
HGMP Resource centre and was sequenced in an attempt to add to the 715bp of
sequence already in the EST database. This sequence (1017bp), when subjected to
BlastN search, displayed significant matches with the Mus musculus cDNA clone
MBI-32 miscellaneous RNA (100% identical over 181bp)(Figure 5.3) and the Homo
sapiens alpha gene sequence (85% identical over 239bp and 87% identical over
118bp)(Figure 5.4).
Novel 1 was then used to probe the mouse mammary gland day 10 lactation cDNA
library and following a primary screen 12 positive plaques were identified (Figure
5.5a). In order to achieve single homogenous clones, these were each plated out and
subjected to a secondary screen, which identified 16 positive plaques (Figure 5.5b).
Phage DNA was recovered from six of these and sequenced. The sequences
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Sequences producing significant alignments: (bits) Value
gi | 13063738 | gb | BG2 987 61.1 |BG298761 602396687F1 NIH_MGC_94 M...315 9e-84
giI 2811800|gb|AA7 62053.11AA762053 vv49h04.rl Soares_thymus_... 315 9e-84
giI 177664 4|gb|AA190040.11AA190040 mt91h05.rl Soares mouse 1... 315 9e-84
>gi|13063738|gb|BG2 987 61.1 I BG2 987 61 602396687F1 NIH_MGC_94
Mus musculus cDNA clone IMAGE: 4511445 5'.
Length = 838
Score = 315 bits (159), Expect = 9e-84
Identities = 159/159 (100%)
Query: 4 tgtgtggcaagaatcaagcaagcagtattgtatcgagaccaaagtggtatcatggtcggt 63
I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
Sbjct: 172 tgtgtggcaagaatcaagcaagcagtattgtatcgagaccaaagtggtatcatggtcggt 231
Query: 64 tttgattagcagtggggactaccctaccgtaacaccttgttggaattgaagcatccaaag 123
I II I I II II II I I I II I II II I I I I II I I II I II II I I I I I I II I I I I I I I I I I II I I II
Sbjct: 232 tttgattagcagtggggactaccctaccgtaacaccttgttggaattgaagcatccaaag 291
Query: 124 aaaatacttgagaggccctgggcttgttttaacatctgg 162
I I I I I II II II I I I I I I II I I I II I I I I I II II II I I II
Sbjct: 292 aaaatacttgagaggccctgggcttgttttaacatctgg 330
Figure 5.2 BlastN comparison of novel 1 cDNA sequence against the EST
databases
(a) Novel 1 cDNA sequence, (b) Computer assisted homology search of the EST
databases (BlastN) revealed that novel 1 cDNA was 100% identical to positions 172 - 330
of the Mus musculus cDNA clone with GenBank accession number BG298761.
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Sequences producing significant alignments: (bits) Value
giI 14277082|gb|AF357 4 87.1|AF357 4 87 Mus musculus clone MBI-3... 359 5e-96
giI 2529712|gb|AF001540.1 IAF001540 Homo sapiens clone alphal. . . 172 6e-40
giI 6979641|gb|AF203815.1IAF203815 Homo sapiens alpha gene s... 170 2e-39
>gi | 14277082 | gb | AF357 487 .1 | AF3574 87 MUS milSClllVLS clone MBI-32
miscellaneous RNA, partial sequence
Length = 181
Score = 359 bits (181), Expect = 5e-96
Identities = 181/181 (100%)
Query: 310 cttgagaggccctgggcttgttttaacatctggaaaaaaggctgtttttatagcagcggt 369
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I
Sbjct: 1 cttgagaggccctgggcttgttttaacatctggaaaaaaggctgtttttatagcagcggt 60
Query: 370 taccagcccaaacctcaagttgtgcttgcaggggagggaaaagggggaaagcgggcaacc 429
I II I I I I I I I I II I II I I I I I I I I I I I I II I I I I I I I I I I II II I II I II II I I II II II
Sbjct: 61 taccagcccaaacctcaagttgtgcttgcaggggagggaaaagggggaaagcgggcaacc 120
Query: 430 agtttccccagcttttccagaatcctgttacaaggtctccccacaagtgatttctctgcc 489
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I II I I I II I I II II I I II
Sbjct: 121 agtttccccagcttttccagaatcctgttacaaggtctccccacaagtgatttctctgcc 180
Query: 490 a 490
I
Sbjct: 181 a 181
Figure 5.3 BlastN comparison of mouse cDNA clone BG298761 against
non-redundant nucleic acid databases
(a) Mouse cDNA clone BG298761 sequence, (b) Computer assisted homology search of
the non-redundant nucleic acid databases (BlastN) revealed that the cDNA clone
BG298761 was 100% identical to the Mus musculus clone MBI-32miscel\aneous RNA.
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(a)
>gi I 69796411 gb| AF203815.11AF203815 Homo sapiens alpha gene sequence
Length = 8586
Score = 170 bits (86), Expect = 2e-39
Identities = 205/239 (85%) Gaps = 8/239 (3%)
Query: 374 agcccaaacctcaagttgtgcttgcaggggagggaaaagggggaaagcgggcaaccagtt 433
I I I I I I I I I I I I I I I I II I I I I I I I I II I I I I I I I I I II I I I I I I II II I II II
Sbjct: 7073 agcccaaatctcaagcggtgcttgaaggggagggaaa-gggggaaagcgggcaaccactt 7131
Query: 434 tcccc-agcttttccagaatcctgtta caaggtctccccacaagtgatttctctgc 488
I III II I I I I I I I I I I I I I I I I I I I I I I I II I I I I I II I I I I I I I I I II I
Sbjct: 7132 ttccctagcttttccagaagcctgttaaaagcaaggtctccccacaagcaacttctctgc 7191
Query: 489 cacatcgccaccatgggcctttggcctaatcacagacccttcacccctcaccttgatgca 548
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
Sbjct: 7192 cacatcgccaccccgtgccttttgatctagcacagacccttcacccctcacctcgatgca 7251
Query: 549 gccagtagc-tggatccttgaggtcacgttgcat-atcggtttcaaggtaaccatggtg 605
I I I I I I I I I I I I I I II I I I II II I I III I I I I I I I I I II I I I I I I I I I I I I
Sbjct: 7252 gccagtagcttggatccttgtgggcatgatccataatcggtttcaaggtaacgatggtg 7310
(b)
Score = 125 bits (63), Expect = le-25
Identities = 103/118 (87%) Gaps = 3/118 (2%)
Query: 73 tgttggccttggggtggaggggtgaggtgggcgctaagccnnnnnnnaagatttttcagg 132
I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I II I I I I I I I I I I I I I I I
Sbjct: 6764 tgttggcgtgggggtggaggggtgaggtgggcgctaagcctttttttaagatttttcagg 6823
Query: 133 tacccctcactaaaggcactgaaggcttaatgtaggacagc ggagccttcctgtg 187
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I II I I I I I I I
Sbjct: 6824 tacccctcactaaaggcaccgaaggcttaaagtaggacaaccatggagccttcctgtg 6881
Figure 5.4 BlastN comparison ofmouse cDNA clone BG298761 against
non-redundant nucleic acid databases
Computer assisted homology search of the non-redundant nucleic acid databases (BlastN)
revealed that the cDNA clone BG298761 was had two regions identical to Homo sapiens
alpha gene sequence (a) region one was 85% identical over 239bp and (b) region two
was 87% identical over 118bp.
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(') (ii)
Figure 5.5 Isolation of novel 1 cDNA positive clones from a mouse
mammary gland cDNA library (a) i and ii are typical primary screen
autoradiographs identifying novel 1 positive plaques. Duplicate lifts were taken and
only plaques that were positive on both filters were picked, (b) (i) Secondary screen
autoradiograph with 4 novel 1 positive plaques (intense black spots). The multiple spots
ofweaker intensity represent background hybridisation, (ii) Duplicate autoradiograph
confirming that the 4 plaques are novel 1 positive.
168
(~1200bp in length) were found to be identical. As shown in Figure 5.6, BlastN
search of the non-redundant nucleic acid databases revealed that this longer novel 1
cDNA sequence (novel ]'243bp) was 100% identical to the entire 18 lbp of the Mus
musculus clone MBI-32 miscellaneous RNA. Additionally, novel 1l243bp cDNA
matched the Homo sapiens alpha gene sequence in two regions, the first was 85%
identical over 185bp and the second was 87% identical over 239bp (Figure 5.7).
Figure 5.8 summarises the above information and details that whilst the novel 1
sequence obtained from DDRT-PCR has sequence identity with the cDNA clone
(BG298761) and the clone isolated from the cDNA library screen (novel ]I243hp} it
does not share any similarity with alpha gene. However both the cDNA clone
(BG298761) and novel ]!243bp have two regions that share sequence identity with
alpha gene. Consequently, it was unclear whether the DDRT-PCR clone (novel 1)
represented a fragment of alpha gene. Two methods, northern and Southern blotting,
were used to attempt to decipher the relationship between novel 1 and alpha gene.
Northern analysis was used in an effort to determine if novel 1 and alpha gene
represent the same gene. Figure 5.9 details five probes designed against various
regions of novel 1 l243b'\ which either do or do not have sequence identity with
regions of alpha gene. Probes 1-4 were generated by PCR using specific primers
designed against the novel ]I243bp template. An additional probe (probe 5) was
designed against a region of alpha gene way downstream from the region in question
(4192-4492bp). It was hypothesised that if these probes hybridised to different
transcripts then it remained possible that novel 1 was not derived from the alpha
gene locus. Hybridisation of these probes to northern blotted mammary gland RNA
from control (cre+ Apc+l2S0S and ere" Apc5H0S/2H(lS) and Ape deleted (cre+ H/>c580S/580S)
mouse mammary glands revealed similar patterns of hybridisation (Figure 5.10 and
Figure 5.11). On closer examination, (Figure 5.11), it was determined that although
different in intensity the patterns of hybridisation were identical and the transcript
hybridising to each probe was the same size. This data is consistent with all five
probes hybridising to the same transcript - alpha gene. To rule out the possibility of
more than one gene hybridising a Southern analysis approach was used.
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Sequences producing significant alignments:
Score E
(bits) Value
giI 14277082|gb|AF3574 87.1|AF357487 Mus musculus clone MBI-3.
giI 697 96411gb|AF203815.11AF203815 Homo sapiens alpha gene s.
gi|4884449|emb|AL050210.1|HSM800507 Homo sapiens mRNA; cDNA.
gi117425224|dbj|AP0007 69.4| Homo sapiens genomic DNA, chrom.






>gi I 14277082 | gb | AF357487 . l IAF357487 Mus musculus clone MBI-32
miscellaneous RNA, partial sequence
Length = 181
Score = 359 bits (181), Expect
Identities = 181/181 (100%)
6e-96
Query: 564 tggcagagaaatcacttgtggggagaccttgtaacaggattctggaaaagctggggaaac 623
I I I I I I I I I I II I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
Sbjct: 181 tggcagagaaatcacttgtggggagaccttgtaacaggattctggaaaagctggggaaac 122
Query: 624 tggttgcccgctttcccccttttccctcccctgcaagcacaacttgaggtttgggctggt 683
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
Sbjct: 121 tggttgcccgctttcccccttttccctcccctgcaagcacaacttgaggtttgggctggt 62
Query: 684 aaccgctgctataaaaacagccttttttccagatgttaaaacaagcccagggcctctcaag 744
II I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
Sbjct: 61 aaccgctgctataaaaacagccttttttccagatgttaaaacaagcccagggcctctcaag 1
Figure 5.6 BlastN comparison of cDNA library clone novel l1243bP against
non-redundant nucleic acid databases
(a) Mouse cDNA clone novel l'243bP sequence, (b) Computer assisted homology search of
the non-redundant nucleic acid databases (BlastN) revealed that novel ],243bP 100%
identical to the Mus musculus clone M5/-.^miscellaneous RNA.
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(a)
>gi I 69796411 gb | AF203815.11AF203815 Homo sapiens alpha gene sequence
Length = 8586
Score = 186 bits (94), Expect = 5e-44
Identities = 162/185 (87%) , Gaps = 11/185 (5%)
Query: 73 aagctagggaaaggccaaaaagcaaaacctgagaaaacaaaaggt—tgttttctcagga 130
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I
Sbjct: 7733 aagctagaaaaaggccaaaaagcaaaacctgagaaaacaatacgtgttgttttctcagga 7674
Query: 131 aaagaaaaacctttacaaccctactgacga atctgcttccactaagatgct 181
I I I I I I I I II I I I I I I I I I II I II II III I I I I II I II I I I I I II
Sbjct: 7673 aaagaaaaaccttcatgaccctactgaagagcattggagatcagcttccgctaagatgct 7614
Query: 182 agcttggccaagtctgttatgtccacctgaaaaagtcttagcagagaatttttgcaatcc 241
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I III
Sbjct: 7613 agcttggccaagtctgttatgttcacctgaaaaagtcttagcagagaatttttgcattcc 7554
Query: 242 caccc 246
II I I I
Sbjct: 7553 caccc 754?
(b)
Score = 170 bits (86), Expect = 3e-39
Identities = 205/239 (85%), Gaps = 8/239 (3%)
Query: 449 caccatggttaccttgaaaccgat-atgcaacgtgacctcaaggatcca-gctactggct 506
I I I I I I I II I I II I I I I I II I I I III I I II II I I I I I I I I II I I I I I I I I I I
Sbjct: 7310 caccatcgttaccttgaaaccgattatggatcatgcccacaaggatccaagctactggct 7251
Query: 507 gcatcaaggtgaggggtgaagggtctgtgattaggccaaaggcccatggtggcgatgtgg 566
II I I I I II I I I I I I I I II I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I
Sbjct: 7250 gcatcgaggtgaggggtgaagggtctgtgctagatcaaaaggcacggggtggcgatgtgg 7191
Query: 567 cagagaaatcacttgtggggagaccttg taacaggattctggaaaagct-ggggaa 621
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I III II
Sbjct: 7190 cagagaagttgcttgtggggagaccttgcttttaacaggcttctggaaaagctagggaaa 7131
Query: 622 actggttgcccgctttcccccttttccctcccctgcaagcacaacttgaggtttgggct 680
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I
Sbjct: 7130 agtggttgcccgctttccccc-tttccctccccttcaagcaccgcttgagatttgggct 7073
Figure 5.7 BlastN comparison of of cDNA library clone novel l1243hP
against non-redundant nucleic acid databases
Computer assisted homology search of the non-redundant nucleic acid databases (BlastN)
revealed that novel ll243bP had two regions identical to Homo sapiens alpha gene




























































































































































































































































Figure 5.10 Northern analysis to identify if novel 1 cDNA and alpha
gene represent the same gene Probes 1-4 were generated by PCR using specific
primers to novel ],243bP cDNA, and probe 5 was generated by PCR using specific
primers against alpha gene. Blots were stripped and re-probed with an 18S rDNA probe
to allow normalisation for loading variations.
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Ape +
-7 0 2 4
Ape -















Figure 5.11 Northern analysis to identify if novel 1 cDNA and
alpha gene represent the same gene Northern results as for Figure 5.10
but without the loading controls so as to allow direct comparison of the patterns
of hybridisation for each probe. All probes hybridised to a transcript of the same
size and produced similar patterns of hybridisation.
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Southern analysis was perfonned on mouse genomic DNA digested with 9 different
restriction enzymes (BamHI, EcoRI, Hindlll, Ncol, PstI, PvuII, Seal, StuI and Xbal).
Digested DNA was electrophoresed on a 0.8% agarose gel, blotted onto a nylon
membrane, and incubated overnight with one of three radiolabeled probes (cDNA
clone BG298761, novel 1 or probe 4) (Figure 5.12). There were similarities between
blots labelled with all three probes, for example consistently one Hindlll band, one
Xbal band, and one Ncol band were observed on all three autoradiographs.
Significantly, the pattern of hybridisation between the DDRT-PCR probe (novel 1)
and probe 4 (novel ]1243hp} were identical except for the ZNtZ-digested DNA which
displays an additional band when labelled with probe 4, reflecting the longer length
of probe 4. The results of Southern analysis argue towards the existence of only one
gene.
5.3.2.2 Novel 1 Discussion
Mouse mammary gland cDNA library screening, using Novel 1 (176bp) as a probe,
identified a longer length positive clone of 1217bp termed novel 1 l243l'p. Following
BlastN search of the non-redundant nucleic acid databases it was discovered that
novel ]l243bp was 100% identical to the entire 18 lbp of the Mus musculus clone MBI-
32 miscellaneous RNA. As mentioned in section 4.3.4, Mus musculus clone MBI-32
represents a novel, small, non-messenger RNA that does not exhibit any sequence or
structural motifs that would make it possible to assign a genomic location or a
specific function to this RNA. Thus, it was hypothesised that clone MBI-32 represents
a degradation product of an unknown human RNA (Huttenhofer et al., 2001).
Additionally, novel ]l243bp cDNA matched the Homo sapiens alpha gene sequence in
two regions, the first of which was 23 lbp in length and 85% identical to alpha gene
and the second region was 173bp long and 87% identical. Despite the name, alpha
gene represents a transcript of unknown function. Alpha gene was identified during
the construction of a transcript map for the 2.8-Mb region containing the multiple
endocrine neoplasia type I (MEN1) locus (Guru et al., 1997). (MEN1 is an inherited










































































pancreatic, and pituitary tumours. The MEN1 gene is tightly linked to the PYGM
(muscle glycogen phosphorylase) locus on human chromosome 11 q 13 and linkage
analysis has placed the MEN1 gene within a 2-Mb interval of this locus (Larsson et
al., 1988). To aid in the cloning of the MEN1 gene a 2.8-Mb clone contig, from which
33 transcripts are predicted, was generated (Guru et al., 1997). Alpha gene was
identified as one of twelve transcripts of unknown function that mapped to the contig
and each was named with sequential Greek letters (Guru et al., 1997). Although novel
21243bp ^as twQ sectjons 0f signif1Cant homology with alpha gene, the DDRT-PCR
clone (novel 1) had no sequence similarity to alpha gene, thus it was unclear whether
novel 1 represented a fragment of alpha gene. Northern analysis using four different
probes derived from novel 1l243bp and one probe derived from alpha gene, revealed
identical patterns of hybridisation to a transcript of identical size, thus it remained
likely that novel 1 represented a fragment of alpha gene. Southern analysis was used
to determine if there was more than one alpha gene family member as it was possible
that the probes were hybridising to different members of the same gene family.
However these results argued against the presence of a second gene. Finally in
chapter 4 it was observed that northern analysis using the novel 1 DDRT-PCR
fragment did not confirm the DDRT-PCR expression pattern expected, revealing
instead a contradictory differential expression pattern that appears to be specifically
580S/580S *
upregulated in mutant (ere Ape ) mouse mammary glands (Figure 4.16). Two
reasons why this may have occurred were detailed in chapter 4 (either the existence of
an alternatively spliced family member which appeared identical in size by northern
analysis and masked the differential expression pattern expected or a different
member of the same gene family was being detected). As mentioned above, the
results of Southern analysis argue against there being two genes present, thus it
remains possible that the novel 1 DDRT-PCR fragment hybridised to an alternatively
spliced transcript.
The identification of a mouse homologue of alpha gene has not yet been reported,
and it remains possible that the novel gene, novel 1, identified in this thesis represents
this gene. Thus areas of sequence divergence could be explained due to species
difference. Unfortunately there is no published information on the expression or
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functions of human alpha gene and consequently speculations as to its role in the
mouse mammary gland cannot be made.
5.3.2.3 Characterisation of transcript 'Novel 2'
A BlastN search of the non-redundant nucleic acid databases revealed that novel 2
cDNA (436bp) had a 228bp region 99% identical to positions 19006 - 19233 ofMus
musculus chromosome 15 clone RP24-116K14 (section 4.3.5). When novel 2 cDNA
sequence was subjected to computer-assisted homology search of the EST databases,
172bp of this same region was found to be 98% identical to the Mus musculus cDNA
clone with GenBank accession no. BE916654 (Figure 5.13). The cDNA clone
(BE916654) had originally been isolated from a virgin mouse mammary cDNA
library generated from a tumour biopsy sample. This EST clone was obtained from
the MRC UK E1GMP Resource centre and sequencing added 326bp to the known
sequence of 617bp. BlastN search of this cDNA clone (BE916654, 943bp) identified
a region of 587bp that was 97% identical to positions 19040 - 19626 of Mus
musculus chromosome 15 clone RP24-116K14 (Figure 5.14).
Novel 2 was then used to probe the mouse mammary gland day 10 lactation cDNA
library and following a primary screen only 2 positive plaques were identified. In
order to achieve single homogenous clones, these were each plated out and subjected
to a secondary screen, which unfortunately failed to identify any positive plaques. A
PCR approach was used to confirm whether the mouse mammary gland cDNA
library contained clones with homology to novel 2. PCR of an aliquot of the cDNA
library with primers against the novel 2 cDNA sequence and the cDNA clone
(BE916654) produced PCR products of the expected size (Figure 5.15). This result
established that clones with novel 2 identical sequence were present in the mouse
mammary gland cDNA library. However, due to the failure of the cDNA library
screen to isolate any of these novel 2 identical clones a different approach was
undertaken. It was anticipated that by performing PCR reactions on an aliquot of the
cDNA library with one primer against the vector arm and the other against the novel
179









Sequences producing significant alignments: (bits) Value
gi|10417510|gb|BE916654.1] BE916 65 4 601667260F1 nci_cgap_Mam. . 301 2e-79
>gi|10417510|gbIBE916654.1|BE916654 601667260F1 nci_cgap_Maml
Mus musculus cDNA clone image: 3967167 5'.
Length = 617
Score = 301 bits (152), Expect = 2e-79
Identities = 169/172 (98%), Gaps = 2/172 (1%)
Query: 21 gcagacatattactcaccagtgggtctacctataattaaagtttcatgtattggtaaata 80
I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
Sbjct: 170 gcagacatattactcaccagtgggtctacctataattaaagtttcatgtattggtaaata 111
Query: 81 agactagatttaaatctatgaaagaatagtaagagatgaaataaattcccagtagagtct 140
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I II I I I I I I
Sbjct: 110 agactacatttaaatctatgaaagaatagtaagagatgaaataaattcccagtagagtct 51
Query: 141 gacatgtttgattcaaaatgttagtcttaatcacacaagcttctgattgcta 192
I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I
Sbjct: 50 gacatgtttgattc-aaatgttagtcttaatcacac-agcttctgattgcta 1
Figure 5.13 BlastN comparison of novel 2 cDNA sequence against the
EST databases
(a) Novel 2 cDNA sequence, (b) Computer assisted homology search of the EST
databases (BlastN) revealed that novel 2 cDNA was 98% identical to positions 1-170 of
the Mus musculus cDNA clone with GenBank accession number BE916654.
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Sequences producing significant alignments:
Score E
(bits) Value
giI 22748533|gb|AC112158.4| Mus musculus chromosome 15 clone.
gi113124448|gb|AF172398.2|AF172398 Homo sapiens junctional .
1068 0.0
3e-17
>gi I 22748533 | gb | AC112158. 4 | Mus musculus chromosome 15 clone
RP24-116K14, complete sequence
Length = 175171
Score = 1068 bits (539), Expect = 0.0
Identities = 575/587 (97%), Gaps = 2/587 (0%)
Query: 82 aaaagaacaggattttaattgttagcaatnagaagcttgtgtgattaagactaacatttt 141
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I 1 I I I I I I I
Sbjct: 19040 aaaagaacaggattttaattgttagcaatcagaagcttgtgtgattaagactaacatttt 19099
Query: 142 gaatcaaacatgtcagactctactgggaatttatttcatctcttactattctttcataga 201
I I I II I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II
Sbjct: 19100 gaatcaaacatgtcagactctactgggaatttatttcatctcttactattctttcataga 19159
Query: 202 tttaaatgtagtcttatttaccaatacatgaaactttaattataggtagacccactggtg 261
I I I I II I I I I I I I I I I I I I I I II I I II I I I I I I I I I I I I I I I I I I I I I I I II I II I I I I I
Sbjct: 19160 tttaaatgtagtcttatttaccaatacatgaaactttaattataggtagacccactggtg 19219..
..Query: 622 attgnagtg-agcctttctgga-ggagaaaaggagagactgagtaag 666
I I I I I II I I I I I I I I I I I I I I I II I I I I I I I I I II I I I I I I II
..Sbjct: 19580 attgcagtgaagccttcctggagggagaaaaggagagactgagtaag 19626
Figure 5.14 BlastN comparison ofmouse cDNA clone BE916654 against
non-redundant nucleic acid databases
(a) Mouse cDNA clone BE916654 sequence, (b) Computer assisted homology search of
the non-redundant nucleic acid databases (BlastN) revealed that the cDNA clone



















































































































































2 cDNA or the cDNA clone (BE916654), the PCR products would represent full-
length novel 2 clones. The mouse mammary gland cDNA library is in the Lambda
Zap express vector and primers were designed to the vector arms on either side of the
multiple cloning site (Figure 5.16a). PCR reactions were performed in both
directions, as the orientation of the novel 2 cDNA within the cDNA library was not
known and the results show only the primer combinations that generated PCR
products (Figure 5.16b). DNA was recovered from four PCR products (ranging in
size from 600-1000bp) by gel purification, but only one (clone 2.1) was successfully
cloned into the pGEM®-T Easy vector. Sequencing of clone 2.1 (659bp), followed by
computer-assisted homology search (BlastN) of the non-redundant nucleic acid
databases revealed that the first 20bp were identical to positions 19561-19580 of the
mouse chromosome 15 clone. Flowever, this sequence represented the primer (EST
Fwd) used to PCR clone 2.1 out of the mouse mammary cDNA library (Figure 5.17).
Thus BlastN failed to identify any sequences of significant homology.
5.3.2.4 Novel 2 Discussion
Novel 2 (436bp), the DDRT-PCR cDNA isolated as described in chapter 4, has a
228bp region 99% identical to positions 19006 - 19233 of Mus musculus
chromosome 15 clone. Additionally, when novel 2 cDNA sequence was subjected to
BlastN of the EST databases, a cDNA clone (BE916654) which was 98% identical
was isolated and when sequenced this cDNA clone was also identical to Mus
musculus chromosome 15 clone (97% identical over a 587bp region). Unfortunately,
novel 2 screening of the mouse mammary gland cDNA library failed to identify any
novel 2 positive plaques. One reason for this failure was the possibility that this
mouse mammary gland cDNA library, which was specific for lactation day 10, did
not contain any novel 2 homologous clones. Nevertheless, PCR reactions using the
mouse mammary gland cDNA library as a template and with primers specific for the
novel 2 cDNA and the cDNA clone BE916654, established that clones with novel 2
identical sequence were present in the mouse mammary gland cDNA library.





















912 931 951 1207 1226 1150 1169 4519
Lambda
Zap Express
Figure 5.16 Isolation of full-length clones with homology to novel 2 cDNA
from the mouse mammary gland cDNA library
(a) Schematic representation of the Lambda Zap Express vector and the primers (represented
by coloured arrows) used to PCR full length clones out of the library. The cDNA clone
BE916654 is shown is two orientations, (b) Agarose gel electrophoresis detailing the PCR
reactions that produced products. The arrows indicate the bands from which DNA was
recovered and these were numbered 2.1 - 2.4.
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Sequences producing significant alignments: (bits) Value
giI 227 48533|gb|AC112158.4| Mus musculus chromosome 15 clone... 40 0.006
>gi I 22748533 | gb | AC112158 . 4 | Mus musculus chromosome 15 clone
RP24-116K14, complete sequence
Length = 175171
Score = 40.1 bits (20), Expect = 0.006
Identities = 20/20 (100%)
Query: 1 gttggtgggcagctacctta 20
I II I I II I I I I II I I I I I I I
Sbjct: 19561 gttggtgggcagctacctta 19580
Figure 5.17 BlastN comparison of cDNA library clone 2.1 against
non-redundant nucleic acid databases
(a) Mouse cDNA library clone 2.1 sequence, (b) Computer assisted homology
search of the non-redundant nucleic acid databases (BlastN) revealed that the first
20bp of this cDNA clone 2.1 were 100% identical to positions 19561 - 19580 of the
mus musculus chromosome 15 clone
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rate. There are several possible reasons for this, firstly, the mouse mammary gland
cDNA library represented a very 'dirty' DNA template (i.e. impurities may be
present (due to the nature of the sample) which inhibit PCR) and even though the
PCR reactions used a Taq polymerase with increased sensitivity (TITANIUMIM
Tciq), it remains possible that the level of primers annealing was not at a maximum.
Additionally, DNA isolated from PCR products that were generated was of very low
concentration resulting in poor ligation efficiency into the pGEM -T Easy vector.
One clone (2.1) was successfully isolated from the cDNA library but subsequent
BlastN of the non-redundant nucleic acid databases failed to identify any sequences
of significant homology. Thus novel 2 cDNA represents a small section of the mouse
chromosome 15 DNA clone (l-175171bp) and may represent a novel gene.
5.3.2.5 Characterisation of transcript 'Novel 3'
Sequencing and subsequent computer-assisted homology search (BlastN) of the non-
redundant nucleic acid databases revealed that novel 3 cDNA sequence (187bp) was
94% identical to positions 752 - 901 of H.sapiens mRNA for the 3'UTR of an
unknown protein (section 4.2.3.6). In an attempt to acquire a novel 3 cDNA sequence
longer than 187bp, novel 3 cDNA was used to probe the mouse mammary gland day
10 lactation cDNA library. Following a primary screen only 2 positive plaques were
identified. In order to achieve single homogenous clones, these were each plated out
and subjected to a secondary screen, which unfortunately failed to identify any
positive plaques. Thus, as for novel 2 cDNA, the library screen failed and so as to
ensure that the mouse mammary gland cDNA library contained clones with
homology to novel 3, PCR was used. Primers were designed against the novel 3
cDNA and the human 3'UTR sequence for an unknown protein (Figure 5.18a). The
primary PCR reaction, using the mouse mammary gland cDNA library as a template,
and with primers specific to the human 3'UTR (spanning the region homologous to
novel 3) produced a product of the expected size (Figure 5.18b). However when
these primary PCR products were used in a nested PCR reaction the results were less
























































































































































designed against the human 3'UTR of an unknown protein was hybridised to
northern blotted mammary gland RNA from control (cre+ Apc+/sms and ere"
Apc580S/580S) and Ape deleted (cre+ .4pc580S/580S) mouse mammary glands. This probe
represented the primary PCR product of 976bp, equivalent to positions 370 to 1343
of the human 3'UTR of an unknown protein. It was anticipated that if the DDRT-
PCR expression pattern was replicated it would indicate that novel 3 cDNA
represented a fragment of the human 3'UTR of an unknown protein. However,
northern analysis revealed that this probe did not hybridise to any specific transcript
(data not shown).
5.3.2.6 Novel 3 Discussion
Novel 3 cDNA (186bp) was identified as a transcript differentially expressed during
I 580S/S80S
lactation in Ape deleted (ere Ape ) mouse mammary glands (Figure 4.20).
However, despite exhaustive attempts neither 'cold' Southern analysis or northern
blotting confirmed this expression pattern. This could be due to the decreased ability
to radioactively label DNA fragments shorter than 200bp or alternatively novel 3
cDNA may represent a false positive. These two reasons further explain why the
cDNA library screen, using novel 3, failed to identify novel 3 positive plaques. In a
final attempt to obtain additional sequence information for the novel 3 cDNA, a PCR
based approach was used. Although the primary PCR reaction identified a fragment
of the expected size, when this was used in a nested PCR reaction with primers
specific for novel 3 cDNA sequence the results were not definitive. Thus it was
unclear whether the cDNA library contained clones with novel 3 identical sequences.
Finally, northern analysis using a 976bp probe (100% identical to positions 370 to
1343 of the human 3'UTR of an unknown protein, and 94% identical to positions 16
to 168 of novel 3 cDNA) revealed high levels of background hybridisation, which
after high stringency washing failed to expose any transcript hybridisation. Thus,
despite exhaustive attempts to confirm that novel 3 cDNA represents a real
I 5R0S/580S
differentially expressed transcript in Ape deleted (ere Ape ) mouse mammary
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glands, these results indicate that novel 3 cDNA most likely represents a false
positive produced by DDRT-PCR.
5.4 Summary
This chapter aimed to further investigate the roles of the six genes (casein delta, al
type IV collagen, Gm2a and three presumed novel genes), identified by DDRT-PCR,
in the mouse mammary gland. It was anticipated that this information may help to
understand the relationship between mammary gland metaplasia and Ape deficiency.
al type IV collagen is a known component of mammary gland basement membrane
and its upregulation was localised to the metaplastic lesions that arise following Ape
loss. This expression pattern is indicative of a dysregulated basement membrane
_j_ 580S/580Swithin these lesions. Although it is unclear how Ape deletion in ere Ape
mouse mammary glands leads to an upregulation of al type IV collagen expression,
the spatial and temporal expression of al type IV collagen is consistent with a role in
metaplastic lesion formation.
Despite exhaustive attempts to identify the novel genes only one had sequence
homology with a known gene. Novel 1 may represent the mouse homologue of the
human alpha gene. However, there is no published information on the expression or
functions of human alpha gene and consequently speculations as to its role in the
mouse mammary gland cannot be made. Thus it remains possible that the functions
of the novel genes (novel 1 and novel 2) may be related to metaplasia formation.
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6 A preliminary characterisation of two Wnt
genes (Wnt8b & WntlOa) identified from mouse
mammary gland cDNA
6.1 Introduction
The previous chapters concentrated on the analysis of the functions of the Ape gene
in mouse mammary secretory epithelium using a conditional knockout mouse (cre+
Apc580S/580S). In a separate but related study, a biochemical and functional analysis of
two Wnt genes identified from mouse mammary gland cDNA was initiated. Wnt
genes and the Wnl signalling pathway are described in detail in section 1.3. Briefly,
Wnt genes constitute one of the major families of developmentally significant
signalling molecules with a number of actions in a wide variety of organisms,
including defining segment polarity in Drosophila and controlling early lineage and
gut development in C. elegans. (Nusslein-Volhard and Roth, 1989; McMahon and
Moon, 1989; McMahon and Moon, 1989; Nusslein-Volhard, 1991; Han, 1997). The
mouse Wnt gene family comprises at least 18 members, each of which encodes a
secretory glycoprotein of between 350 and 380 amino acids in length and containing
a characteristically spaced pattern of cysteine residues. Both spontaneous mutations
and gene knockout studies have demonstrated the importance of a number of these
Wnt genes in normal mouse development (reviewed by Cadigan and Nusse 1997).
Specifically, Wntl knockout mice have defects in mid- and hindbrain development
(McMahon and Bradley, 1990; Thomas et al., 1991), Wnt2 mutants die perinatally
owing to placental defects (Monkley, 1996) and Wnt4 mutant mice fail to form
kidneys (Stark et al., 1994) and have defects in mammary gland morphogenesis
during pregnancy (Brisken et al., 2000). Wnt genes have been subdivided into two
distinct classes, the Wntl class, including: Wntl/3/3a/8, and the Wnt5a class,
including Wnt4/5a and Wnt6 (see Table 6.1.1). This classification is based on two
assays of Wnt gene function, the first of which uses mammary epithelial cells and the
second requiring Xenopus embryos, both ofwhich are discussed below.
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Table 6.1.1 Wnt assays
Wnt genes have been subdivided into two distinct classes {WntI class and Wnt5a class)
based on two assays of Wnt gene function, (1) the ability to induce morphological
transformation and altered growth characteristics ofmammary epithelial cell lines(C57 or
RAC311C mammary epithelial cells) and (2) the overexpression of Wnts mXenopus
embryos through mRNA injection.
Wnt Gene Transformation of Xenopus









(Shimizu et al., 1997)
Wnt3a Yes
















Wnt genes can be divided into three groups (highly transforming (Wntl/3/3a/7a/8),
transforming (Wnt2/5b/7b) and non-transforming (Wnt4/5a/l 1) depending on their
ability to induce morphological transformation and altered growth characteristics of
mammary epithelial cell lines, either C57 mammary epithelial cells (C57MG cells)
or RAC311C mammary epithelial cells (Wong et al., 1994; Rijsewijk et al., 1987).
C57MG cells, an epithelial cell line derived from normal mouse mammary tissue
(Vaidya et al., 1978), grow in a monolayer with a regular, cuboidal appearance at
confluence. However, Wntl expression causes the cells to become refractile and
elongated, growing over other cells in a disorganised pattern. This transformation is
considered partial (semi-transformation) because cells are unable to form tumours in
syngeneic host animals (Brown et al., 1986). In contrast, RAC311C mammary
epithelial cells, derived from a mammary tumour that has lost its tumourigenic
capacity, are fully transformed by Wntl exhibiting morphological transformation in
vitro and tumour formation in vivo (Rijsewijk et al., 1987). In the mouse, a subset of
Wnt genes are involved in the development of the mammary gland, Wnt2, Wnt4,
Wnt5a, Wnt5b, Wnt6, Wnt7b, and WntlOb (see section 1.2) (Weber-Hall et al., 1994;
Lane and Leder, 1997) and aberrant expression of those Wnt genes normally silent or
expressed at low levels in this tissue induces mammary gland carcinoma.
Accordingly, mouse Wnt 1, Wnt 3 and Wnt 10b have been shown to function as
mammary oncogenes during MMTV-insertional carcinogenesis (section 1.1.3)(Nusse
and Varmus, 1982; Roelink et al., 1990; Lane and Leder, 1997). Interestingly, the
Wnt genes Wnt4 and Wnt5a, which are normally expressed in the mammary gland,
are incapable of inducing morphological transformation and deregulated growth of
C57MG cells. In the case of Wnt4, this may be because its function in mammary
gland development is well defined. Wnt4 has an as essential role in side branching
during early pregnancy (Brisken et al., 2000). Thus, transformation is not due to
simply overexpressing a Wnt protein, but rather appears to depend on the interaction
of specific Wnt protein with its specific Frizzled receptor, which in the case of Wnts
4 and 5a may not be present on the surface of C57MG cells (Wong et al., 1994).
The second assay of Wnt gene function involves the overexpression of Wnts in
Xenopus embryos through mRNA injection (Moon et al., 1993a). Ectopic expression
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of the Wntl class in Xenopus embryos causes anterior duplication of the embryonic
axis, whilst the Wnt5a class perturbs gastrulation but does not result in axial
duplication (McMahon and Moon, 1989; Moon et al., 1993b). Sokol et al, (1991)
propose that this axis duplication arises due to Wntl induction of a new ectopic
organiser (Spemann organiser). Thus one set of dorsal axial structures in the injected
embryos is initially specified in the embryo, while Wntl induces the other. However,
there is no data concerning an endogenous Wnt in induction of the primary axis as no
known Wnt is expressed at the time when mesoderm induction begins (early blastula
stages). McMahon and Moon, (1989) hypothesise that the Wntl class of proteins are
acting on a receptor for a yet unidentified member of the Wnt family, which is
normally active in dorsal axis formation in vivo. Consistent with this model is the
observation that Wnt5a induced axis duplication and an ectopic Spemann organiser
when coexpressed with the human frizzled5 Wnt receptor. Thus it is possible that the
Wnt5a class of Wnt genes are non-duplicating due to a lack of Wnt5a receptors
during axis formation (He et al., 1997).
This chapter focuses on the biochemical and functional analysis of two Wnt genes
originally identified in a PCR screen designed to amplify novel members of the Wnt
gene family from 11-day lactating mouse mammary gland. Degenerate
oligonucleotides, designed to correspond to the conserved amino acid motifs
CKCHG [5'-GGGGCTGAGTG(CT)AA(AG)TG(CT)CA(CT)GG-3'J and FHWCC
[5' -GGAATCTAGA(AG)CA(AG)CACCA(AG)TG(AG)AA-3'], resulted in the
identification of fragments of two novel Wnt genes - Wnt8b and WntlOa.
Subsequently, full length Wnt8b sequence was compiled from a clone isolated from a
mouse embryonic cDNA library screen and an EST sequence derived from a dbEST
database search (Richardson et al., 1999). Wnt8b is expressed in the developing
forebrain of chicks, mice and humans (Hollyday et al., 1995; Lako et al., 1998;
Richardson et al, 1999). Full length WntlOa cDNA was isolated from a rat brain
cDNA library. WntlOa is expressed in the murine adult pituitary, thymus, spleen and
embryonic liver (Wang and Shackleford, 1996). Wnt proteins are secreted
glycoproteins and during synthesis the primary translation product has an N-terminal
hydrophobic signal peptide, which is cleaved by signal peptidase, the resulting
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protein then being sequentially glycosylated at up to 4 sites. N-linked glycosylation,
involving the attachment of carbohydrate groups to the side chain of the amino acid
asparagines, is a common post-translational modification of secretory signal
peptides, however site-directed mutagenesis has shown that in the case of Wntl no
single glycosylation is required for biological activity or secretion (Papkoff, et al.,
1987; Mason et al., 1992). In this study, western analysis was used to identify the
presence of Wnt8b and WntlOa protein and their respective glycosylation status in
stably transfected HEK293 (human embryonic kidney) cells. The functional assays
described above (C57 mammary epithelial cell transformation and axis duplication in
Xenopus) were then performed with the aim of classifying Wnt8b and WntlOa. These
experiments produced some interesting preliminary observations however shortage
of time prevented a complete analysis.
6.2 Results
6.2.1 Biochemical analysis ofWnt8b and WntlOa
In the absence of effective anti-Wnt antibodies, epitope tagged Writs were generated.
This involved cloning of the HA epitope tag (57bp sequence encoding an internal
region of the influenza haemagglutinin antigen (Appendix E) into a pBluescript
plasmid, and subsequent insertion of the Wnt8b, WntlOa, or Wntl (used as a positive
control) cDNA sequences. Site directed mutagenesis was used to recombine the Wnt
cDNA and HA sequences (Figure 6.1). The HA-tagged Wnt cDNAs were then
cloned into the phosphoglycerate kinase (PGK) mammalian expression vector
(pHPmPGKpS-BstXl(+Svori)) (a gift from Dr. I. Chambers, Centre for Genome
Research, University of Edinburgh) which carries a hygromycin B antibiotic
resistance gene and thus permits selection of stably transfected clones. These three
epitope tagged Wnt cDNA expression vectors (PGK Wntl-HA, PGK Wnt8b-HA, and
PGK WntlOa-HA (Appendix E)) were then stably transfected into HEK293 cells.
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Figure 6.1 Generation of HA epitope tagged Wnt cDNA expression
vectors
Wnt8b, WntlOa, or Wntl cDNA sequences were cloned into a pBluescript plasmid
containing an HA epitope tag. Site directed mutagenesis was used to fuse in frame the
Wnt cDNA and HA sequences. The HA-tagged Wnt cDNAs were then cloned into the
phosphoglycerate kinase (PGK) mammalian expression vector (pHPmPGKpS-
BstXl(+Svori)) which carries a hygromycin B antibiotic resistance gene. See Appendix
E for vector maps.
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Protein was harvested, quantified and subjected to SDS-polyacrylamide gel
electrophoresis. The protein was then transferred onto PVDF membrane and Ponceau
S staining confirmed both equal loading and efficient transfer of protein samples.
Wnt proteins were detected upon incubation with an anti-HA antibody (a rabbit
affinity-purified polyclonal antibody raised against a peptide mapping to an internal
region of the influenza haemagglutinin (HA) protein). Figure 6.2a details schematic
representations of the Wntl, 8b and 10a proteins. The results ofwestern analysis for
each of these Wnt proteins are detailed below.
Western analysis identified two of the five reported Wnt 1 protein species (Figure
6.2b). Wntl has four potential N-linked glycosylation sites producing five different
protein species of 36, 38, 40, 42 and 44 kDa (Brown et al., 1987; Papkoff et al.,
1987). In this analysis two bands resolving at 38kDa and 40kDa were observed with
the 40kDa band being present in greater abundance.
The predicted Wnt8b protein is 350aa in length and contains 22 cysteines. Signal
sequence cleavage is predicted to occur between amino acids 21 and 22, and there
are two potential N-linked glycosylation sites. Thus, Wnt8b is predicted to produce
up to three different protein species at around 36kDa. All three Wnt8b protein
species were identified (37kDa, 40kDa and 42kDa) although the sizes were greater
then predicted using a peptide molecular weight calculator. The 40kDa band was
expressed at significantly higher levels than the 37kDa and 42 kDa bands.
The predicted WntlOa protein consists of 417 amino acids, with cleavage of the N-
terminal signal sequence predicted to occur between amino acids 35 and 36. There
are 23 cysteine residues and two potential N-linked glycosylation sites, which predict
three different WntlOa protein species at around 42kDa. Only one WntlOa protein
species was identified by western analysis, which resolved at approximately 40kDa.
Two methods were used to determine the size of the unglycosylated forms ofWnt8b
and WntlOa. Tunicamycin is an inhibitor ofN-linked glycosylation and was added to
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Figure 6.2 Western analysis of Wnt8b and WntlOa
(a) Schematic representation ofWntl, Wnt8b and WntlOa proteins detailing the site of
signal sequence cleavage and sites of potential N-linked glycosylation. (b) Western
analysis of stably transfected HEK 293 cells using an anti-HA antibody. Wntl-HA
transfected HEK 293 cells were used as a positive control and displayed two of the five
known Wntl protein species (38 and 40kDA). Wnt8b-HA transfected HEK 293 cells
displayed three protein species of approximately 37, 40 and 42kDA. WntlOa transfected
HEK 293 cells displayed only one protein species of approximately 40 kDa
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5pg/ml for 6 hours prior to protein isolation. Tunicamycin treatment did not
effectively eliminate all glycosylation (data not shown), thus an alternative method
exploiting Endoglycosidase H (Endo H) was incorporated into this study. Endo H is
a glycosidase that cleaves the chitobiose core of high mannose and some hybrid
oligosaccharides from N-linked glycoproteins. Thus Endo H treatment of protein
samples, prior to electrophoresis, removes the N-linked carbohydrates and should
convert Wntl, Wnt8b and WntlOa to their respective unglycosylated forms. Wntl,
Wnt8b and WntlOa protein samples (20pg) were treated with Endo H for 1, 4 or 24
hours and subsequent western analysis revealed a single band representing the
unglycosylated form of the protein (Figure 6.3a). However, complete removal of all
N-linked carbohydrates was detected after 1 hour (Figure 6.3b). Endo H treatment
reduced the two Wntl protein species (resolving 38kDa and 40kDa) to one
unglycosylated form resolving at approximately 36kDa. The Wnt8b protein was not
reduced to a single unglycosylated band. In this experiment only two Wnt8b protein
species were observed (42kDa and 37kDa) and the larger 42kDa band was reduced to
38kDa, while the 37kDa band was reduced to 32kDa. The WntlOa protein, which
resolved at 40kDa, was reduced to a single unglycosylated form that resolved at
approximately 38kDa following Endo H treatment.
6.2.2 Functional analysis of Wnt8b and WntlOa
Having established that the Wnt8b-HA and WntlOa-HA expression vectors produce
proteins of the expected sizes, these were then used in two functional assays - C57
mammary epithelial cell transformation and axis duplication in Xenopus - with the
aim of identifying whether these Wnts belong to the Wntl class or Wnt5a class of
Wnt genes. Despite these experiments resulting in interesting observations, this data
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Figure 6.3 Western analysis of Endo H treated Wnt8b and WntlOa
(a) Protein extracts from Wntl-HA, Wnt8b-HA and WntlOa-HA stably transfected HEK
293 cells were incubated at 37°C with Endo El for 1, 4 or 24 hours. Endo H removed all
N-linked carbohydrates and revealed the size of the unglycosylated protein which was
36kDa forWntl, approximately 34kDa for Wnt8b and approximately 38kDa for
WntlOa. (b) Complete removal of all N-linked carbohydrates was detected after just 1
hour of Endo El treatment.
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6.2.2.1 Functional assay 1: C57 mammary epithelial cells
As described in section 6.1, C57MG cells are an epithelial cell line derived from
normal mouse mammary tissue (Vaidya et al., 1978), which grow in a monolayer
with a regular, cuboidal appearance at confluence (Figure 6.4a). Subsequent
elimination of serum from the cell culture medium suppresses the background of
spontaneously semi-transformed colonies sometimes observed when untransfected
C57MG cells are grown in the presence of serum (Figure 6.4b). Additionally, the
morphological changes induced by Wntl are more readily observed in serum free
medium (Mason et al., 1992). Transfection efficiency of C57MG cells using the
FuGene1M6 transfection reagent was examined using an EGFP (enhanced green
fluorescent protein) expression plasmid, which produces a tagged EGFP that
localises to the mitochondria of cells. This experiment indicated that transfection
efficiency was low as only 4-5 clones of EGFP positive cells could be detected per
T75 tissue culture flask (Figure 6.5a). The PGK Wntl-HA, Wnt8b-HA and WntlOa-
HA expression plasmids were then transfected into C57MG cells and the culture
medium changed after 24 hours to select for stable transfections. Stable clones were
then pooled and once the cells were 90% confluent the medium was replaced with a
serum free medium. Wntl-HA was again used as a positive control as its effects in
C57MG cells are well documented (Brown et al., 1986; Jue et al., 1992; Mason et
al., 1992). Additionally, Shimizu et al, (1997) have reported that the placement of the
HA epitope tag at the C-terminus does not interfere with Wntl function in C57MG
cells. As expected, Wntl expression induced a morphological change from flat
cuboidal cells to elongated, densely packed, highly refractile cells (semi-transformed
phenotype) (Figure 6.5b). However, when these stably transfected Wntl expressing
clones were pooled and the medium changed to serum free medium not all cells
displayed a semi-transformed phenotype (Figure 6.5c).
Wnt8b expression also induced a morphological change identical to that of Wntl
(Figure 6.6a). The stably transfected Wnt8b clones were pooled, grown to 90%
confluence and the medium replaced with serum free medium. However, as for
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(a)
Figure 6.4 Control untransfected C57 mammary epithelial cells
(a) C57MG cells at confluence showing a regular, cuboidal appearance, (b) C57MG
cells grown in serum free conditions so as to suppress spontaneous semi-transformation
and thus facilitate the observation of any morphological changes induced by Wnt genes.
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Figure 6.5 Control transfections of C57 mammary epithelial cells
(a) Control EGFP transfection showing a pool ofEGFP positive cells, (b) A stably transfected
Wntl expressing clone showing a semi-transformed phenotype (i.e.morphological change
from flat cuboidal cells to elongated, densely packed, highly refractile cells), (c) Pooled stably

















































Wntl, this resulted in some loss of the semi-transformed phenotype, with many cells
appearing indistinguishable from control cells (Figure 6.6b).
The results for WntlOa were less clear as its expression resulted in some stable
clones with a non-transformed phenotype and others where morphological alteration
had been induced (Figure 6.7a). Flowever, upon pooling of all stably transfected
clones and a switch to serum free medium, all cells appeared flat and cuboidal and
indistinguishable from control cells (Figure 6.7b).
6.2.2.2 Functional assay 2: Xenopus embryos
The second assay of Wnt gene function involved the overexpression of Wntl, Wnt8b,
and WntlOa in Xenopus embryos through mRNA injection. Ectopic expression of the
Wntl class in Xenopus embryos causes anterior duplication of the embryonic axis,
whilst the Wnt5a class perturbs gastrulation but does not result in axial duplication
(McMahon and Moon, 1989; Moon et al., 1993b). The HA tagged Wnts (1, 8b and
1 Oa) were directionally cloned into the Xenopus expression vectors pSP64TBX or
pSP64TXB (Appendix E). The Xenopus Wnt gene, XWnt5a, was used as a negative
control as its overexpression in Xenopus embryos (ventral injection) does not cause
axis duplication (Moon et al., 1993b). The Xenopus XWnt8 gene, which causes axis
duplication, was used as a positive control (Christian et al., 1991). Following
linearisation, mRNA was generated through in vitro transcription from the Sp6
promoter. This mRNA was quantified by gel electrophoresis (Figure 6.8) and
10ng/pl was injected ventrally into two-cell stage Xenopus embryos. Xenopus
injections were performed by Dr. Stefan Hoppler, University of Dundee. Embryos
were then cultured, at 18°C for 24 - 48 hours, and their development monitored. The
effects of ectopic expression of Wntl, Wnt8b and WntlOa are shown in Figure 6.9.
XWnt8 expression resulted in the complete dorsalisation of 98% of injected Xenopus
embryos. The XWnt5a negative control resulted in axis duplication in 39.5% of
Xenopus embryos. Ectopic Wntl expression caused axis duplication in only 1.8% of
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Figure 6.7 WntlOa transfected C57 mammary epithelial cells
(a)(i) Stably transfected WntlOa expressing clones showing an non-transformed
phenotype identical to untransfected cells, (ii) Stably transfected WntlOa expressing
clones showing morphological change from flat cuboidal cells to elongated, densely
packed, highly reffactile cells, (b) Pooled stably transfected WntlOa expressing clones
in serum free medium displaying a non-transformed phenotype.
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Figure 6.8 Wnt mRNA for Xenopus injection
Wntl, Wnt8b, WntlOa and XWntSa mRNA generated by in vitro transcription using
the Ambion mMESSAGE MACHINE™ transcription kit. A control template that
was supplied in this kit was in vitro transcribed in parallel so as to ensure reactions
were at optimum efficiency. mRNA (2pi) was subjected to denaturing agarose gel
electrophoresis prior to Xenopus injection to analyse the quality and quantity of
mRNA synthesised. Quantification was estimated by comparing the intensity of the
Wnt mRNAs to an aliquot ofRNA of known concentration (2pg/pl). Wntl was
estimated to be the same concentration as the known sample (i.e. 2 pg/pl). Wnt8b
appeared to be approximately twice this concentration (4 pg/pl). XWnt5a and







Figure 6.9 Effects of ectopic expression of Wnt genes (1, 8b, and 10a)
on normal Xenopus development (a) Ectopic expression ofXwnt8 causes
complete dorsalisation ofXenopus embryos. Axis duplication was observed following
injection with (c) XWnt5a, (e) Wntl, (g) Wnt8b and (i) WntlOa. (b) Uninjected Xenopus
embryo showing normal development. Xenopus embryos showing no effect of ectopic
expression of (d) XWnt5a, (f) Wntl, (h) Wnt8b and (j) WntlOa.
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injected Xenopus embryos, while 31% of embryos showed axis duplication following
Wnt8b injection. WntlOa expression resulted in axis duplication in 1.6% of injected
Xenopus embryos (Figure 6.10). Although this data is surprising, there was
insufficient time available to repeat the experiments. Thus meaningful interpretation
of this data is therefore difficult and is discussed in section 6.3.2.2.
6.3 Discussion
6.3.1 Biochemical analysis of Wnt8b and WntlOa proteins
A biochemical analysis of two Wnt genes (Wnt8b and WntlOa) identified from
mouse mammary gland cDNA was carried out. Proteins extracted from Wntl-HA,
Wnt8b-HA and WntlOa-HA, stably transfected HEK 293 cells were subjected to
western analysis, which confirmed that these cells were expressing Wnt protein. The
glycosylation status of Wnt8b and WntlOa proteins was investigated with the use of
a glycosidase (Endo H) because the amino acid sequence of these proteins predicts
several potential N-linked glycosylation sites.
The deduced Wnt8b protein sequence contains two potential N-linked glycosylation
sites, at positions N102 and N258, and was predicted to produce up to three different
protein species of approximately 36kDa (predicted using a peptide molecular weight
calculator). Western analysis identified three Wnt8b protein species at 37kDa, 40kDa
and 42kDa suggesting that both glycosylation sites were used. These proteins were
larger then predicted and this could be due to the secondary structure of the Wnt8b
protein. Glycosidase treatment did not reduce Wnt8b protein to a single
unglycosylated form. Specifically, it appears that the 42kDa band was reduced to
40kDa and the 37kDa band was reduced to 32kDa.
WntlOa protein sequence indicates two potential N-linked glycosylation sites at
positions N106 and N36, which predict three different WntlOa protein species of
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uninjected XWnt5a Wnt1 Wnt8b WntlOa XWnt8
Wnt gene injected
Figure 6.10 Xenopus axis duplication assay
For each Wnt gene to be tested between 50 and 60 two-cell stage
Xenopus embryos were ventrally injected with lOOpg of Wnt RNA.
XWnt8 resulted in the complete dorsalisation of 98% of injected
Xenopus embryos. Xwnt5a resulted in axis duplication in 39.5% of
Xenopus embryos injected. Wntl caused axis duplication in only
1.8% of injected Xenopus embryos, while 31% of embryos showed
axis duplication following Wnt8b injection. WntlOa expression
resulted in axis duplication in 1.6% of injected Xenopus embryos.
Axis duplication was not observed in uninjected embryos.
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approximately 42kDa. However, only one WntlOa protein species was identified by
western analysis, which resolved at approximately 40kDa. Subsequent Endo H
treatment reduced this protein species to a single unglycosylated form that resolved
at approximately 38kDa. This result suggests that WntlOa is normally glycosylated
at only one of its two potential N-linked glycosylation sites. Additionally, the
WntlOa protein was expressed at much lower levels in HEK 293 cells than either the
Wntl or Wnt8b proteins. Shimizu et al, (1997) report similar findings for the Wnt4
and Wnt5b proteins. Western analysis indicated that Wnt4 and Wnt5b were
expressed at much lower levels in C57MG cells than Wntl. To overcome this
problem and improve the expression of these proteins, the Wntl 5' untranslated
region (UTR) was substituted for the 5'UTR of Wnt4 and Wnt5b. Subsequent
western analysis of transiently transfected C57MG cells showed that the levels of
these proteins had increased to levels comparable to that of other Wnt proteins
(Shimizu et al., (1997). Thus, 5' UTR switch could be used to overcome the problem
of low expression levels ofWntlOa in future experiments.
Wntl-HA was used as a positive control as its protein species are well documented.
Wntl has four potential N-linked glycosylation sites (N29, N316, N346 and N359)
producing five different protein species of 36, 38, 40, 42 and 44 kDa (Brown et al.,
1987; Papkoff et al., 1987). In this analysis only two of these protein species were
observed (38kDa and 40kDa). This can be explained by the fact that experiments
identifying all five Wntl protein species involved in vivo labelling, whereas western
analysis identifies only the mature protein species. This suggests that the 38kDa and
40kDa proteins represent the mature Wntl protein species produced in HEK 293
cells. One explanation why these two proteins represent the predominant forms
produced in HEK 293 cells is that the potential glycosylation site at position N29
may not be available for glycosylation. Wntl protein contains an N-terminal signal
sequence (necessary for the entry of nascent Wntl protein into the ER) cleavage of
which is predicted to occur after either alanine 27 or alanine 28. However,
presumptive cleavage at position 28 inhibits glycosylation at N29 suggesting that the
choice of cleavage site determines whether this glycosylation occurs (Mason et al.,
1992). Additionally, Mason et al, (1992) identified through mutational analysis that
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normally all, or almost all, of the Wntl protein chains are glycosylated at positions
N316 and N359. However, only occasional glycosylation at N346 was reported
(Mason et ah, 1992; Papkoff et al., 1987) and this may be due to the presence of
cysteine residues on either side of N346, which if involved in disulphide bond may
impede access of glycosylation machinery (Mason et al., 1992). The two protein
species identified by western analysis at 38kDa and 40kDa most likely represent
Wntl proteins glycosylated at one or both of positions N316 and N359. Subsequent
glycosidase treatment (Endo H) removed the N-linked carbohydrates and converted
Wntl to its unglycosylated form, which resolved at the expected size of 36kDa
(Brown et al., 1987).
6.3.2 Functional analysis of Wnt8b and WntlOa
6.3.2.1 Morphological transformation of C57MG cells
Morphological transformation of C57MG cells has been used to assay the biological
activity of different Wnt gene family members. This assay groups Wnt genes into one
of three functional classes, highly transforming (Wntl/3/3a/7a/8), transforming
(Wnt2/5b/7b) and non-transforming (Wnt4/5a/l 1) depending on their ability to
induce morphological transformation and altered growth characteristics of the C57
mammary epithelial cell line (Wong et al., 1994). Morphological transformation, as
defined by experiments with Wntl, is characterised by three observations; (1) a
morphological change in shape from flat cuboidal cells to elongated, densely packed,
highly refractile cells, (2) loss of contact inhibition, and (3) decreased serum
dependency (Brown et al., 1986; Jue et al., 1992). However, this transformation is
considered partial because cells are unable to form tumours in syngeneic host
animals (semi-transformation) (Brown et al., 1986). In this analysis, although the
Wntl positive control induced morphological transformation of C57 mammary
epithelial cells, when these stably transfected Wntl expressing clones were pooled
and the medium changed to serum free medium not all cells displayed the semi-
transformed phenotype. One possible explanation for this phenotype is that some
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cells were no longer expressing Wntl. The results for Wnt8b were similar,
specifically initial transfection of C57MG cells resulted in Wnt8b expressing clones
displaying a morphologically transformed phenotype with cells changing in shape
from flat, cuboidal cells to elongated highly refractile cells that had lost contact
inhibition. Pooling of Wnt8b stably transfected clones, followed by serum
deprivation resulted in some loss of semi-transformation with patches of cells
appearing indistinguishable from control cells. Thus it appears some cells may have
lost Wnt8b expression. These observations suggest that Wnt8b belongs to the Wntl
class of highly transforming Wnt genes, although ideally the entire culture should
display the morphologically transformed phenotype. C57MG cells stably transfected
with Wnt 10a mostly appeared identical to control cells with only a few stable clones
displaying a morphologically transformed phenotype. Upon pooling of all Wnt10a
stably transfected clones and a switch to serum free medium, all cells appeared flat
and cuboidal and indistinguishable from control cells. The results for Wnt10a suggest
that it belongs to the Wnt5a class of non-transforming Wnt genes, as stably
transfected clones grown in serum free conditions were flat and cuboidal. The
appearance of some semi-transformed cells following WntlOa transfection is most
likely due to spontaneous semi-transformation, which was suppressed when C57MG
cells were switched to serum free medium. However, it is noteworthy that western
analysis indicated that WntlOa expression levels were much lower than either Wntl
or Wnt8b (section 6.2.1), and this may account for the lack of effect in the C57 semi-
transformation assay.
C57 mammary epithelial cells expressing Wnt proteins display compromised growth
patterns, with cells growing and dividing more slowly (personal communication (Dr.
J.O. Mason)). One hypothesis for the observation that stably transfected Wntl and
Wnt8b clones when pooled lost some of their semi-transformed phenotype is that any
untransfected cells or cells that have spontaneously lost Wnt expression have a
selective growth advantage over Wnt expressing cells and thus dominate the culture.
To overcome this problem in future experiments, stably transfected clones should not
be pooled as this may increase the chance of contamination by either untransfected
cells or cells that have spontaneously lost Wnt expression. A further recommendation
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is that the transfections should be performed in smaller (e.g. 10cm tissue culture
dishes) rather than the large T75 tissue culture flasks that were used in this
experiment. However, shortage of time prevented further analysis, thus these
observations remain preliminary.
6.3.2.2 Axis duplication in Xenopus embryos
Overexpression of Writs in Xenopus embryos through mRNA injection has been used
to assay Wnt gene function (Moon et al., 1993a). Two distinct phenotypes are
observed. Injection of mRNAs encoding Xenopus Wnt8 (XWnt8) (Christian et al.,
1991), XWnt3a (Wolda et al., 1993), Drosophila wg (Chakrabarti et al., 1992) or
mouse Wntl (McMahon and Moon, 1989) leads to dorsal axis duplication in Xenopus
embryos due to the induction of an ectopic Spemann organiser (Sokol et al., 1991).
In contrast, overexpression of XWnt5a affects morphogenetic movements without
producing a duplication of the axis (Moon et al., 1993b). These observations divide
Wnt genes into one of two functional classes, the Wntl class (Wntl/3/3a/8), which
causes duplication of the embryonic axis, and the Wnt5a class (Wnt4/5a and Wnt6),
which does not (McMahon and Moon, 1989; Moon et al., 1993b). In this study
ventral injection of the XWnt8 mRNA (positive control) resulted in the complete
dorsalisation of 98% of injected Xenopus embryos. In contrast ectopic Wntl
expression caused axis duplication in only 1.8% of injected Xenopus embryos. This
unexpected result probably represents the overestimation of the quantity of Wntl
RNA injected. It has been observed that RNA doses of less than lpg do not have any
effect on Xenopus embryos (Sokol et al., 1991). Additionally, the negative control,
XWnt5a, induced axis duplication in 39.5% ofXenopus embryos injected. It has been
observed that non-duplicating Wnts will cause axis duplication in RNA doses of
~500pg (compared with 30pg for a duplicating Wnt)(Dr. Stefan Hoppler, personal
communication) thus it is feasible that this result represents an underestimation of the
quantity of mRNA injected. Wnt8b expression induced axis duplication in 31% of
injected Xenopus embryos, while WntlOa expression resulted in axis duplication in
1.6% of injected Xenopus embryos. These preliminary observations suggest that
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Wnt8b belongs to the Wntl class of Wnt genes and WntlOa belongs to the Wnt5a
class of Wnt genes, and correlates with the results of the C57MG cell transformation
assay. These data fit a model in which Wnt8b and WntlOa proteins have intrinsically




The background work to this thesis involved the generation of a transgenic mouse
with conditional inactivation of the Ape gene in the mammary gland. To specifically
inactivate Ape in the mouse mammary gland, mice harbouring a floxed allele ofApe
(Apc580S/580S) were crossed to transgenic mice expressing a transgene that drives
expression of ere recombinase specifically in the mammary gland (BLG-cre), and the
_i_ 5«0S/580S *
progeny, BLG-cre floxed Ape mice (ere Ape ), underwent specific
inactivation of mammary Ape (Gallagher et al., 2002). Preliminary phenotypic data
highlighted a critical role of Ape in both the growth and development of the
mammary gland whereby virgins displayed delayed ductal growth and areas of
metaplasia which increased during lactation (Gallagher et al., 2002). Using the BLG-
l SR0S/S80S '
ere floxed Ape mice (ere Ape ) this thesis further explored the role of wild
type Ape in the mouse mammary gland.
• • 4- S80S/5^0S • • • • ■ .
Further characterisation of the ere Ape mice involving proliferation analysis
and immunohistochemistry of candidate downstream genes confirmed that
conditional inactivation of Ape from the mouse mammary gland resulted in
dysregulated Wnt signalling and increased proliferation within the metaplastic
lesions. Several groups have observed mammary hyperplasia and adenocarcinoma as
a consequence of dysregulated Wnt signalling in the mouse mammary gland
(Tsukamoto et al., 1988; Edwards et al., 1992; Wang et al., 1994; Imbert et al., 2001;
Michaelson and Leder, 2001). Additionally, mammary tumours induced by
mutations in genes of the canonical Wnt pathway exhibit characteristic features, the
most characteristic of which is squamous differentiation. The authors speculate that
this may be related to the dysregulation of /3-catenin (Rosner et al., 2002; Miyoshi et
al., 2002). In this thesis, conditional inactivation of Ape from the mouse mammary
secretory epithelium did result in the formation of multiple extensive metaplastic
nodules, within which /3-catenin was dysregulated (section 3.2)(Gallagher et al.,
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2002). However neoplasia was not a phenotype of the cre+ Apc580S/5HOS mice. The
author speculates that the levels of (3-catenin dysregulation may be a critical
determinant in mammary gland tumourigenesis, and that in this instance deficiency
of Ape alone was insufficient to result in complete deregulation of (3-catenin in the
mouse mammary secretory epithelium.
In an effort to understand the relationship between Ape deficiency and mouse
mammary gland metaplasia, DDRT-PCR was incorporated into this analysis as a
means of investigating the effect ofApe deletion on expression levels of downstream
genes. Several genes were identified as being differentially expressed as a
consequence ofApe deletion, including casein, al type IV collagen, Gm2a and three
novel genes. In addition, due to the spatial and temporal expression of some of these
(al type IV collagen, novel 1 and novel 2) it was speculated that their functions
might be related to metaplastic nodule formation. Despite these efforts, the
relationship between mammary gland metaplasia and Ape deficiency remains
unclear. These observations highlight the complexity of Ape function in mouse
mammary gland secretory epithelium.
7.2 Technical limitations of differential display
Although several widely used techniques exist for the identification and subsequent
isolation of differentially expressed genes, DDRT-PCR was the method chosen in
this thesis. DDRT-PCR has several advantages over other techniques (section 4.1.1).
However, a criticism of this technique include reports of significantly high false
positive rates, where expression studies using isolated clones have failed to replicate
the differential expression patterns seen on the original display gel (Li et al., 1994;
Sun et al., 1994). There exist two methods of overcoming the isolation of false
positives (mSSCP and cold Southern blotting) and these were incorporated into this
study to decrease the incidence of false positives. Despite this, differential display
had several technical limitations. Firstly, the main drawback of the protocol is that
the analysis of large populations of mRNA with differential display requires about
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240 different primer combinations per sample to achieve 95% coverage of the
genome (Liang and Pardee, 1997). Thus, due to constraints of time and resources this
thesis analysed only a quarter of the mammary gland transciptome. Secondly,
differential display is only capable of determining the 3' region of the gene so full-
length cDNA needs to be isolated by probing a cDNA library or by doing rapid
amplification of cDNA ends (5'RACE), thus making differential display very
laborious. Finally, despite including several steps to decrease the chances of isolating
false positives, they still remain a significant drawback to this technique.
7.3 Future Work
This thesis aimed to gain insight into the relationship between mammary gland
metaplasia and Ape deficiency using a method of differential analysis to identify
transcriptional changes in response to loss of Ape in the mouse mammary gland.
DDRT-PCR was the method chosen although as described above this has several
technical limitations. As a parallel analysis our collaborators have initiated a study
employing cDNA microarray technology, a method in its infancy at the time of
commencing this study. Microarrays are microscopic-slide-sized glass plates dotted
with several thousand genes that can be analysed in one hybridisation experiment.
The major advantage of DNA microarrays is that they are capable of profiling gene
expression patterns of tens of thousands of genes in a single experiment. However it
is not a good method to look for novel genes as it is limited by what has been put on
the slide. In contrast, using DDRT-PCR and microarrays in parallel provides a
powerful analysis of gene expression. A study has been initiated using Affymetrix
GeneChip™ technology (oligonucleotide array) to identify transcriptional changes in
response to loss of Ape in the mouse mammary gland. The RNA isolated and used
for DDRT-PCR in this thesis has been provided for this collaborative effort. It
remains to be seen if this array technique identifies any of the genes isolated in this
thesis. Additionally, it is possible that the microarray experiment will provide
information that may help understand the relationship between mammary gland
metaplasia and Ape deficiency.
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Another experiment that could be used to examine the function of wild type Ape in
the mouse mammary gland involves primary mouse mammary epithelial cell culture.
Primary cultures ofmammary epithelial cells from mice harbouring floxed alleles of
Ape (Apcm,s/ms) could be used to examine the in vitro effects of Ape inactivation
using an adenovirus ere recombinase. RNA isolated from cultures of primary mouse
mammary epithelial cells before and after ere recombinase adenovirus treatment
could be used in DDRT-PCR or microarray experiments to examine transcriptional
changes in response to loss of Ape in mouse mammary epithelial cells. This
experiment would prove useful for the identification of direct targets ofApe in mouse
mammary epithelial cells. In addition to the analysis of transcriptional changes in
primary epithelial cultures following Ape deletion, one could also assess the effects
of Ape deficiency by functional assay. For example, one could examine ductal
branching in the mouse mammary gland by exploiting the property of mammary
epithelial cells to organize into duct-like structures when grown embedded within or
on top of collagen gels (Daniel et al., 1984; Ormerod and Rudland, 1988). This may
provide insight into the observed marked delay in normal ductal development in Ape
deleted mouse mammary glands. In addition, when mouse mammary epithelial cells
are cultured on Engelbreth-Holm-Swarm (EHS) matrix (a reconstituted basement
membrane derived from the Engelbreth-Elolm-Swarm tumour) they aggregate and
develop three-dimensional structures that resemble secretory alveoli in vivo. These
alveolar-like structures secrete milk proteins into the lumen thus reproducing the dual
role ofmammary epithelia to secrete and sequester milk proteins (Barcellos-Hoff, et
al., 1989). Thus the role ofApe in alveolar formation its function in mouse mammary
gland secretory epithelium could be examined.
These experiments and those carried out in this thesis would provide an in-depth
analysis of the role of Ape in the mouse mammary gland and should lead to the
identification of downstream targets of Ape. This information might help understand
the relationship between Ape mutation and human breast cancer.
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0.5g Ampicillin (Sigma A-9518)
dH20 to 100ml, filter-sterilise and store at -20°C (100pg/ml working concentration)
10% Ammonium persulphate
1 g Ammonium persulphate
dH20 to 1 Ornl (store at 4°C)
BCA Reagent A
250ml of reagent containing sodium carbonate, sodium bicarbonate, bicinchoninic
acid and sodium tartrate in 0.1M sodium hydroxide
BCA Reagent B
25ml solution containing 4% cupric sulphate
Buffer QBT (Equilibration buffer)
750mM NaCl
50mM MOPS (pH 7.0)
15% isopropanol
0.15% Triton® X-100.
Buffer QC (wash buffer)
1,0M NaCl
50mM MOPS (pH 7.0)
15% isopropanol.
Buffer QF (Elution buffer)
1.25M NaCl
50mM Tris (pH 8.5)
15% isopropanol
Church Hybridisation Buffer
5g BSA (Bovine Serum Albumin)
Dissolve in 75 ml ofwater, then add









200mg RNase A (Sigma R-5500)
3.3jixl 3M NaOAc, pH 4.5
dH20 to 10ml
boil for lOminutes (aliquot and store at-20°C)
0.5 M EDTA, pH 8.0 (disodium ethylenediamine tetraacetate)
186.1 g Na2EDTA
Dissolve in approx. 400ml dH20, adjust pH to 8.0 with 10N NaOH, and adjust to 1
litre final volume with water.
100 mM EDTA
20ml 0.5 M EDTA
80ml dH20
5mg/ml ethidium bromide (EtBr)
















48g aluminium potassium sulphate
48g choral hydrate
600ml water
Solution B heated gently, added to solution A and left at room temperature for 48










dH20 to 1 litre ofwater, autoclave to sterilize, and pour into sterile petri dishes











dH20 to 950ml, adjust pH to 7.0 with 5M NaOH, and adjust volume to 1L with





dH20 to 1 litre, autoclave to sterilize, cool to 55°C, add antibiotic if desired, and pour




Stored at room temperature
Loading Buffer 6X
1 M MOPS
20.93g MOPS (3-(-morpholino)propanesulphonic acid) (Sigma M-1254)
Dissolved in 80ml dH20, adjust pH to 7.5 with 1 N NaOH, and bring volume to
100ml.
10X MOPS buffer
0.2M MOPS (Sigma M-1254)
0.5M sodium acetate
0.01M EDTA
dH20 to 950ml, adjust pH to 7.0 with 1 N NaOH, and adjust volume to 1L with










3M potassium acetate, pH 5.5





1 Og NZ amine (casein hydrolysate)
dH20 to 950ml, adjust pH to 7.5 with 1 N NaOH, and adjust volume to 1L with





1 Og NZ amine (casein hydrolysate)
15g agar
dH20 to 950ml, adjust pH to 7.5 with 1 N NaOH, and adjust volume to 1L with




1 litre NZY broth
autoclave to sterilise and cooled to 47°C before use.
PCR lOx reaction buffer




Mix equal amounts of phenol and chloroform, equilibrate the mixture by extracting
several times with 0.1M Tris HCL (pH 7.6). Store the equilibrated mixture under an














dH20 to 800ml, adjust pH to 7.4 with IN HCL and adjust volume to 1L with
distilled water.
Resuspension/Solution PI
50mM Tris-HCl (pH 8.0)
lOmM EDTA
100p.g/ml RNase A
















Stored at -20° C
10% SDS (sodium dodecyl sulfate)
lOg SDS (Fisher S529-3)
dH20 to 100ml
Sequenase® enzyme dilution buffer






75ml 40% acrylamide solution
50ml lOXtbe
175ml dH20.
For each 60ml of the above solution was mixed with 60pl ofTEMED and 60pl of






0.5g/l xylene cyanol FF
Sequencing Termination Mixes
one each of:
80pM dATP + 8pM ddATP
80pM dCTP + 8pM ddCTP
80pM dGTP + 8pM ddGTP




50ml 1M Tris-Cl pH 7.5
5ml gelatin
dH20 to 1L and autoclave
SOC Media
2% w/v Bacto- tryptone
0.5% w/v Bacto -yeast extract
0.05% NaCl '
Autoclave and add the following fdter sterilised reagents. 1% (v/v) 1M MgCl2, 1%
(v/v) 1M MgS04 and 0.1% (v/v) 2M glucose solution.
3M NaOAc, pH 4.5
408.24g Na0Ac-3H20
Dissolve in approx. 800ml dH20, adjust pH to 4.5 with glacial acetic acid and bring
to a final volume of 1 L with dH20.













SSC (20X) (standard saline-citrate)
88.3g sodium citrate
175.3g NaCl
Dissolved in approximately 900ml water, adjust pH to 7.0 with IN HCL and bring










10ml 1 M Tris-HCl (pH 7.6)
2ml 0.5 M EDTA
dH20 to 1L
TENT buffer






Store protected from light at 15°C.
Tissue Lysis Buffer















dH20 to 800ml, adjust pH to 7.4 with IN HCL and bring final volume to 1L.
TBS-T
100ml 1 Ox TBS
lml 20% (v/v) Triton
dH20 to 1L
1M Tris-HCl, pH 7.6, 8.0, 8.5, 9.0, 9.5
121.lg Tris base
dH20 to 800ml
Adjust pH with concentrated HC1 and then add dH20 to 1 L.





pH 7.9 at 25°C












Control (cret^/?c+/58uS) Ape deleted (cre+v4/?c580S/580S)


























Mammary gland collection data
Control (Cre+APC"/iisus mice)
Female Mid-gestation Day 0 Day 2 lactation Day 4 lactation
Pair no: Pair no: Pair no: Pair no:
3981 4021 4011 3981
D.O.B: D.O.B: D.O.B: D.O.B:













Plug: Plug: Plug: Plug:
15/06/00 10/05/00 21/03/00 28/04/00
Take: Take: Take: Take:
28/06/00 29/05/00 11/04/00 21/05/00
Pair no: Pair no: Pair no: Pair no:
3981 4021 4011 4021
D.O.B: D.O.B: D.O.B: D.O.B:













Plug: Plug: Plug: Plug:
17/06/00 11/05/00 9/04/00 21/03/00
Take: Take: Take: Take:
Cre+APC580s/580s 30/06/00 30/05/00 30/04/00 15/04/00
Pair no: Pair no: Pair no: Pair no:


















Plug: Plug: Plug: Plug:
17/06/00 13/05/00 13/04/00 21/03/00
Take: Take: Take: Take:
30/06/00 30/05/00 5/05/00 12/04/00
Pair no: Pair no: Pair no: Pair no:
3981 4021 4021 4021
D.O.B: D.O.B: D.O.B: D.O.B:












Plug: Plug: Plug: Plug:
17/06/00 20/04/00 3/05/00 23/03/00
Take: Take: Take: Take:
30/06/00 12/05/00 24/05/00 15/04/00
Pair no: Pair no: Pair no: Pair no:
4021 4031 4011 4021
D.O.B: D.O.B: D.O.B: D.O.B:
118 15/03/00 138 14/04/00 134 14/04/00 42 9/02/00
Mate@ Mate@ Mate@ Mate@
17/05/00 16/06/00 16/06/00 12/04/00
Plug: Plug: Plug: Plug:
16/06/00 18/06/00 17/06/00 10/05/00
Take: Take: Take: Take:
29/06/00 7/07/00 8/07/00 2/06/00
Experimental (Cre+APCJOUSOSUS)
Female Mid-gestation Day 0 Day 2 lactation Day 4 lactation
Pair no: Pair no: Pair no: Pair no:
4001 4001 4001 4001
D.O.B: D.O.B: D.O.B: D.O.B:









27/03/00 27/03/00 14/06/00 27/03/00
Plug: Plug: Plug: Plug:
30/03/00 28/03/00 5/07/00 2/04/00
Take: Take: Take: Take:
12/04/00 17/03/00 27/07/00 25/04/00
Pair no: Pair no: Pair no: Pair no:
4001 4001 3991 3991
D.O.B: D.O.B: D.O.B: D.O.B:






















Take: Take: Take: Take:
12/04/00 5/05/00 22/04/00 26/04/00
Pair no: Pair no: Pair no: Pair no:
3991 3991 3991 3991
D.O.B: D.O.B: D.O.B: D.O.B:









12/04/00 17/06/00 22/04/00 22/04/00
Plug: Plug: Plug: Plug:
27/04/00 4/07/00 28/04/00 27/04/00
Take: Take: Take: Take:
10/05/00 23/07/00 19/05/00 20/05/00
Pair no: Pair no: Pair no: Pair no:
4021 4021 4011 3981
D.O.B: D.O.B: D.O.B: D.O.B:









19/03/00 9/05/00 12/04/00 11/04/00
Plug: Plug: Plug: Plug:
Cre+APC580s/580s
24/03/00 10/05/00 15/04/00 14/04/00
Take: Take: Take: Take:









D.O.B: D.O.B: D.O.B: D.O.B:
44 9/02/00 129 14/04/00 8 16/01/00 35 31/01/00
Mate@ Mate@ Mate@ Mate@
12/04/00 16/06/00 19/03/00 3/04/00
Plug: Plug: Plug: Plug:
13/04/00 22/06/00 21/03/00 4/04/00
Ta ke: Take: Take: Take:
26/04/00 8/07/00 11/04/00 26/04/00
Appendix C
5' - d(TTTTTTTTTTTTAA) - 3'
5' - d(TTTTTTTTTTTTGA) - 3'
5' - d(TTTTTTTTTTTTCA) - 3'
5' - d(TTTTTTTTTTTTAG) - 3'
5' - d(TTTTTTTTTTTTGG) - 3'
5' - d(TTTTTTTTTTTTCG) - 3'
5' - d(TTTTTTTTTTTTAC) - 3'
5' - d(TTTTTTTTTTTTGC) - 3'
5' - d(TTTTTTTTTTTTCC) - 3'
5' - d(TTTTTTTTTTTTAT) - 3'
5' - d(TTTTTTTTTTTTGT) - 3'
















Rl: 5'-d (GGAACTCCGT) -3'
R2: 5'-d (GGCAAGTCAC) -3'
R3: 5'-d (CCTCCGTAAG) -3'
R4: 5' -d (AGGACCGCTA) -3'
R5: 5'-d (CGGACCCCGG) -3'
R6: 5'-d (TAACTAACTC) -3'
R7: 5' -d (TACAACGAGG) -3'
R8: 5'-d (TGGATTGGTC) -3'
R9: 5' -d (TGGTAAAGGG) -3'
RIO: 5' -d (TCGGTCATAG) -3'
Rl 1: 5'-d (TACCTAAGCG) -3'
R12: 5' -d (CTGCTTGATG) -3'
Rl3: 5'-d (GATCTGACAC) -3'
R14: 5' -d (GATCGCATTG) -3'
Rl 5: 5'-d (GATCTGACTG) -3'
Rl 6: 5'-d (GATCTAAGGC) -3'
R17: 5' -d (GATCTAACCG) -3'
R18: 5' -d (GGAACCAATC) -3'
R19: 5' -d (CTTTCTACCC) -3'
R20: 5'-d (AGCCAGCGAA) -3'
Sox: 5'-d (GCGACCCATG) -3'
TK2: 5'-d (CTTGATTGCC) -3'
Max2: 5' -d (CACAGTTTGC) -3'
Max3: 5' -d (CCACAGAGTA) -3'
Amhl:5' -d (ACAGAGCACA) -3'
Amh2:5' -d (ACGTATCCAG) -3'
P3: 5'-d (GCCGTTGGAT) -3'
Reamplification Extended oligonucleotides (EcoRl sites):
d(T),2ext: 5' - d (GGGTCAGAATTCTTTTTTTTTTTT) - 3'
P3ext: 5' - d (GTCAGAATTCGCCGTTCCAT) -3'
P4ext: 5' - d (GTCAGAATTCAGGACCGCTA) -3'
Rl 7ext: 5' - d (GTCAGAATTCGATCTAACCG) -3'




Autoradiograph no. Primer combinations
DDRT-PCR gel 1: d(T)12MC and DM-6, DM-7
DDRT-PCR gel 2 d(T),2MC and DM-2, DM-3, DM-4
DDRT-PCR gel 3 d(T),2MC and DM-1, DM-5, DM-8, DM-9
DDRT-PCR gel 4 d(T),2MC and DM-8, DM-10, DM-11, DM-12
DDRT-PCR gel 5 d(T)12MC and DM-13, DM-14, DM-15, DM-16
DDRT-PCR gel 6 d(T),2MC and DM-17, DM-18, DM-19, DM-20
DDRT-PCR gel 7 d(T)12MC and A4, A5, A7, A8
DDRT-PCR gel 8 d(T),2MC and R2, R4, R5, R6
DDRT-PCR gel 9 d(T)12MC and SOX, MAX 1, MAX 2, DM-5
DDRT-PCR gel 10 d(T)i2MC and AMH1, AMH2, MAX 3, R20
DDRT-PCR gel 11 d(T)i2MC and DM-5, DM-6, DM-9, DM-15
DDRT-PCR gel 12 d(T)12MC and DM-10, A5, A7, A9
DDRT-PCR gel 13 d(T)12MC and DM-5, DM-20, R4, MAX 3
DDRT-PCR gel 14 d(T)i2MC and DM-20, R4, MAX 3, DM-5
DDRT-PCR gel 15 d(T)]2MC and DM-1, DM-7, DM-13, DM-14
DDRT-PCR gel 16 d(T),2MC and A7, A8, DM-9, DM-11















































































































B| = S SiIIPI '
Ippl
B


















. Aft n »~
■ B HI H PI ^ ''
« MM M MM
































M M M ^ M
- «■» m M M*














































































400 . 3np h *
«M JiliiBr- sat;







li L *ii i L
'U*
Sj ili U 4 - -
| tt|< t..
b < 1 i hh












































































































































(a) Ha oligonucleotide epitope tag
(57bp)
3' - TCG, TAC, CGT, ATG, GGG, ATG, CTA, CAG, GGT, CTG, ATA, CGC,
TCA, AAT, CCC, GGG, CCT, GGA, ATT - 5'
(18aa)
SMAYPYDVPDYASLGPGP stop
(b) Phagemid Cloning Vectors
272





































































Nsir HindIII Asp718I KpnI Eol136II SacI BamHl/Bstl SpeI EcoRl Pstl EcoRV NotI XhoI NsiI4 XbaI Drall ApaI
pBluescript II KS +
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Inactivation of Ape perturbs mammary development, but only directly
results in acanthoma in the context of Tcf-1 deficiency
Ronald CJ Gallagher2-36, Trevor Hay1, Valerie Meniel1, Catherine Naughton2,
Thomas J Anderson3, Hiroyuki Shibata4, Masaki Ito4, Hans Clevers5, Tetsuo Noda4,
Owen J Sansom1, John O Mason2 and Alan R Clarke*-1
'Department ofBiological Sciences, Cardiff University, Cardiff CF10 3US, UK; 2Department of Biomedical Sciences, University of
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Ape (adenomatous polyposis colt) encodes a tumour
suppressor gene that is mutated in the majority of
colorectal cancers. Recent evidence has also implicated
Ape mutations in the aetiology of breast tumours. Ape is
a component of the canonical Wnt signal transduction
pathway, of which one target is Tcf-1. In the mouse,
mutations of both Ape and Tcf-1 have been implicated in
mammary tumorigenesis. We have conditionally inacti¬
vated Ape in both the presence and absence of Tcf-1 to
examine the function of these genes in both normal and
neoplastic development. Mice harbouring mammary-
specific mutations in Ape show markedly delayed
development of the mammary ductal network. During
lactation, the mice develop multiple metaplastic growths
which, surprisingly, do not spontaneously progress to
neoplasia up to a year following their induction. However,
additional deficiency of Tcf-1 completely blocks normal
mammary development and results in acanthoma.
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1205892
Keywords: Ape; Tcf-1; mammary; acanthoma; ere
Introduction
The tumour suppressor gene adenomatous polyposis coli
(Ape) was first identified in the dominantly inherited
disorder familial adenomatous polyposis (FAP)
(Groden et al., 1991). This is characterized by the
development of multiple colorectal adenomas some of
which progress to carcinoma. It is now clear that Ape
is mutated in the vast majority of colorectal cancers,
both spontaneous and inherited (Fearnhead et al.,
2001). Ape encodes a very large protein of 2843 amino
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acids. Our understanding of the mechanisms by which
loss of Ape function leads to colon cancer is far from
complete. However, it is clear that one of the functions
of Ape lies in its regulation of the Wnt signalling
pathway. Wnts are secretory glycoproteins that have
important roles in the development of many tissues
(Cadigan and Nusse, 1997). Activation of the canonical
Wnt signalling pathway leads to the stabilisation of [1-
catenin, a multifunctional protein normally found in
adherens junctions. Ape forms part of a complex which
normally targets cytoplasmic /i-catenin for degradation
by the proteasome (Fearnhead et al., 2001; Polakis,
2000). In response to Wnt signals, stabilized cytoplas¬
mic /i-catenin translocates to the nucleus where it
interacts with members of the LEF/TCF family of
transcription factors (Roose and Clevers, 1999). Many
Ape mutations associated with neoplasia give rise to a
form of the protein unable to target /1-catenin for
ubiquitination and degradation, resulting in accumula¬
tion of nuclear /1-catenin. It is now commonly accepted
that the key tumour suppressor function of Ape lies in
its ability to destabilize free /i-catenin (Smits et al.,
1999; Bienz and Clevers, 2000). A number of genes
activated by this pathway have been identified,
including cyclin D1 (Tetsu and McCormick, 1999;
Shtutman et al., 1999), c-myc (He et al., 1998), PPA R8
(He et al., 1999) and Tcf-1 (Roose et al., 1999). Cyclin
D1 has recently been shown to be central to ras and
neu mediated mammary oncogenesis, although this
despondency apparently does not extend to pathways
driven by c-myc or Wntl (Yu et al., 2001). TCF
functions often depend on partner proteins and on
simultaneous signalling by other pathways. Thus, TCF
is believed to play a key role in integrating multiple
positional inputs (Bienz and Clevers, 2000). The
activation of Tcf-1 by /?-catenin/7c/-4 acts within a
feedback repressor pathway, whereby Tcf-1 isoforms
lacking a /J-catenin interaction domain bind to DNA
target sequences but fail to mediate gene activation.
Negative regulation by Tcf-1 may also involve
Groucho-related transcriptional repressors, as Tcf-1
has been shown to interact with Groucho proteins in
Xenopus (Roose et al., 1998, 1999).
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Overexpression of Wntl, Wnt3 and WntlOB genes in
the mammary epithelium promotes tumorigenesis
(Nusse and Varmus, 1982; Tsukamoto et al., 1988;
Lane and Leder, 1997); and stabilization of cytoplas¬
mic /J-catenin is critical for Wnt-mediated oncogenicity
(Shimizu et al., 1997). It has recently been shown by
two groups that mice overexpressing a mutant,
stabilized form of /i-catenin in the mammary gland
also develop tumours (Imbert et al., 2001; Michaelson
and Leder, 2001), although other workers have
reported that conditional mutation of /i-catenin can
lead to metaplasia, rather than neoplasia (Miyoshi et
al., 2002).
Mice deficient in Tcf-1 are viable and capable of
lactation, but acanthomas are reported to develop in
the females, with an earliest onset of 4 months and
with a peak incidence of 25% at 12 months of age
(Roose et al., 1999). Synergy has already been
demonstrated between mutations in Tcf-1 and Ape
through accelerated tumorigenesis on the Ape m
heterozygous background (Roose et al., 1999).
Although Wntl overexpression leads to tumour
development, Wntl itself is not normally expressed in
the mammary gland, suggesting that ectopically
expressed Wnt mediates its effect through receptors
for other Wnts that are normally expressed there. A
number of Wnts are expressed in dynamic patterns in
the mammary gland and some of these have been
shown to affect its normal development (Bradbury et
al., 1995; Brisken et al., 2000).
In the last few years, strong evidence of a link
between Ape mutation and human breast cancer has
begun to accumulate. First, loss of heterozygosity at
5q21 (the chromosomal location of human Ape) has
been observed in sporadic tumours of the breast
(Kashiwaba et al., 1994; Thompson et al., 1993).
Second, lost or reduced Ape protein expression has
been demonstrated in human breast cancers (Ho et al.,
1999; Schlosshauer et al., 2000). Third, the Ape I1307K
polymorphism has been shown to increase the risk of
breast cancer in association with BRCA founder
mutations (Woodage et al., 1998). Fourth, a recent
study has demonstrated the presence of somatic Ape
mutations in 18% of primary breast cancers of a range
of histological types (Furuuchi et al., 2000). Interest¬
ingly, the mutations reported by Furuuchi et al. (2000)
are scattered throughout the Ape coding region and
not confined to the mutation cluster region (MCR)
defined by Ape mutations found in colon tumours.
Finally, it has now been shown that the Ape promoter
is frequently hypermethylated in breast cancers (Jin et
al., 2001). Of note, this study was performed over a
range of histological classes of primary breast cancer,
with no clear association reported between histological
type and methylation status.
Mice homozygous for inactivating mutations in Ape
(such as Ape '") die at an early embryonic stage
(Moser et al., 1995). Heterozygous mice are viable, but
prone to the development of intestinal adenomas and
mammary carcinomas (Moser et al., 1993). Homo¬
zygous lethality therefore precludes the direct analysis
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of the developmental role of Ape in adult organ
systems. In order to analyse the role of Ape both in the
development of the mammary gland and in mammary
tumorigenesis, we have used a cre-loxP based strategy
(Gu et al., 1994) to conditionally inactivate Ape. We
have also investigated the interaction between Ape and
Tcf-1 deficiency by subsequently crossing onto a Tcf-1
null background. Here we report that deficiency of Ape
perturbs development and leads to metaplasia, and that
combined deficiency of Ape and Tcf-1 blocks normal
mammary gland development and results directly in
acanthoma formation.
Results
Mammary gland specific inactivation of Ape
Mice homozygous for a /oxP-flanked ('floxed') exon 14
Ape have previously been shown to develop normally.
These were designated Apc580s/5S0s, where 's' denotes
silent mutation. Cre-mediated excision of the floxed
exon 14 leads to a frameshift mutation at codon 580, in
the region of the armadillo repeats. These mice
developed adenomas within 4 weeks when ere
recombinase was introduced to the colorectal region
via infection with an adenovirus encoding the
recombinase (Shibata et al., 1997). To examine the
role played by Ape in mammary gland development we
used a transgenic approach where the ere gene is under
the control of the ovine /i-lactoglobulin enhancer
(BLG-cre). This transgene has previously been shown
to induce very efficient excision of floxed DNA
molecules in mice (Selbert et al., 1998; Chapman et
al., 1999).
We generated mice homozygous for the floxed Ape
allele (Apc580s/580s) and carrying the BLG-cre transgene.
All mice so far generated have developed normally
with litter sizes being similar between cre+ Apc580s/580s,
cre+ Apc580s/+ and ere- A^c.58<)s/580s females. Numbers
of male and female offspring have shown no bias
towards either sex from control versus experimental
strains. However, it was noted that offspring from the
cre+ Apc580s/580s mothers did not thrive.
As a sensitive measure of ere recombinase activity in
the epithelium of virgin glands, we crossed our BLG-
cre transgenic animals to the ere ROSA reporter strain
(Soriano, 1999). Virgin mammary glands were removed
from double transgenics and stained for /i-galactosi-
dase activity (Figure 1). Wholemount and histological
analysis of these glands showed widespread and highly
efficient recombination throughout the epithelium of
the virgin gland. By day 10 of lactation the level of
recombination as scored by the reporter strain rose to
nearly 100% of epithelial cells (Figure 1). This analysis
reflects the efficiency of ere mediated recombination at
a single lox flanked allele.
Despite the very high levels of recombination
indicated by the reporter strain and previous high
levels of recombination obtained at other loci using
this strain (Chapman et al., 1999; Selbert et al., 1998),
densitometric analysis of Southern blots showed only
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Figure 1 The pattern of Cre-mediated recombination as scored using the flox-STOP Rosa 26 reporter strain, where LacZ positivity
indicates ere mediated recombination: (a) 8 week old virgin gland transgenic for the BLG-cre transgene and for the reporter con¬
struct (x 4 magnification). Inset shows an age matched control virgin (BLG-cre negative, reporter construct positive, x 1 magnifica¬
tion) within which no LacZ staining was evident at either high or low power; (b) medium power (x 30 magnification) of detail in (a)
showing a mosaic pattern of recombination within duct termini); (c) Cre mediated recombination at full lactation, low power photo¬
graph of an entire BLG-cre positive, reporter construct positive gland. No LacZ staining was observed in control glands, (d) High
power (x 400) of a 5 gm section showing recombination in alveoli derived from (c); (e) High power (x 400) of a 5 ^m section show¬
ing recombination in a duct derived from (a); (f) High power ( x 200) of a 5 /rm section showing no recombination in a duct derived
from control mice
approximately 30% of entire mammary gland DNA
from cre + . Apc580s/S80s had undergone cre mediated
recombination at day 10 of lactation (unpublished
data). This reduced level of recombination may reflect
relatively inefficient recombination at the Ape allele, the
requirement for two recombination events within each
cell or the effect of inclusion of non-epithelial cells
(Southern analysis was performed on entire mammary
glands, inclusive of lymph nodes). If, indeed, the low
level of recombination directly reflects low efficiency
recombination, this would predict a high incidence of
heterozygous Ape mutant cells within the gland, and
rather small numbers of homozygous mutant cells. We
favour a second possibility, namely that of efficient
recombination at the Ape allele, but subsequent strong
selection against the recombined cells during mammary
gland development, possibly mediated by apoptotic
deletion of the recombined cells. We are currently
investigating this possibility within our model.
Ape is required in virgin mammary gland
To investigate any potential role for Ape in the virgin
gland, we examined wholemount mammary gland
preparations from virgin animals. The extent of ductal
growth of mammary glands from cre+ Apc580s/5S0s
mice was markedly delayed when compared with
littermate control genotypes (Figure 2), consistent
with a role for Ape in the normal growth of the
gland. Although delayed in development, mutant
glands appeared otherwise normal, showing neither
the increased branching observed in MMTV-WTztf
transgenic mice (Tsukamoto et al., 1988; Imbert et al.,
2001) or the precocious lobulo-alveolar development
seen in MMTV-AN89/i-catenin mice (Imbert et al.,
2001).
Loss ofApe leads to mammary gland metaplasia
We next analysed the consequence of Ape disruption
during lactation. Histological examination of day 10
lactating mammary glands from cre+ ^pc580s/580's
mice revealed extensive metaplastic nodules through¬
out each mammary gland examined. This phenotype
was 100% penetrant, being observed in all glands in
all mice examined. The nodules consist of tightly
bound balls of epithelial cells emanating from ducts,
which transdifferentiate into squamous cells (Figure
30- Small areas of similar appearance were found in
virgin mammary sections (Figure 3b). Immunohis-
tochemistry was performed to confirm that these
areas arose following loss of Ape function using a c-
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Figure 2 Growth of the mammary ductal network is delayed in cre+ Apc5SOsl5ms animals. A minimum of three mice were analysed
for each genotype at each time point and representative photographs taken. Wholemount mammary preparations from cre+
Apc5SOsl+ animals (a,c,e,g,i) and cre+ Apc5S0s/ littermates (b,d,f,h,j). Growth of the ductal network initiates at the nipple end
of the mammary fat pad (left) and progresses past the lymph node (LN) to completely fill the pad. The tip of the growing ductal
network is marked by an arrow. Virgin glands shown are 4 weeks (a,b), 6 weeks (c,d), 8 weeks (e,f) and 12 weeks (g,h). (i) shows a
70 day control mammary at parturition and (j) shows a 70 day experimental mammary at parturition. Note that at this time point,
despite the mammary having developed lobular alveolar structures, ductal growth has failed to reach the end of the fat pad. Ana¬
lyses of older cre+ ^c5805'5"08 mice show that ductal growth does eventually succeed in reaching the end of the fat pad
terminal Ape antibody. This analysis confirmed loss
of Ape specifically within the tightly bound balls of
epithelial cells (see Figure 6g,h) Ductal structures in
mutant mammary glands appeared disorganized and
papillary growth occurs into ducts (Figure 3g).
Figure 3h shows a section of normal ductal
epithelium with a secretory lobule apparently devel¬
oping from it that shows prominent squamous
metaplasia. We observed keratohyaline granules, the
hallmark of keratinizing squamous differentiation
(Figure 4a), although more often we noted an
eosinophilic material deriving from non-keratinizing
squamous differentiation (Figures 3f and 4c). This
material was frequently seen to form areas which
contained no nuclei, but which were characterized by
open spaces (Figure 4c).
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Figure 3 Mammary glands of cre+ Apc5SOsl5SOs animals contain metaplastic lesions. At each time point a minimum of three animals
were scored of each genotype and representative photographs taken. Haematoxylin and eosin stained sections of mammary glands
from cre+ Apc5SOs,+ (a,c,e) and cre+ ^4/>c580s S80s (b,d,f,g,h) animals, examples of metaplastic areas are indicated by arrows: (a,b), 8
week old virgin glands; (c,d) mammary glands at parturition; (e,f), mammary glands at day 10 of lactation; (g), a section from a
mutant mammary gland at day 10 of lactation showing metaplastic areas extending into the lumen of the duct; (h), shows what
would presumably have been a secretory lobule developing away from a duct
The number of metaplastic nodules increased during
lactation, with least evidence of the phenotype at
parturition (Figure 3d). By day 10 of lactation,
multiple foci were apparent (Figure 3f). To investigate
if the mammary metaplasias would revert to normal
tissue, we examined glands that had undergone
postlactational involution. We found that the area of
metaplasia remain after involution and increased in
number and extent after two lactation cycles (Figure
5), but that no progression to neoplasia occurred. Mice
have been allowed to pass through up to four complete
lactation cycles, however, we have not observed
progression to neoplasia up to 1 year following the
initial lactation cycle (n = 10).
Characterization of the metaplastic lesions
In order to investigate whether the metaplastic areas
were composed of cycling cells, we assessed which cells
were in S phase by the use of BrdU labelling. In
contrast to the acinar epithelial cells, the parabasal
cells in the metaplastic units were frequently found to
be cycling (Figure 6b). Histological analysis revealed
frequent apoptosis within areas associated with the
maturing squamous cells, but not in the mature
squamous epithelium (Figure 4b). TUNEL analysis
confirmed the presence of apoptosis, but also showed
the mature squamous cells to be weakly TUNEL
positive (Figure 4d). This latter observation may reflect
a process of anucleation within these cells, which
Oncogene
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Figure 4 Histological analysis of metaplastic lesions: (a) Keratohyaline granules in squamous cells associated with metaplasia (ar¬
rowed); (b) apoptosis (examples indicated by arrows); (c) eosinophilic area, apparently the result of extensive cell death - example
ghosts of nuclei are marked by the arrows; (d) TUNEL analysis, identifying weakly TUNEL positive cells within an area of squa¬
mous cells
ultimately results in the formation of 'ghost' nuclei and
open spaces.
To examine whether /1-catenin is dysregulated in
these metaplasias, we used immunohistochemistry to
examine the localization of /(-catenin in mammary
tissue. The balls of metaplastic squamous epithelium
stain strongly for /3-catenin throughout the cell
cytoplasm and nucleus (Figure 6d), whereas normal
mammary acinar epithelium stains only at the cell
membrane where /i-catenin is found in adherens
junctions (Figure 6c). Little or no expression of ji-
catenin was observed in the mature squamous
epithelium (Figure 6b,d). We analysed expression of
cyclin D1 and c-myc, two of the putative target genes
activated by the /1-catenin-TCF/LEF pathway. We
found increased levels of cyclin D1 could be detected
in the balls of epithelial cells (Figure 6f), but could not
show upregulation of c-myc by immunohistochemistry
(data not shown).
Synergy between the ApcJSfe mutation and Tcf-1
deficiency
Tcf-1 deficient mice have previously been reported to
develop acanthoma, with earliest onset of 7 months
and with approximately 15% penetrance by 12
months (Roose et al., 1999). This phenotype is
accelerated on the ApcMm background, resulting in
acanthoma development as early as 2 months of age
(Roose et al., 1999). To address the extent of synergy
between Ape and Tcf-1 in our model, we crossed the
floxed Ape allele onto a Tcf-1 null background.
Female mice which were BLG-cre positive and
homozygous for both the floxed Ape allele and the
null Tcf-1 allele were examined at between 3.5 weeks
and 8 weeks of age (Figure 7). At all ages no normal
mammary epithelium was observed, with each gland
in every mouse analysed (n = 6) being replaced by
adenoacanthoma. No tumours have been observed in
age matched Tcf-1 +/ + , Cre+ Apc580s/580s littermates
derived from this cross. These results therefore show
that absence of both genes absolutely blocks the
normal programme of mammary development and
directly results in acanthoma. The very rapid onset of
neoplasia in the absence of both genes is particularly
remarkable given the level of recombination reported
by the lacZ reporter strain. This phenotype presum¬
ably reflects very rapid outgrowth from cells marked
by early recombination.
Discussion
A role for Ape in virgin mammary gland
We have conditionally inactivated Ape in mammary
epithelium and found that functional Ape is required
for the normal growth of virgin mammary glands.
Mutant glands grow more slowly than controls
(Figure 2) but do ultimately reach the end of the fat
pad. In driving ere expression from the promoter of a
milk protein gene, we anticipated that the effects of
cre-mediated Ape deletion would be found primarily
Oncogene
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Figure 5 Metaplastic lesions remain in mutant glands during and following involution, and accumulate with subsequent pregnan¬
cies. The upper panels (a-d show wholemounts of mammary glands during and following postlactational involution: (a) control
animal at day 14 of involution; (b) cre+ ^c580s'580s animal at day 14 of involution; (c) 150 day old cre+ Apc5S0s/580s animal after
one pregnancy; (d) 150 day old cre+ /(/>cS80s'580s animal after two pregnancies. The lower panels (e-h) show haematoxylin and eosin
stained sections of mammary glands from the same animals shown in (a-d)
in the lactating mammary gland. Crossing the BLG-
cre mice to a reporter strain demonstrated the
presence of substantial ere activity in virgin glands
(Figure 1). Thus, the discovery of a phenotype in
virgin gland is not wholly unexpected. Growth
retardation is perhaps a surprising consequence of
loss of Ape, as this is more commonly associated with
increased cell proliferation (and indeed we demon¬
strate here increased proliferation in the absence of
Ape - see Figure 6). One potential explanation of this
apparent paradox comes from the observation that
Ape binds cytoskeletal components - both the actin
cytoskeleton and microtubules (Fearnhead et al.,
2001). Thus, disruption of the cytoskeleton in the
absence of Ape could lead to a decreased ability of the
tip of the growing duct to invade or grow through the
fat pad. Consistent with this, Imbert et al. (2001)
report a mild retardation in ductal extension in mice
overexpressing AN89/l-catenin, a mutant stabilized
form of /i-catenin lacking the N-terminal 89 amino
acids - N-terminal deleted /1-catenin has been
suggested to interfere with Ape's ability to bundle
microtubules at the tips of cell extensions (Nathke et
al., 1996; Pollack et al., 1997).
Several Wnt genes are expressed in the postnatal
mammary gland, and these are thought to be
involved in its morphogenesis. For example, Wnt4
acts downstream of the progesterone receptor to
induce side-branching in the mammary epithelial
ductal network during early pregnancy (Brisken et
al., 2000). Overexpression of certain Wnt genes or
stabilized mutant /1-catenin affects morphogenesis of
Oncogene
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Figure 6 Cell proliferation and expression of /?-catenin and cyclin D1 and Ape are disrupted in metaplastic areas of mutant glands.
The left hand panels (a,c,e) show sections from cre+ Apc5S0s/+ control tissue. The right hand panels (b,d,f) show sections from cre +
Apc5Ws,5SOs mutant tissue. (a,b) BrdU labelling. Note the increased number of BrdU labelled cells (arrows) in the acinar epithelial
cells of the mutant gland. (c,d) /?-catenin immunohistochemistry on day 10 lactation mammary tissue. In control tissue (c) /J-catenin
is detected in the adherens junctions (example arrowed) but not in the nuclei. In mutant glands (d) /I-catenin is found in the ad¬
herens junctions of normal epithelium (arrow, top left), but also in the nuclei of basal cells and within metaplastic cells within
epithelial balls (arrow, bottom right). (e,f) Cyclin D1 immunohistochemistry on day 10 lactation tissue. Arrows indicate cyclin
D1 positive cells. Again, these are increased in the mutant and localized to the parabasal regions. (g,h) Immunohistochemical ana¬
lysis of Ape expression in (g) wild type glands, showing expression of Ape within the alveoli: note this staining appears predomi¬
nantly cytoplasmic, although it is concentrated towards the apical surface; (h) Failure to stain for Ape within the tightly bound balls
of epithelial cells characteristic of the metaplasias
the mammary ductal network. Mice overexpressing
Wntl or WntlOB in the mammary gland exhibit
ductal hyperbranching and increased lobuloalveolar
development (Tsukamoto et al., 1988; Lane and
Leder, 1997), whereas mammary expression of
AN89/i-catenin leads to inappropriate lobuloalveolar
development in virgin glands (Imbert et al., 2001). In
our mice, loss of Ape leads to reduced ductal growth,
but there are no comparable morphological effects to
those described above (Figure 2). Possible explana¬
tions for these apparent discrepancies are discussed
below.
Metaplasia as a consequence of loss of Ape
Cre4 Apc5HOySHOs animals develop numerous small
areas of metaplasia in the ductal epithelium (Figure
3b). Pregnancy in these mice results in multiple
metaplastic foci, none of which has so far progressed
to neoplasia. Although we do not observe tumorigen-
esis, many of the histological features we report here
resemble those observed in adenosquamous carcino¬
mas, as defined by the Annapolis meeting (Cardiff et
al., 2000), however the multiple intraduct squamous
papillomas reported here are novel. These results show
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Figure 7 The effects of conditional mutation of Ape in a Tcf-1 deficient background: (a) Wholemount of example gland showing
acanthoma. No glands were found with normal arechitecture; (b) Representative acanthoma histology (haematoxylin and eosin
stained, x 200); (c) the pattern of /J-catenin expression in the acanthomas
that Ape controls the structural development and
differentiation state of the gland, processes at least
partly mediated through /i-catenin and cyclin Dl. We
also show that additional loss of Tcf-1 transforms this
phenotype by directly promoting acanthoma develop¬
ment, which strongly argues that Tcf-1 and Ape act in
consort to maintain the normal differentiation
programme.
Ape mutation is associated with mammary tumor-
igenesis in both human (Woodage et al., 1998;
Furuuchi et al., 2000) and mouse (Moser et al.,
1993), most likely as a consequence of increased f>-
catenin stability. Hyperplasia and malignant transfor¬
mation has previously been reported in mouse
mammary epithelium when Wntl, WntlOB or
truncated forms of /1-catenin (both AN89 and AN90
mutants) are overexpressed (Tsukamoto et al., 1988;
Edwards et al., 1992; Imbert et al., 2001; Michaelson
and Leder, 2001), again most likely as a result of
increased (i-catenin levels. This contrasts with the
apparent failure to observe malignancy in the absence
of Ape in our model (at least at high frequency
considering the high number of Ape deficient cells
present within the postlactational gland). There are
subtle differences in the experimental paradigms that
make direct comparisons difficult; however, in the
single absence of Ape, although this leads to fl-
catenin stabilization (and accompanying high levels of
cyclin Dl) within areas of metaplasia, no tumours
are seen.
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Thus, in both the virgin gland and during pregnancy
and lactation, the effects of inactivating Ape appear to
differ from the effects of ectopic Wnt signalling or
overexpression of stabilized /i-catenin. There are
several possible explanations for these apparent
differences. First, the transgenes may be expressed in
different cell types. The adult mammary gland contains
a population of stem cells that are able to give rise to
complete, functional mammary glands (Kordon and
Smith, 1998) and it has been suggested that MMTV-
induced mammary tumours arise from infection of
these stem cells (Callahan and Smith, 2000). Thus, one
possibility was that the BLG promoter was failing to
drive deletion of the Ape gene within those stem cells
that can give rise to tumours. Clearly, our results from
the Tcf-1 intercross show that this is not the case, as
the BLG promoter is clearly driving loss of Ape in cells
which can be the founders of tumours.
Second, levels of /i-catenin may be critical. Different
levels of /i-catenin might determine whether mammary
ductal development proceeds normally, or whether
hyperbranching or precocious lobuloalveolar develop¬
ment occurs instead. Further, there may be a threshold
level of /I-catenin above which tumorigenesis is
triggered. This explanation fits well with the reported
failure to observe tumorigenesis following ere mediated
mutation of /i-catenin (Miyoshi et al., 2002), as this
model does not rely on over expression of mutant /?-
catenin. In our model, one might argue that single
deficiency of either Ape or Tcf-1 is insufficient to result
in complete deregulation of /i-catenin levels, but that
this occurs in the absence of both genes. Alternatively,
transcriptional activity may be regulated by the ratio of
/i-catenin to Tcf-1. Both of these explanations imply
that /i-catenin levels are a critical determinant of
activity. In contrast to this view, Imbert et al. (2001)
have argued that /i-catenin levels are not relevant, as
both high and low-expressing lines of their MMTV-
AN/f-catenin transgenic mice display the same pheno-
type, with low expressors showing a longer latency.
However, given that expression of endogenous /i-
catenin is downregulated in these animals, and that
even the low expressing line produces around threefold
more /i-catenin from the transgene than the endogen¬
ous locus, it is difficult to draw clear conclusions about
/i-catenin levels from these experiments.
Third, mutant forms of /i-catenin may have different
properties to wild type /i-catenin. As described above,
MMTV-AN/i-catenin transgenic mice develop
mammary adenocarcinomas (Imbert et al., 2001;
Michaelson and Leder, 2001) /i-catenin has a cluster
of putative phosphorylation sites for GSK3/I in its
amino terminal region. Phosphorylation at these sites
results in targeting of the protein for proteasomal
degradation. Deletion of the amino-terminal 89 amino
acids of /i-catenin results in the loss of these sites,
thereby generating a stable mutant protein. However,
deletion of either the 89 or 90 N-terminal amino acids
may affect more than /i-catenin stability. Guger and
Gumbiner (2000) have shown that amino acid
alterations at the amino terminus of /i-catenin affect
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signalling independent of any effect on /i-catenin levels.
Furthermore, /i-catenin is thought to be required for
the formation of a stable complex between the nemo¬
like kinase (NLK) and TCF/LEF (Ishitani et al., 1999).
The effects of both AN90 /i-catenin AN89 /i-catenin
overexpression could be due to disruption of such an
interaction. This hypothesis fits well with our observed
synergy between the Tcf-1 and Ape mutations.
Fourth, it is well recognized that susceptibility to
mammary hyperplasias and carcinomas in Apcmm/ +
mice is influenced by genetic background (Moser et al.,
2001). However, our animals are on a mixed genetic
background, and therefore our failure to observe
neoplasia is unlikely to be a reflection of a single
resistant background. Furthermore, the dramatic
increase in spontaneous tumorigenesis in the additional
absence of Tcf-1 demonstrates that the background we
are using is permissive for tumorigenesis.
Finally, the nature of the mutation at the Ape allele
may determine final phenotype. There are phenotypic
differences among the different Ape alleles described to
date. Cre-mediated deletion of Apc580s in colonic
epithelium leads to the efficient formation of adeno¬
carcinomas (Shibata et al., 1997). However, we find no
(or very low penetrance) tumorigenesis when the same
mutation is specifically targeted to the mammary
gland, although mutation of Ape in the context of
Tcf-1 deficiency does directly lead to neoplasia. Thus
mammary and colonic epithelia appear to respond
differently following Ape mutation. Perhaps the
mammary epithelium requires higher levels of /i-catenin
for malignant transformation, or perhaps some Apc-
independent method of /i-catenin regulation (such as
by feedback repression by Tcf-1) is found in the
mammary gland. Mutations in different parts of the
Ape protein can give rise to different phenotypes,
however, in this case the same allele (Ape5 0s) appears
to have different effects in different tissues.
We observe increased expression of cyclin Dl, a
putative target of /I-catenin in mutant glands. Studies
of human breast cancer have reported that /I-catenin
mediates upregulation of cyclin Dl (Lin et al., 2000),
and that cyclin Dl expression is associated with
metastasis (Buckholm et al., 2000). Further, mice
expressing cyclin Dl under the control of the MMTV
LTR develop mammary adenocarcinomas (Wang et al.,
1994) and cyclin Dl deficiency has been shown to
block ras and neu mediated (but critically not Wnt
mediated) mammary tumorigenesis. The implication
from these studies is that elevated levels of cyclin Dl
can be potent in driving neoplasia. In our model high
levels of both /i-catenin and cyclin Dl were observed,
but these were clearly associated with metaplasia and
not neoplasia. It will be of great interest to study the
phenotype of the Ape and Tcf-1 mutants in the
additional absence of cyclin Dl.
In conclusion, we propose a model whereby loss of
Ape within mammary epithelial cells leads to dysregu-
lated growth, as a consequence of which cells adopt a
transdifferentiation programme to non-cycling squa¬
mous epithelial cells. Dysregulation of /I-catenin
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characterizes these areas of metaplasia. In the presence
of functional Tcf-1, this process either fails to lead to
neoplasia or does so at very low efficiency. In contrast,
combined loss of Tcf-1 and Ape dramatically blocks
normal mammary development and results in the direct
formation of acanthoma. As we know that deficiency
of Ape (from studies of the ApcMm mouse) can
predispose to acanthoma these results therefore
strongly implicate loss of Tcf-1 as a secondary event
in this process. Investigation of the mechanism under¬
lying these findings should yield valuable insights into
the normal functions of Ape and Tcf-1 in the
mammary gland, and also into their role in suppressing
neoplasia within this tissue.
Materials and methods
Genotyping ofmice
Detection of Ape and Tcf-1 alleles was carried out by PCR as
previously described (Shibata et al., 1997; Roose et al., 1999).
The BLG-cre transgene was detected using the PCR also
previously described (Selbert et al., 1998). Mice were
maintained on an outbred genetic background segregating
for C57B1/6, 01al29 and C3H genomes and therefore where
direct comparisons were performed these were made between
littermates.
Mammary gland wholemount
This procedure was carried out as described on the mammary
gland website: http://mammary.nih.gov.
Tissue sections and immunohistochemistry
Five pm sections were cut from paraffin embedded tissue
retrieved at necropsy. For control tissue, lung, liver, pancreas,
salivary gland, spleen and kidney were taken. Control tissues
were stained with haematoxylin and eosin and examined, no
dysregulated growth or histological abnormalities were
found. Immunohistochemistry was carried out using the
DAKO EnVision plus system (cat. no. K4006) following the
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